KinKin的个人主页 - 老虎社区

KinKin

KinKin

暂无个人介绍

IP属地：未知

520关注

15粉丝

0主题

0勋章

2021-05-07

Pls like & comment Thank you

抱歉，原内容已删除

2021-04-27

Boom.!

Tesla posts record net income of $438 million, revenue surges by 74%<blockquote>特斯拉净利润创纪录4.38亿美元营收暴增74%</blockquote>

2021-06-18

Get your post featured? What’s that means.?

Dow drops 400 points at the open, extending losses in its worst week since January<blockquote>道琼斯指数开盘下跌400点，延续1月份以来最糟糕的一周跌幅</blockquote>

2021-05-14

Buy buy buy

抱歉，原内容已删除

2021-04-29

Need ur like & comment

NIO Q1 2021 Earnings Report Preview: What to Look For<blockquote>蔚来2021年第一季度收益报告预览：寻找什么</blockquote>

2021-11-29

Hi

Spotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify股票：逢低买入10月初的水平？</blockquote>

2021-09-28

Hi

Cannabis stocks jumped in Monday morning trading<blockquote>大麻股周一早盘上涨</blockquote>

2021-05-15

Pls like & comment

Why AMC Entertainment Stock Jumped Again Friday<blockquote>为什么AMC院线股价周五再次上涨</blockquote>

2021-06-08

Pls comment. Thank you

抱歉，原内容已删除

2021-05-15

Pls like & comment

Delta Mandates All New Employees Must Have COVID-19 Vaccinations<blockquote>达美航空要求所有新员工必须接种COVID-19疫苗</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3574428256060280","uuid":"3574428256060280","gmtCreate":1611334232605,"gmtModify":1613355334024,"name":"KinKin","pinyin":"kinkin","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":15,"headSize":520,"tweetSize":277,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.14%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":693007445,"gmtCreate":1639920441087,"gmtModify":1639920441277,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693007445","repostId":"2192035909","repostType":4,"isVote":1,"tweetType":1,"viewCount":4211,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690219638,"gmtCreate":1639668882052,"gmtModify":1639669004700,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690219638","repostId":"2191453039","repostType":4,"isVote":1,"tweetType":1,"viewCount":3948,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605853928,"gmtCreate":1639147282871,"gmtModify":1639147283089,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605853928","repostId":"1148141788","repostType":4,"repost":{"id":"1148141788","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639147224,"share":"https://www.laohu8.com/m/news/1148141788?lang=zh_CN&edition=full","pubTime":"2021-12-10 22:40","market":"us","language":"en","title":"Vaccine stocks dropped in morning trading<blockquote>疫苗股早盘下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1148141788","media":"Tiger Newspress","summary":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","content":"<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech&nbsp;and&nbsp;Novavax&nbsp;fell&nbsp;between 2% and 11%.</p><p><blockquote>疫苗股早盘下跌。Moderna、BioNTech和Novavax跌幅在2%至11%之间。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks dropped in morning trading<blockquote>疫苗股早盘下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks dropped in morning trading<blockquote>疫苗股早盘下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-10 22:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech&nbsp;and&nbsp;Novavax&nbsp;fell&nbsp;between 2% and 11%.</p><p><blockquote>疫苗股早盘下跌。Moderna、BioNTech和Novavax跌幅在2%至11%之间。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148141788","content_text":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","news_type":1,"symbols_score_info":{"NVAX":0.9,"BNTX":0.9,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":3383,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601457892,"gmtCreate":1638550394827,"gmtModify":1638550394958,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601457892","repostId":"1158981658","repostType":4,"isVote":1,"tweetType":1,"viewCount":3224,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600765168,"gmtCreate":1638198782315,"gmtModify":1638198822415,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600765168","repostId":"1180693909","repostType":4,"repost":{"id":"1180693909","kind":"news","pubTimestamp":1638198357,"share":"https://www.laohu8.com/m/news/1180693909?lang=zh_CN&edition=full","pubTime":"2021-11-29 23:05","market":"us","language":"en","title":"Spotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify股票：逢低买入10月初的水平？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1180693909","media":"TheStreet","summary":"Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the","content":"<p>Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the move as bearish, while others could find it an opportunity to buy SPOT cheaper.</p><p><blockquote>继第三季度后盈利飙升后，Spotify股价在11月份失去了大量动力。一些人可能认为此举是看跌的，而另一些人可能会发现这是一个以更便宜的价格购买现货的机会。</blockquote></p><p> In late October, Spotify&nbsp;announced third quarter results. The numbers excited investors and sent Spotify stock&nbsp;up nearly 15% quickly. The key metric supporting bullishness was the large increase in the platform's MAUs (monthly active users) over the previous year, followed by an almost 30% YoY growth in revenue.</p><p><blockquote>10月下旬，Spotify公布了第三季度业绩。这些数字令投资者兴奋不已，并使Spotify股价迅速上涨近15%。支持看涨的关键指标是该平台的MAU（月活跃用户）较上一年大幅增长，随后收入同比增长近30%。</blockquote></p><p> However, almost a month after the earnings announcement, shares have dipped 10% and returned to the same levels of early October. Today, MavenFlix tries to make sense of what is happening with SPOT, and debates whether the recent drop can be considered a buying opportunity.</p><p><blockquote>然而，财报公布近一个月后，股价已下跌10%，回到10月初的水平。今天，MavenFlix试图了解SPOT的情况，并讨论最近的下跌是否可以被视为买入机会。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1a76b6dc048e3702eb0b6ef48bbc0409\" tg-width=\"1240\" tg-height=\"698\" width=\"100%\" height=\"auto\"><span>Figure 1: Spotify app icon.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：Spotify应用程序图标。</span></p></blockquote></p><p> <b>Recent downfall and a future opportunity</b></p><p><blockquote><b>最近的失败和未来的机会</b></blockquote></p><p> SPOT hit $205 per share in August and, since then, embarked on a strong bullish ride to six-month highs. However, in November, not long after the announcement of the company's third quarter results, Spotify stock dropped from a high of $300 to less than $250.</p><p><blockquote>现货在8月份触及每股205美元，此后开始强劲看涨，升至六个月高点。然而，11月，在公司第三季度业绩公布后不久，Spotify股票就从300美元的高点跌至250美元以下。</blockquote></p><p> One of the possible causes for such decline is profit taking. If so, an opportunity to buy the dip could exist for those who like the fundamentals of the company, but that believed SPOT may have been too expensive or overvalued. Today, Spotify is trading at the lowest price in the last 3 months.</p><p><blockquote>这种下跌的可能原因之一是获利了结。如果是这样的话，对于那些喜欢该公司基本面但认为现货可能太贵或估值过高的人来说，可能存在逢低买入的机会。今天，Spotify的交易价格是过去3个月来的最低价格。</blockquote></p><p> <b>Podcast growth and ad revenue</b></p><p><blockquote><b>播客增长和广告收入</b></blockquote></p><p> Unlike what many might think, Spotify is not merely a music platform, but an audio one. Therefore, one should not only consider growth in the music streaming space when calculating the fair value of the stock.</p><p><blockquote>与许多人的想法不同，Spotify不仅仅是一个音乐平台，还是一个音频平台。因此，在计算股票的公允价值时，不应只考虑音乐流媒体领域的增长。</blockquote></p><p> As we discussed in “Spotify Earnings: Why The Stock Spiked On Q3 Results”, one of the most relevant growth drivers for Spotify today is podcast. This sub-segment of streaming audio is expanding fast and could become a substantial part of the company's P&amp;L in the foreseeable future.</p><p><blockquote>正如我们在“Spotify收益：为什么该股在第三季度业绩中飙升”中讨论的那样，当今Spotify最相关的增长动力之一是播客。流媒体音频的这一细分市场正在快速扩张，在可预见的未来可能成为公司损益的重要组成部分。</blockquote></p><p> With ad-supported accounts growing at the same rate as paid users, monetizing on podcasts is a key next step for Spotify. We think that this could be a catalyst pushing Spotify stock higher in the future – even if not in the next few weeks or months.</p><p><blockquote>随着广告支持的账户以与付费用户相同的速度增长，通过播客赚钱是Spotify的下一步关键。我们认为这可能是未来推高Spotify股价的催化剂——即使不是在未来几周或几个月内。</blockquote></p><p> <b>Spotify dominates audio streaming</b></p><p><blockquote><b>Spotify主导音频流</b></blockquote></p><p> Spotify has one of the largest music libraries. However, we do not think that this sets the company apart from its competitors. Apple and Amazon, for example, continue to invest their bottomless piles of cash to boost their platforms’ content offerings as well.</p><p><blockquote>Spotify拥有最大的音乐库之一。然而，我们并不认为这使该公司从竞争对手中脱颖而出。例如，苹果和亚马逊也继续投入大量现金来增加其平台的内容产品。</blockquote></p><p> What makes Spotify stand out, in our view, is its footprint in audio streaming. Despite the growth prospects, the market is still concentrated in the hands of few players, unlike what happens in video streaming. Spotify has clear market dominance, as the chart below depicts.</p><p><blockquote>在我们看来，Spotify之所以脱颖而出，是因为它在音频流领域的足迹。尽管有增长前景，但市场仍然集中在少数玩家手中，这与视频流媒体的情况不同。如下图所示，Spotify拥有明显的市场主导地位。</blockquote></p><p> The investments in podcasts should only help Spotify to establish itself at the top for years to come. Currently, there are about 2.6 million podcast titles available on the platform.</p><p><blockquote>对播客的投资应该只会帮助Spotify在未来几年确立自己的地位。目前，该平台上大约有260万个播客标题。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ab561adf751b756fe06b8fa8d2bff0ee\" tg-width=\"609\" tg-height=\"458\" width=\"100%\" height=\"auto\"><span>Figure 2: Music streaming market share.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：音乐流媒体市场份额。</span></p></blockquote></p><p> <b>Our view</b></p><p><blockquote><b>我们的观点</b></blockquote></p><p> After Spotify stock dropped more than 10% since the beginning of November, a window of opportunity may have opened for those who appreciate Spotify's business model. Buying SPOT today, however, may only prove to be a good long-term strategy, since volatility in the short term in unlikely to subside.</p><p><blockquote>自11月初以来，Spotify股价下跌超过10%，对于那些欣赏Spotify商业模式的人来说，机会之窗可能已经打开。然而，今天购买现货可能只是一个很好的长期策略，因为短期内的波动不太可能消退。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Spotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify股票：逢低买入10月初的水平？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSpotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify股票：逢低买入10月初的水平？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-11-29 23:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the move as bearish, while others could find it an opportunity to buy SPOT cheaper.</p><p><blockquote>继第三季度后盈利飙升后，Spotify股价在11月份失去了大量动力。一些人可能认为此举是看跌的，而另一些人可能会发现这是一个以更便宜的价格购买现货的机会。</blockquote></p><p> In late October, Spotify&nbsp;announced third quarter results. The numbers excited investors and sent Spotify stock&nbsp;up nearly 15% quickly. The key metric supporting bullishness was the large increase in the platform's MAUs (monthly active users) over the previous year, followed by an almost 30% YoY growth in revenue.</p><p><blockquote>10月下旬，Spotify公布了第三季度业绩。这些数字令投资者兴奋不已，并使Spotify股价迅速上涨近15%。支持看涨的关键指标是该平台的MAU（月活跃用户）较上一年大幅增长，随后收入同比增长近30%。</blockquote></p><p> However, almost a month after the earnings announcement, shares have dipped 10% and returned to the same levels of early October. Today, MavenFlix tries to make sense of what is happening with SPOT, and debates whether the recent drop can be considered a buying opportunity.</p><p><blockquote>然而，财报公布近一个月后，股价已下跌10%，回到10月初的水平。今天，MavenFlix试图了解SPOT的情况，并讨论最近的下跌是否可以被视为买入机会。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1a76b6dc048e3702eb0b6ef48bbc0409\" tg-width=\"1240\" tg-height=\"698\" width=\"100%\" height=\"auto\"><span>Figure 1: Spotify app icon.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：Spotify应用程序图标。</span></p></blockquote></p><p> <b>Recent downfall and a future opportunity</b></p><p><blockquote><b>最近的失败和未来的机会</b></blockquote></p><p> SPOT hit $205 per share in August and, since then, embarked on a strong bullish ride to six-month highs. However, in November, not long after the announcement of the company's third quarter results, Spotify stock dropped from a high of $300 to less than $250.</p><p><blockquote>现货在8月份触及每股205美元，此后开始强劲看涨，升至六个月高点。然而，11月，在公司第三季度业绩公布后不久，Spotify股票就从300美元的高点跌至250美元以下。</blockquote></p><p> One of the possible causes for such decline is profit taking. If so, an opportunity to buy the dip could exist for those who like the fundamentals of the company, but that believed SPOT may have been too expensive or overvalued. Today, Spotify is trading at the lowest price in the last 3 months.</p><p><blockquote>这种下跌的可能原因之一是获利了结。如果是这样的话，对于那些喜欢该公司基本面但认为现货可能太贵或估值过高的人来说，可能存在逢低买入的机会。今天，Spotify的交易价格是过去3个月来的最低价格。</blockquote></p><p> <b>Podcast growth and ad revenue</b></p><p><blockquote><b>播客增长和广告收入</b></blockquote></p><p> Unlike what many might think, Spotify is not merely a music platform, but an audio one. Therefore, one should not only consider growth in the music streaming space when calculating the fair value of the stock.</p><p><blockquote>与许多人的想法不同，Spotify不仅仅是一个音乐平台，还是一个音频平台。因此，在计算股票的公允价值时，不应只考虑音乐流媒体领域的增长。</blockquote></p><p> As we discussed in “Spotify Earnings: Why The Stock Spiked On Q3 Results”, one of the most relevant growth drivers for Spotify today is podcast. This sub-segment of streaming audio is expanding fast and could become a substantial part of the company's P&amp;L in the foreseeable future.</p><p><blockquote>正如我们在“Spotify收益：为什么该股在第三季度业绩中飙升”中讨论的那样，当今Spotify最相关的增长动力之一是播客。流媒体音频的这一细分市场正在快速扩张，在可预见的未来可能成为公司损益的重要组成部分。</blockquote></p><p> With ad-supported accounts growing at the same rate as paid users, monetizing on podcasts is a key next step for Spotify. We think that this could be a catalyst pushing Spotify stock higher in the future – even if not in the next few weeks or months.</p><p><blockquote>随着广告支持的账户以与付费用户相同的速度增长，通过播客赚钱是Spotify的下一步关键。我们认为这可能是未来推高Spotify股价的催化剂——即使不是在未来几周或几个月内。</blockquote></p><p> <b>Spotify dominates audio streaming</b></p><p><blockquote><b>Spotify主导音频流</b></blockquote></p><p> Spotify has one of the largest music libraries. However, we do not think that this sets the company apart from its competitors. Apple and Amazon, for example, continue to invest their bottomless piles of cash to boost their platforms’ content offerings as well.</p><p><blockquote>Spotify拥有最大的音乐库之一。然而，我们并不认为这使该公司从竞争对手中脱颖而出。例如，苹果和亚马逊也继续投入大量现金来增加其平台的内容产品。</blockquote></p><p> What makes Spotify stand out, in our view, is its footprint in audio streaming. Despite the growth prospects, the market is still concentrated in the hands of few players, unlike what happens in video streaming. Spotify has clear market dominance, as the chart below depicts.</p><p><blockquote>在我们看来，Spotify之所以脱颖而出，是因为它在音频流领域的足迹。尽管有增长前景，但市场仍然集中在少数玩家手中，这与视频流媒体的情况不同。如下图所示，Spotify拥有明显的市场主导地位。</blockquote></p><p> The investments in podcasts should only help Spotify to establish itself at the top for years to come. Currently, there are about 2.6 million podcast titles available on the platform.</p><p><blockquote>对播客的投资应该只会帮助Spotify在未来几年确立自己的地位。目前，该平台上大约有260万个播客标题。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ab561adf751b756fe06b8fa8d2bff0ee\" tg-width=\"609\" tg-height=\"458\" width=\"100%\" height=\"auto\"><span>Figure 2: Music streaming market share.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：音乐流媒体市场份额。</span></p></blockquote></p><p> <b>Our view</b></p><p><blockquote><b>我们的观点</b></blockquote></p><p> After Spotify stock dropped more than 10% since the beginning of November, a window of opportunity may have opened for those who appreciate Spotify's business model. Buying SPOT today, however, may only prove to be a good long-term strategy, since volatility in the short term in unlikely to subside.</p><p><blockquote>自11月初以来，Spotify股价下跌超过10%，对于那些欣赏Spotify商业模式的人来说，机会之窗可能已经打开。然而，今天购买现货可能只是一个很好的长期策略，因为短期内的波动不太可能消退。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/streaming/spot/buy-spotify-stock-at-pre-q3-earnings-levels\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPOT":"Spotify Technology S.A."},"source_url":"https://www.thestreet.com/streaming/spot/buy-spotify-stock-at-pre-q3-earnings-levels","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180693909","content_text":"Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the move as bearish, while others could find it an opportunity to buy SPOT cheaper.\nIn late October, Spotify announced third quarter results. The numbers excited investors and sent Spotify stock up nearly 15% quickly. The key metric supporting bullishness was the large increase in the platform's MAUs (monthly active users) over the previous year, followed by an almost 30% YoY growth in revenue.\nHowever, almost a month after the earnings announcement, shares have dipped 10% and returned to the same levels of early October. Today, MavenFlix tries to make sense of what is happening with SPOT, and debates whether the recent drop can be considered a buying opportunity.\nFigure 1: Spotify app icon.\nRecent downfall and a future opportunity\nSPOT hit $205 per share in August and, since then, embarked on a strong bullish ride to six-month highs. However, in November, not long after the announcement of the company's third quarter results, Spotify stock dropped from a high of $300 to less than $250.\nOne of the possible causes for such decline is profit taking. If so, an opportunity to buy the dip could exist for those who like the fundamentals of the company, but that believed SPOT may have been too expensive or overvalued. Today, Spotify is trading at the lowest price in the last 3 months.\nPodcast growth and ad revenue\nUnlike what many might think, Spotify is not merely a music platform, but an audio one. Therefore, one should not only consider growth in the music streaming space when calculating the fair value of the stock.\nAs we discussed in “Spotify Earnings: Why The Stock Spiked On Q3 Results”, one of the most relevant growth drivers for Spotify today is podcast. This sub-segment of streaming audio is expanding fast and could become a substantial part of the company's P&L in the foreseeable future.\nWith ad-supported accounts growing at the same rate as paid users, monetizing on podcasts is a key next step for Spotify. We think that this could be a catalyst pushing Spotify stock higher in the future – even if not in the next few weeks or months.\nSpotify dominates audio streaming\nSpotify has one of the largest music libraries. However, we do not think that this sets the company apart from its competitors. Apple and Amazon, for example, continue to invest their bottomless piles of cash to boost their platforms’ content offerings as well.\nWhat makes Spotify stand out, in our view, is its footprint in audio streaming. Despite the growth prospects, the market is still concentrated in the hands of few players, unlike what happens in video streaming. Spotify has clear market dominance, as the chart below depicts.\nThe investments in podcasts should only help Spotify to establish itself at the top for years to come. Currently, there are about 2.6 million podcast titles available on the platform.\nFigure 2: Music streaming market share.\nOur view\nAfter Spotify stock dropped more than 10% since the beginning of November, a window of opportunity may have opened for those who appreciate Spotify's business model. Buying SPOT today, however, may only prove to be a good long-term strategy, since volatility in the short term in unlikely to subside.","news_type":1,"symbols_score_info":{"SPOT":0.9}},"isVote":1,"tweetType":1,"viewCount":4273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877598648,"gmtCreate":1637940510618,"gmtModify":1637940510696,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/877598648","repostId":"1158420182","repostType":4,"repost":{"id":"1158420182","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637939738,"share":"https://www.laohu8.com/m/news/1158420182?lang=zh_CN&edition=full","pubTime":"2021-11-26 23:15","market":"fut","language":"en","title":"WTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.<blockquote>WTI原油下跌9.02%至每桶71.28美元，布伦特原油下跌8.16%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1158420182","media":"Tiger Newspress","summary":"WTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.","content":"<p>WTI crude tumbled&nbsp;9.02% to $71.28 a barrel,&nbsp;Brent&nbsp;fell&nbsp;8.16%.<img src=\"https://static.tigerbbs.com/6e118e6a5e909412e48ca104b2c37b30\" tg-width=\"884\" tg-height=\"611\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/1ac1680f3b9d8085d5fd9b6a868ce9c3\" tg-width=\"870\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote>WTI原油下跌9.02%至每桶71.28美元，布伦特原油下跌8.16%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.<blockquote>WTI原油下跌9.02%至每桶71.28美元，布伦特原油下跌8.16%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.<blockquote>WTI原油下跌9.02%至每桶71.28美元，布伦特原油下跌8.16%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-26 23:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>WTI crude tumbled&nbsp;9.02% to $71.28 a barrel,&nbsp;Brent&nbsp;fell&nbsp;8.16%.<img src=\"https://static.tigerbbs.com/6e118e6a5e909412e48ca104b2c37b30\" tg-width=\"884\" tg-height=\"611\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/1ac1680f3b9d8085d5fd9b6a868ce9c3\" tg-width=\"870\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote>WTI原油下跌9.02%至每桶71.28美元，布伦特原油下跌8.16%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158420182","content_text":"WTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.","news_type":1,"symbols_score_info":{"CLmain":0.9,"BZmain":0.9}},"isVote":1,"tweetType":1,"viewCount":3322,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877912421,"gmtCreate":1637863611074,"gmtModify":1637863611159,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877912421","repostId":"1122037796","repostType":4,"repost":{"id":"1122037796","kind":"news","pubTimestamp":1637849010,"share":"https://www.laohu8.com/m/news/1122037796?lang=zh_CN&edition=full","pubTime":"2021-11-25 22:03","market":"us","language":"en","title":"7 stocks with the most Thanksgiving exposure, according to Bank of America<blockquote>美国银行称感恩节风险最大的7只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122037796","media":"finance.yahoo","summary":"Thanksgiving feasts will likely draw larger crowds than last year and incur higher costs.\nA recent B","content":"<p>Thanksgiving feasts will likely draw larger crowds than last year and&nbsp;incur higher costs.</p><p><blockquote>感恩节盛宴可能会吸引比去年更多的人群，并产生更高的成本。</blockquote></p><p> A recent Bank of America note detailed which companies have the most exposure to the top holiday dishes amid supply chain bottlenecks, inflation, lingering COVID concerns, low inventories, and evolving consumer behaviors.</p><p><blockquote>美国银行最近的一份报告详细介绍了在供应链瓶颈、通货膨胀、挥之不去的新冠疫情担忧、低库存和消费者行为不断变化的情况下，哪些公司对顶级节日菜肴的敞口最大。</blockquote></p><p> Those companies are Campbell's Soup Company (CPB), General Mills (GIS), The Kraft Heinz Company (KHC), Conagra Brands (CAG), Hormel Foods Corporation (HRL), McCormick &amp; Company (MKC), and The Duckhorn Portfolio, Inc. (NAPA).</p><p><blockquote>这些公司包括金宝汤公司(CPB)、通用磨坊(GIS)、卡夫亨氏公司(KHC)、康尼格拉品牌(CAG)、荷美尔食品公司(HRL)、味好美公司(MKC)和鸭角投资组合公司(NAPA)。</blockquote></p><p> \"We looked at companies’ exposure to the top Thanksgiving dishes: turkey, stuffing, dinner rolls, gravy, green bean casserole, potatoes, mac &amp; cheese dessert and wine,\" the analysts stated. \"Overall CPB, GIS, KHC, CAG, MKC, HRL and NAPA are the most exposed. KHC and NAPA are our favorite stocks in this group.\"</p><p><blockquote>分析师表示：“我们研究了公司对感恩节顶级菜肴的敞口：火鸡、馅料、晚餐卷、肉汁、绿豆砂锅、土豆、通心粉和奶酪甜点以及葡萄酒。”“总体而言，CPB、GIS、KHC、CAG、MKC、HRL和NAPA的风险敞口最大。KHC和NAPA是我们在该组中最喜欢的股票。”</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/39aa902f366c0bd07e076520c33cdf52\" tg-width=\"705\" tg-height=\"409\" width=\"100%\" height=\"auto\"><span>Key companies exposed to Thanksgiving meal trends. (Source: BofA)Thanksgiving 'center of the plate' items see more pricing power</span></p><p><blockquote><p class=\"t-img-caption\"><span>接触感恩节大餐趋势的主要公司。（来源：美国银行）感恩节“盘子中心”商品拥有更多定价权</span></p></blockquote></p><p> People appear to be gathering around the table again, the analysts stated, as data from social media conversations found mentions of \"vaccines\" on the rise while mentions of \"FaceTime,\" \"social distancing,\" and \"canceled\" declined. (\"Friendsgiving\" and \"day drinking\" also saw increases.)</p><p><blockquote>分析师表示，人们似乎再次聚集在桌子周围，因为社交媒体对话的数据发现，提及“疫苗”的人数有所增加，而提及“FaceTime”、“社交距离”和“取消”的人数有所下降。（“朋友聚会”和“白天饮酒”也有所增加。）</blockquote></p><p> And whether consumers opt for turkey or ham, mashed potatoes or marshmallow-topped sweet potatoes, traditional orplant-based options, they're likely to pay more with inflation hitting food prices.</p><p><blockquote>无论消费者选择火鸡还是火腿、土豆泥还是棉花糖红薯、传统的或植物性的选择，随着通货膨胀打击食品价格，他们可能会支付更多费用。</blockquote></p><p> The&nbsp;American Farm Bureau Thanksgiving cost index&nbsp;projects a 14% year-over-year increase for 2021, led by a 24% increase in turkey prices.</p><p><blockquote>美国农业局感恩节成本指数预计2021年将同比增长14%，其中火鸡价格将上涨24%。</blockquote></p><p> “When you look at more of the center of the plate sort of food items, typically, there has not historically been a lot of pricing power,” Bryan Spillane, a senior food and beverage analyst at BofA Global Research, told Yahoo Finance Live (video above). “But what's unusual this year is that there has been. Food companies, in particular, began raising prices the middle of the year, and there's virtually been no elasticity.”</p><p><blockquote>美国银行全球研究部高级食品和饮料分析师布莱恩·斯皮兰(Bryan Spillane)告诉雅虎财经直播：“当你观察更多的中心食品时，通常情况下，历史上并没有太多的定价权。”（上面的视频）。“但今年不同寻常的是，已经出现了。尤其是食品公司，年中就开始涨价，而且几乎没有弹性。”</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8e60ff60917eb4db45a68c41bd19a337\" tg-width=\"705\" tg-height=\"529\" width=\"100%\" height=\"auto\"><span>Frozen turkeys in Philadelphia, Wednesday, Nov. 17, 2021. (AP Photo/Matt Rourke)</span></p><p><blockquote><p class=\"t-img-caption\"><span>2021年11月17日，星期三，费城的冷冻火鸡。（美联社照片/马特·洛克）</span></p></blockquote></p><p> That said, Spillane added, consumer behavior is expected to change at some point.</p><p><blockquote>斯皮兰补充说，也就是说，消费者行为预计会在某个时候发生变化。</blockquote></p><p> “Something that we're really watching as we move into next year is: At what point does the consumer begin to push back and do we begin to see some trading down or other behavior that demonstrates that consumers are feeling that pinch?” Spillane said.</p><p><blockquote>“进入明年，我们真正关注的是：消费者在什么时候开始抵制，我们是否开始看到一些降价或其他行为表明消费者感受到了压力？”斯皮兰说。</blockquote></p><p> Investor appetite for food and beverage companies</p><p><blockquote>投资者对食品饮料公司的兴趣</blockquote></p><p> The top company with the most upside or downside potential is Campbell's, which BofA gave an \"underperform\" rating.</p><p><blockquote>上涨或下跌潜力最大的公司是金宝汤，美国银行给予该公司“表现不佳”评级。</blockquote></p><p> “Campbell's struggling from a few issues,” Spillane said. “One is they are experiencing a material amount of inflation. They have a product portfolio that's a little bit more skewed… to kind of middle and low-income households. So, that's, maybe, an area where there may be some sensitivity around passing those prices through.”</p><p><blockquote>“坎贝尔正在为一些问题而苦苦挣扎，”斯皮兰说。“一是他们正在经历大幅通货膨胀。他们的产品组合稍微偏向于……中低收入家庭。因此，这可能是一个在传递这些价格方面可能存在一些敏感性的领域。”</blockquote></p><p> The iconic soup company also has a lot of direct and indirect exposure to labor shortages and higher labor costs, Spillane added.</p><p><blockquote>斯皮兰补充说，这家标志性的汤公司还直接和间接面临劳动力短缺和劳动力成本上升的问题。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/be1718627f49a5fcc29f52e9e322313f\" tg-width=\"705\" tg-height=\"470\" width=\"100%\" height=\"auto\"><span>Cans of Campbell's Soup are displayed in a supermarket in New York City, U.S. February 15, 2017. REUTERS/Brendan McDermid</span></p><p><blockquote><p class=\"t-img-caption\"><span>2017年2月15日，美国纽约市一家超市里陈列着罐装金宝汤。路透社/布伦丹·麦克德米德</span></p></blockquote></p><p> BofA also gave seasoning-maker McCormick &amp; Company an \"underperform\" rating, with an $84 price target.</p><p><blockquote>美国银行还给予调味料制造商味好美公司“跑输大盘”评级，目标价为84美元。</blockquote></p><p> McCormick is “still trading at a premium valuation,” Spillane said, adding that while it has benefitted from people having cooked at home more in the last 18 months, “at some point, as things moderate, you're going to see less of that cooking at home behavior. And that's going to create an overhang for McCormick.”</p><p><blockquote>斯皮兰表示，味好美“仍以溢价估值交易”，并补充说，虽然它受益于人们在过去18个月里更多地在家做饭，但“在某个时候，随着情况放缓，你会看到这种情况减少在家做饭的行为。这将给味好美带来悬念。”</blockquote></p><p> On the flip side, “Hershey [HSY] is well-positioned,” Spillane said, especially when it comes to the inflationary environment.</p><p><blockquote>另一方面，“好时[HSY]处于有利地位，”斯皮兰说，尤其是在通胀环境方面。</blockquote></p><p> “The combination of a category that's still growing very strongly where there's still a lot of product innovation and where there's been demonstrated pricing power, we think that Hershey is set up really well to be able to maybe even more than protect margins, maybe potentially grow margins as we cycle through some of this inflation,” he explained.</p><p><blockquote>“这个类别仍在强劲增长，仍然有很多产品创新，并且已经证明了定价能力，我们认为好时的设置非常好，甚至能够保护利润率，也许有可能随着我们经历一些通货膨胀而增长利润率，”他解释道。</blockquote></p><p> BofA also awarded Stove Top stuffing-maker Kraft Heinz a buy rating with a $46 price objective.</p><p><blockquote>美国银行还给予炉灶馅料制造商卡夫亨氏买入评级，目标价为46美元。</blockquote></p><p></p><p> “We believe this is justified based our view that KHC is well positioned to capture growth associated with changing consumer demand patterns related to recessions and pantry stocking offset by higher than average debt levels,” the analysts wrote.</p><p><blockquote>分析师写道：“我们认为这是合理的，因为我们认为KHC处于有利地位，可以捕捉与经济衰退和食品储藏室库存相关的消费者需求模式变化相关的增长，但这些增长被高于平均水平的债务水平所抵消。”</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 stocks with the most Thanksgiving exposure, according to Bank of America<blockquote>美国银行称感恩节风险最大的7只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 stocks with the most Thanksgiving exposure, according to Bank of America<blockquote>美国银行称感恩节风险最大的7只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">finance.yahoo</strong><span class=\"h-time small\">2021-11-25 22:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Thanksgiving feasts will likely draw larger crowds than last year and&nbsp;incur higher costs.</p><p><blockquote>感恩节盛宴可能会吸引比去年更多的人群，并产生更高的成本。</blockquote></p><p> A recent Bank of America note detailed which companies have the most exposure to the top holiday dishes amid supply chain bottlenecks, inflation, lingering COVID concerns, low inventories, and evolving consumer behaviors.</p><p><blockquote>美国银行最近的一份报告详细介绍了在供应链瓶颈、通货膨胀、挥之不去的新冠疫情担忧、低库存和消费者行为不断变化的情况下，哪些公司对顶级节日菜肴的敞口最大。</blockquote></p><p> Those companies are Campbell's Soup Company (CPB), General Mills (GIS), The Kraft Heinz Company (KHC), Conagra Brands (CAG), Hormel Foods Corporation (HRL), McCormick &amp; Company (MKC), and The Duckhorn Portfolio, Inc. (NAPA).</p><p><blockquote>这些公司包括金宝汤公司(CPB)、通用磨坊(GIS)、卡夫亨氏公司(KHC)、康尼格拉品牌(CAG)、荷美尔食品公司(HRL)、味好美公司(MKC)和鸭角投资组合公司(NAPA)。</blockquote></p><p> \"We looked at companies’ exposure to the top Thanksgiving dishes: turkey, stuffing, dinner rolls, gravy, green bean casserole, potatoes, mac &amp; cheese dessert and wine,\" the analysts stated. \"Overall CPB, GIS, KHC, CAG, MKC, HRL and NAPA are the most exposed. KHC and NAPA are our favorite stocks in this group.\"</p><p><blockquote>分析师表示：“我们研究了公司对感恩节顶级菜肴的敞口：火鸡、馅料、晚餐卷、肉汁、绿豆砂锅、土豆、通心粉和奶酪甜点以及葡萄酒。”“总体而言，CPB、GIS、KHC、CAG、MKC、HRL和NAPA的风险敞口最大。KHC和NAPA是我们在该组中最喜欢的股票。”</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/39aa902f366c0bd07e076520c33cdf52\" tg-width=\"705\" tg-height=\"409\" width=\"100%\" height=\"auto\"><span>Key companies exposed to Thanksgiving meal trends. (Source: BofA)Thanksgiving 'center of the plate' items see more pricing power</span></p><p><blockquote><p class=\"t-img-caption\"><span>接触感恩节大餐趋势的主要公司。（来源：美国银行）感恩节“盘子中心”商品拥有更多定价权</span></p></blockquote></p><p> People appear to be gathering around the table again, the analysts stated, as data from social media conversations found mentions of \"vaccines\" on the rise while mentions of \"FaceTime,\" \"social distancing,\" and \"canceled\" declined. (\"Friendsgiving\" and \"day drinking\" also saw increases.)</p><p><blockquote>分析师表示，人们似乎再次聚集在桌子周围，因为社交媒体对话的数据发现，提及“疫苗”的人数有所增加，而提及“FaceTime”、“社交距离”和“取消”的人数有所下降。（“朋友聚会”和“白天饮酒”也有所增加。）</blockquote></p><p> And whether consumers opt for turkey or ham, mashed potatoes or marshmallow-topped sweet potatoes, traditional orplant-based options, they're likely to pay more with inflation hitting food prices.</p><p><blockquote>无论消费者选择火鸡还是火腿、土豆泥还是棉花糖红薯、传统的或植物性的选择，随着通货膨胀打击食品价格，他们可能会支付更多费用。</blockquote></p><p> The&nbsp;American Farm Bureau Thanksgiving cost index&nbsp;projects a 14% year-over-year increase for 2021, led by a 24% increase in turkey prices.</p><p><blockquote>美国农业局感恩节成本指数预计2021年将同比增长14%，其中火鸡价格将上涨24%。</blockquote></p><p> “When you look at more of the center of the plate sort of food items, typically, there has not historically been a lot of pricing power,” Bryan Spillane, a senior food and beverage analyst at BofA Global Research, told Yahoo Finance Live (video above). “But what's unusual this year is that there has been. Food companies, in particular, began raising prices the middle of the year, and there's virtually been no elasticity.”</p><p><blockquote>美国银行全球研究部高级食品和饮料分析师布莱恩·斯皮兰(Bryan Spillane)告诉雅虎财经直播：“当你观察更多的中心食品时，通常情况下，历史上并没有太多的定价权。”（上面的视频）。“但今年不同寻常的是，已经出现了。尤其是食品公司，年中就开始涨价，而且几乎没有弹性。”</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8e60ff60917eb4db45a68c41bd19a337\" tg-width=\"705\" tg-height=\"529\" width=\"100%\" height=\"auto\"><span>Frozen turkeys in Philadelphia, Wednesday, Nov. 17, 2021. (AP Photo/Matt Rourke)</span></p><p><blockquote><p class=\"t-img-caption\"><span>2021年11月17日，星期三，费城的冷冻火鸡。（美联社照片/马特·洛克）</span></p></blockquote></p><p> That said, Spillane added, consumer behavior is expected to change at some point.</p><p><blockquote>斯皮兰补充说，也就是说，消费者行为预计会在某个时候发生变化。</blockquote></p><p> “Something that we're really watching as we move into next year is: At what point does the consumer begin to push back and do we begin to see some trading down or other behavior that demonstrates that consumers are feeling that pinch?” Spillane said.</p><p><blockquote>“进入明年，我们真正关注的是：消费者在什么时候开始抵制，我们是否开始看到一些降价或其他行为表明消费者感受到了压力？”斯皮兰说。</blockquote></p><p> Investor appetite for food and beverage companies</p><p><blockquote>投资者对食品饮料公司的兴趣</blockquote></p><p> The top company with the most upside or downside potential is Campbell's, which BofA gave an \"underperform\" rating.</p><p><blockquote>上涨或下跌潜力最大的公司是金宝汤，美国银行给予该公司“表现不佳”评级。</blockquote></p><p> “Campbell's struggling from a few issues,” Spillane said. “One is they are experiencing a material amount of inflation. They have a product portfolio that's a little bit more skewed… to kind of middle and low-income households. So, that's, maybe, an area where there may be some sensitivity around passing those prices through.”</p><p><blockquote>“坎贝尔正在为一些问题而苦苦挣扎，”斯皮兰说。“一是他们正在经历大幅通货膨胀。他们的产品组合稍微偏向于……中低收入家庭。因此，这可能是一个在传递这些价格方面可能存在一些敏感性的领域。”</blockquote></p><p> The iconic soup company also has a lot of direct and indirect exposure to labor shortages and higher labor costs, Spillane added.</p><p><blockquote>斯皮兰补充说，这家标志性的汤公司还直接和间接面临劳动力短缺和劳动力成本上升的问题。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/be1718627f49a5fcc29f52e9e322313f\" tg-width=\"705\" tg-height=\"470\" width=\"100%\" height=\"auto\"><span>Cans of Campbell's Soup are displayed in a supermarket in New York City, U.S. February 15, 2017. REUTERS/Brendan McDermid</span></p><p><blockquote><p class=\"t-img-caption\"><span>2017年2月15日，美国纽约市一家超市里陈列着罐装金宝汤。路透社/布伦丹·麦克德米德</span></p></blockquote></p><p> BofA also gave seasoning-maker McCormick &amp; Company an \"underperform\" rating, with an $84 price target.</p><p><blockquote>美国银行还给予调味料制造商味好美公司“跑输大盘”评级，目标价为84美元。</blockquote></p><p> McCormick is “still trading at a premium valuation,” Spillane said, adding that while it has benefitted from people having cooked at home more in the last 18 months, “at some point, as things moderate, you're going to see less of that cooking at home behavior. And that's going to create an overhang for McCormick.”</p><p><blockquote>斯皮兰表示，味好美“仍以溢价估值交易”，并补充说，虽然它受益于人们在过去18个月里更多地在家做饭，但“在某个时候，随着情况放缓，你会看到这种情况减少在家做饭的行为。这将给味好美带来悬念。”</blockquote></p><p> On the flip side, “Hershey [HSY] is well-positioned,” Spillane said, especially when it comes to the inflationary environment.</p><p><blockquote>另一方面，“好时[HSY]处于有利地位，”斯皮兰说，尤其是在通胀环境方面。</blockquote></p><p> “The combination of a category that's still growing very strongly where there's still a lot of product innovation and where there's been demonstrated pricing power, we think that Hershey is set up really well to be able to maybe even more than protect margins, maybe potentially grow margins as we cycle through some of this inflation,” he explained.</p><p><blockquote>“这个类别仍在强劲增长，仍然有很多产品创新，并且已经证明了定价能力，我们认为好时的设置非常好，甚至能够保护利润率，也许有可能随着我们经历一些通货膨胀而增长利润率，”他解释道。</blockquote></p><p> BofA also awarded Stove Top stuffing-maker Kraft Heinz a buy rating with a $46 price objective.</p><p><blockquote>美国银行还给予炉灶馅料制造商卡夫亨氏买入评级，目标价为46美元。</blockquote></p><p></p><p> “We believe this is justified based our view that KHC is well positioned to capture growth associated with changing consumer demand patterns related to recessions and pantry stocking offset by higher than average debt levels,” the analysts wrote.</p><p><blockquote>分析师写道：“我们认为这是合理的，因为我们认为KHC处于有利地位，可以捕捉与经济衰退和食品储藏室库存相关的消费者需求模式变化相关的增长，但这些增长被高于平均水平的债务水平所抵消。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/7-stocks-thanksgiving-exposure-bank-of-america-134505457.html\">finance.yahoo</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GIS":"通用磨坊","MKC":"味好美","CPB":"金宝汤","CAG":"康尼格拉","KHC":"卡夫亨氏","HRL":"荷美尔","NAPA":"The Duckhorn Portfolio, Inc."},"source_url":"https://finance.yahoo.com/news/7-stocks-thanksgiving-exposure-bank-of-america-134505457.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122037796","content_text":"Thanksgiving feasts will likely draw larger crowds than last year and incur higher costs.\nA recent Bank of America note detailed which companies have the most exposure to the top holiday dishes amid supply chain bottlenecks, inflation, lingering COVID concerns, low inventories, and evolving consumer behaviors.\nThose companies are Campbell's Soup Company (CPB), General Mills (GIS), The Kraft Heinz Company (KHC), Conagra Brands (CAG), Hormel Foods Corporation (HRL), McCormick & Company (MKC), and The Duckhorn Portfolio, Inc. (NAPA).\n\"We looked at companies’ exposure to the top Thanksgiving dishes: turkey, stuffing, dinner rolls, gravy, green bean casserole, potatoes, mac & cheese dessert and wine,\" the analysts stated. \"Overall CPB, GIS, KHC, CAG, MKC, HRL and NAPA are the most exposed. KHC and NAPA are our favorite stocks in this group.\"\nKey companies exposed to Thanksgiving meal trends. (Source: BofA)Thanksgiving 'center of the plate' items see more pricing power\nPeople appear to be gathering around the table again, the analysts stated, as data from social media conversations found mentions of \"vaccines\" on the rise while mentions of \"FaceTime,\" \"social distancing,\" and \"canceled\" declined. (\"Friendsgiving\" and \"day drinking\" also saw increases.)\nAnd whether consumers opt for turkey or ham, mashed potatoes or marshmallow-topped sweet potatoes, traditional orplant-based options, they're likely to pay more with inflation hitting food prices.\nThe American Farm Bureau Thanksgiving cost index projects a 14% year-over-year increase for 2021, led by a 24% increase in turkey prices.\n“When you look at more of the center of the plate sort of food items, typically, there has not historically been a lot of pricing power,” Bryan Spillane, a senior food and beverage analyst at BofA Global Research, told Yahoo Finance Live (video above). “But what's unusual this year is that there has been. Food companies, in particular, began raising prices the middle of the year, and there's virtually been no elasticity.”\nFrozen turkeys in Philadelphia, Wednesday, Nov. 17, 2021. (AP Photo/Matt Rourke)\nThat said, Spillane added, consumer behavior is expected to change at some point.\n“Something that we're really watching as we move into next year is: At what point does the consumer begin to push back and do we begin to see some trading down or other behavior that demonstrates that consumers are feeling that pinch?” Spillane said.\nInvestor appetite for food and beverage companies\nThe top company with the most upside or downside potential is Campbell's, which BofA gave an \"underperform\" rating.\n“Campbell's struggling from a few issues,” Spillane said. “One is they are experiencing a material amount of inflation. They have a product portfolio that's a little bit more skewed… to kind of middle and low-income households. So, that's, maybe, an area where there may be some sensitivity around passing those prices through.”\nThe iconic soup company also has a lot of direct and indirect exposure to labor shortages and higher labor costs, Spillane added.\nCans of Campbell's Soup are displayed in a supermarket in New York City, U.S. February 15, 2017. REUTERS/Brendan McDermid\nBofA also gave seasoning-maker McCormick & Company an \"underperform\" rating, with an $84 price target.\nMcCormick is “still trading at a premium valuation,” Spillane said, adding that while it has benefitted from people having cooked at home more in the last 18 months, “at some point, as things moderate, you're going to see less of that cooking at home behavior. And that's going to create an overhang for McCormick.”\nOn the flip side, “Hershey [HSY] is well-positioned,” Spillane said, especially when it comes to the inflationary environment.\n“The combination of a category that's still growing very strongly where there's still a lot of product innovation and where there's been demonstrated pricing power, we think that Hershey is set up really well to be able to maybe even more than protect margins, maybe potentially grow margins as we cycle through some of this inflation,” he explained.\nBofA also awarded Stove Top stuffing-maker Kraft Heinz a buy rating with a $46 price objective.\n“We believe this is justified based our view that KHC is well positioned to capture growth associated with changing consumer demand patterns related to recessions and pantry stocking offset by higher than average debt levels,” the analysts wrote.","news_type":1,"symbols_score_info":{"MKC":0.9,"KHC":0.9,"HRL":0.9,"NAPA":0.9,"CAG":0.9,"GIS":0.9,"CPB":0.9}},"isVote":1,"tweetType":1,"viewCount":4067,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875457018,"gmtCreate":1637680850959,"gmtModify":1637680851037,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/875457018","repostId":"1119603099","repostType":4,"repost":{"id":"1119603099","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637680476,"share":"https://www.laohu8.com/m/news/1119603099?lang=zh_CN&edition=full","pubTime":"2021-11-23 23:14","market":"us","language":"en","title":"BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%<blockquote>BioNTech股价早盘下跌近7%，Moderna股价下跌3%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1119603099","media":"Tiger Newspress","summary":"BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%.The U.S. government asked","content":"<p>BioNTech&nbsp;shares&nbsp;fell&nbsp;nearly&nbsp;7%&nbsp;in&nbsp;early&nbsp;trading&nbsp;and&nbsp;Moderna&nbsp;shares&nbsp;slid&nbsp;3%.<img src=\"https://static.tigerbbs.com/89a99816fada5bf2c2120b3cda678cb6\" tg-width=\"871\" tg-height=\"599\" width=\"100%\" height=\"auto\">The U.S. government asked a federal appeals court to immediately lift a court-ordered stay on a sweeping workplace COVID-19 vaccine rule to avoid \"enormous\" harm to public health, or alternatively to allow a masking-and-testing requirement, according to a court filing.</p><p><blockquote>BioNTech股价早盘下跌近7%，Moderna股价下跌3%。根据一份法庭文件，美国政府要求联邦上诉法院立即取消法院下令暂停一项全面的工作场所新冠肺炎疫苗规则，以避免对公共健康造成“巨大”伤害，或者允许掩蔽和测试要求。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%<blockquote>BioNTech股价早盘下跌近7%，Moderna股价下跌3%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%<blockquote>BioNTech股价早盘下跌近7%，Moderna股价下跌3%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-23 23:14</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BioNTech&nbsp;shares&nbsp;fell&nbsp;nearly&nbsp;7%&nbsp;in&nbsp;early&nbsp;trading&nbsp;and&nbsp;Moderna&nbsp;shares&nbsp;slid&nbsp;3%.<img src=\"https://static.tigerbbs.com/89a99816fada5bf2c2120b3cda678cb6\" tg-width=\"871\" tg-height=\"599\" width=\"100%\" height=\"auto\">The U.S. government asked a federal appeals court to immediately lift a court-ordered stay on a sweeping workplace COVID-19 vaccine rule to avoid \"enormous\" harm to public health, or alternatively to allow a masking-and-testing requirement, according to a court filing.</p><p><blockquote>BioNTech股价早盘下跌近7%，Moderna股价下跌3%。根据一份法庭文件，美国政府要求联邦上诉法院立即取消法院下令暂停一项全面的工作场所新冠肺炎疫苗规则，以避免对公共健康造成“巨大”伤害，或者允许掩蔽和测试要求。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119603099","content_text":"BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%.The U.S. government asked a federal appeals court to immediately lift a court-ordered stay on a sweeping workplace COVID-19 vaccine rule to avoid \"enormous\" harm to public health, or alternatively to allow a masking-and-testing requirement, according to a court filing.","news_type":1,"symbols_score_info":{"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":4046,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875076570,"gmtCreate":1637592414989,"gmtModify":1637592415086,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875076570","repostId":"2185872821","repostType":4,"isVote":1,"tweetType":1,"viewCount":4122,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876907118,"gmtCreate":1637247684222,"gmtModify":1637247684325,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876907118","repostId":"1171650346","repostType":4,"repost":{"id":"1171650346","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637247556,"share":"https://www.laohu8.com/m/news/1171650346?lang=zh_CN&edition=full","pubTime":"2021-11-18 22:59","market":"us","language":"en","title":"Semiconductor stocks climbed in morning trading<blockquote>半导体股早盘攀升</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1171650346","media":"Tiger Newspress","summary":"Semiconductor stocks climbed in morning trading.Nvidia,AMD,GlobalFoundries,TSMC,ASML,Micron Technolo","content":"<p>Semiconductor stocks climbed in morning trading.Nvidia,AMD,GlobalFoundries,TSMC,ASML,Micron Technology&nbsp;and&nbsp;Qualcomm&nbsp;rose&nbsp;between 2% and 11%.</p><p><blockquote>半导体股早盘上涨。英伟达、AMD、格芯、台积电、ASML、美光科技和高通涨幅在2%至11%之间。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/299bd7bc3695657a76434e3d339f30ad\" tg-width=\"409\" tg-height=\"425\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Nvidia reported record sales and beat on earnings again;</p><p><blockquote>英伟达公布创纪录的销售额和盈利再次超出预期；</blockquote></p><p> Ford explores buying chips directly from GlobalFoundries to offset shortage;</p><p><blockquote>福特探索直接从格芯购买芯片以弥补短缺；</blockquote></p><p> ASML sees around $2.27 bln in sales in China in 2021, 2022 - CFO.</p><p><blockquote>ASML首席财务官预计2021年和2022年在中国的销售额约为22.7亿美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Semiconductor stocks climbed in morning trading<blockquote>半导体股早盘攀升</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSemiconductor stocks climbed in morning trading<blockquote>半导体股早盘攀升</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-18 22:59</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Semiconductor stocks climbed in morning trading.Nvidia,AMD,GlobalFoundries,TSMC,ASML,Micron Technology&nbsp;and&nbsp;Qualcomm&nbsp;rose&nbsp;between 2% and 11%.</p><p><blockquote>半导体股早盘上涨。英伟达、AMD、格芯、台积电、ASML、美光科技和高通涨幅在2%至11%之间。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/299bd7bc3695657a76434e3d339f30ad\" tg-width=\"409\" tg-height=\"425\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Nvidia reported record sales and beat on earnings again;</p><p><blockquote>英伟达公布创纪录的销售额和盈利再次超出预期；</blockquote></p><p> Ford explores buying chips directly from GlobalFoundries to offset shortage;</p><p><blockquote>福特探索直接从格芯购买芯片以弥补短缺；</blockquote></p><p> ASML sees around $2.27 bln in sales in China in 2021, 2022 - CFO.</p><p><blockquote>ASML首席财务官预计2021年和2022年在中国的销售额约为22.7亿美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ASML":"阿斯麦","AMD":"美国超微公司","MU":"美光科技","TSM":"台积电","GFS":"GLOBALFOUNDRIES Inc.","QCOM":"高通","NVDA":"英伟达"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171650346","content_text":"Semiconductor stocks climbed in morning trading.Nvidia,AMD,GlobalFoundries,TSMC,ASML,Micron Technology and Qualcomm rose between 2% and 11%.\n\nNvidia reported record sales and beat on earnings again;\nFord explores buying chips directly from GlobalFoundries to offset shortage;\nASML sees around $2.27 bln in sales in China in 2021, 2022 - CFO.","news_type":1,"symbols_score_info":{"AMD":0.9,"ASML":0.9,"TSM":0.9,"NVDA":0.9,"MU":0.9,"GFS":0.9,"QCOM":0.9}},"isVote":1,"tweetType":1,"viewCount":3672,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870727475,"gmtCreate":1636651299506,"gmtModify":1636651299710,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870727475","repostId":"1138997737","repostType":4,"isVote":1,"tweetType":1,"viewCount":1043,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841959209,"gmtCreate":1635870072754,"gmtModify":1635870072826,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Come n play","listText":"Come n play","text":"Come n play","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841959209","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1345,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841924826,"gmtCreate":1635869865994,"gmtModify":1635869866103,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841924826","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":765,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855838513,"gmtCreate":1635347993685,"gmtModify":1635347993873,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/855838513","repostId":"2178239526","repostType":4,"isVote":1,"tweetType":1,"viewCount":941,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823236464,"gmtCreate":1633625179113,"gmtModify":1633625179333,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/823236464","repostId":"1123346561","repostType":4,"repost":{"id":"1123346561","kind":"news","pubTimestamp":1633612422,"share":"https://www.laohu8.com/m/news/1123346561?lang=zh_CN&edition=full","pubTime":"2021-10-07 21:13","market":"us","language":"en","title":"Lordstown Motors Is the Poster Child for Blank-Check Firms<blockquote>洛兹敦汽车公司是空白支票公司的典型代表</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1123346561","media":"InvestorPlace","summary":"RIDE stock confirms the importance of due diligence.\n\nA few months ago, I expressed some concerns ab","content":"<p><div> RIDE stock confirms the importance of due diligence.  A few months ago, I expressed some concerns about Lordstown Motors Corp. stock and suffice to say, it was not well received. Source: Postmodern ...</p><p><blockquote><div>RIDE股票证实了尽职调查的重要性。几个月前，我表达了对洛兹敦汽车公司股票的一些担忧，可以说，它并没有受到好评。来源：后现代...</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/10/ride-stock-poster-child-for-spacs/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/10/ride-stock-poster-child-for-spacs/\">网页连接</a></blockquote></p><p></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lordstown Motors Is the Poster Child for Blank-Check Firms<blockquote>洛兹敦汽车公司是空白支票公司的典型代表</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLordstown Motors Is the Poster Child for Blank-Check Firms<blockquote>洛兹敦汽车公司是空白支票公司的典型代表</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">InvestorPlace</strong><span class=\"h-time small\">2021-10-07 21:13</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> RIDE stock confirms the importance of due diligence.  A few months ago, I expressed some concerns about Lordstown Motors Corp. stock and suffice to say, it was not well received. Source: Postmodern ...</p><p><blockquote><div>RIDE股票证实了尽职调查的重要性。几个月前，我表达了对洛兹敦汽车公司股票的一些担忧，可以说，它并没有受到好评。来源：后现代...</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/10/ride-stock-poster-child-for-spacs/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/10/ride-stock-poster-child-for-spacs/\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://investorplace.com/2021/10/ride-stock-poster-child-for-spacs/\">InvestorPlace</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/10/ride-stock-poster-child-for-spacs/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123346561","content_text":"RIDE stock confirms the importance of due diligence.\n\nA few months ago, I expressed some concerns about Lordstown Motors Corp. stock and suffice to say, it was not well received.\nSource: Postmodern Studio / Shutterstock.com\nI could understand why. Even though the criticisms I received regarding my take on RIDE stock did not involve this admission, the reality is that no one likes losing money on a deal.\nHow often have we fretted over losing out on a negotiation rather than the joys that we accrued through victories in other areas. According to an NPR report, this concept has a name,loss aversion. “People care more about losing a dollar than gaining a dollar.” So, I get the anger over losing money from banking on RIDE stock.\nIf it makes anyone feel any better, I’ve put my money down on plenty of clunkers. All I can tell you is that you got to stay in the game through smart money management.\nBut there’s also another point here and that’s the value of due diligence. At the end of September, theNew York Times revealed thatHon Hai Precision Industry Co.(OTCMKTS:HNHPF) – better known as Foxconn – reached an agreement in principle to develop Lordstown’s electric vehicles. Also, it’s quite possible that the EV maker could sell its Ohio factory to Foxconn.\nAdding more woes to stakeholders of RIDE stock, Lordstown “said it would continue to use the factory to make the Endurance by leasing back space from Foxconn if the sale was completed. Foxconn would then offer employment contracts to some Lordstown manufacturing employees. Troubled companies often resort to sale-lease back deals as a way to raise cash.”\nThat’s not all. Under the terms of the agreement, “Foxconn agreed to buy $50 million worth of Lordstown shares at a price of $6.89.” At time of writing, RIDE stock closed at $5.85.\nBlank-Check Fever Was the Blessing and Curse of RIDE Stock\nWith so much attention focused on EVs in light of the massive paradigm shift from the novel coronavirus, it’s easy to forget that RIDE stock came to us via a merger with a special purpose acquisition company. Over the trailing year, SPACs have been the talk of town. But at the end of this period, this distinct manner of an initial public offering has come under scrutiny.\nFor one thing, RIDE stock isn’t an anomaly among post-merger business combinations. True, the hideousness of the losses – down 10% on Oct. 4, down 31% in the trailing five days and down 74% year-to-date – are a bit extreme, even for SPACs. However, SPACs overall have beenunderperforming benchmark indicesso far this year.\nNow, I don’t want to hit on SPACs (with an “S” in front) without providing some balanced context. One of the key benefits of these shell companies is that they open opportunities that would otherwise not be publicly available. Also, for the fullest of full disclosures, I make moneyanalyzing SPACs, so there’s that angle.\nBut the positives of blank-check firms don’t exempt one from conducting due diligence. You just got to do it, especially when you’re betting blind on pre-merger-announcement SPACs.\nBut what really struck me about RIDE stock is that it appears that at least with some SPACs, even their backers haven’t conducted a thorough examination. AnotherNew York Timesarticle describes how the scrutiny of a key architect of the SPAC that merged with Lordstown “was most likely far lessthan the inspection that a company undergoes in a conventional initial public offering.”\n“In an I.P.O., a company is held to strict reporting standards about its finances and prospects. By contrast, SPAC mergers give companies that would find it challenging to go public on their own an easier path to the public markets.”\nBe Careful Out There\nI’m not about to tell you not to buy SPACs – that would be SPAC-ist. Because let’s be real, even traditional IPOs can suffer from questionable antics. Otherwise, the filmThe Wolf of Wall Streetwouldn’t be as colorful as it was.\nBut the takeaway is that SPACs do seem to tempt the worst of behaviors from sponsors that seem to have their own interest in mind rather than the long-term viability of the deals they’re quarterbacking.\nPerhaps that’s the legacy of RIDE stock if this equity unit doesn’t make it out of this mess. Don’t be too comfortable flying with SPAC Air: there might not be anyone in the cockpit.","news_type":1,"symbols_score_info":{"RIDE":0.9}},"isVote":1,"tweetType":1,"viewCount":1067,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829445986,"gmtCreate":1633538342129,"gmtModify":1633538342340,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/829445986","repostId":"2173091050","repostType":4,"isVote":1,"tweetType":1,"viewCount":733,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820152447,"gmtCreate":1633360994670,"gmtModify":1633361053911,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/820152447","repostId":"1185304471","repostType":4,"repost":{"id":"1185304471","kind":"news","pubTimestamp":1633360698,"share":"https://www.laohu8.com/m/news/1185304471?lang=zh_CN&edition=full","pubTime":"2021-10-04 23:18","market":"us","language":"en","title":"Fed's Bullard: U.S. businesses having no problems raising prices<blockquote>美联储布拉德：美国企业提价没有问题</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1185304471","media":"finance.yahoo","summary":"(Reuters) - U.S. businesses are having few problems raising prices on customers for the first time i","content":"<p>(Reuters) - U.S. businesses are having few problems raising prices on customers for the first time in years, St. Louis Federal Reserve Bank President James Bullard said on Monday, as he warned that inflation could remain elevated for some time to come amid fears higher expectations become entrenched.</p><p><blockquote>（路透社）-圣路易斯联邦储备银行行长詹姆斯·布拉德周一表示，美国企业多年来首次向客户提价几乎没有问题，他警告称，由于担心通胀可能在未来一段时间内保持高位。更高的预期变得根深蒂固。</blockquote></p><p> Bullard's business contacts in his Fed district and around the country \"typically say 'don't worry my company's going to be profitable because I am going to raise prices and we've had no difficulty raising prices in this environment,'\" Bullard said during an event held by the International Economic Forum of the Americas.</p><p><blockquote>布拉德在美联储地区和全国各地的业务联系人“通常会说‘不要担心我的公司会盈利，因为我将提高价格，而在这种环境下我们提高价格没有任何困难，’”布拉德在美洲国际经济论坛举办的一次活动中说道。</blockquote></p><p> Bullard is among the strongest advocates at the U.S. central bank for aggressive moves to combat higher-than-expected inflation and he sees two interest rate hikes needed in 2022. Interest rates remain near zero currently, where they have been since the onset of the COVID-19 pandemic in early 2020.</p><p><blockquote>布拉德是美联储最强烈主张采取积极行动应对高于预期的通胀的人之一，他认为2022年需要加息两次。目前利率仍接近于零，自2020年初COVID-19大流行爆发以来一直如此。</blockquote></p><p> \"I am concerned about the changing mentality, I would say, around prices in the economy and the relative freedom that businesses feel that they can just pass on increased costs easily to their customers. For years, that's not been the case,\" Bullard added.</p><p><blockquote>“我想说，我担心经济中围绕价格的心态不断变化，以及企业认为可以轻松地将增加的成本转嫁给客户的相对自由。多年来，情况并非如此，”布拉德补充道。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fed's Bullard: U.S. businesses having no problems raising prices<blockquote>美联储布拉德：美国企业提价没有问题</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed's Bullard: U.S. businesses having no problems raising prices<blockquote>美联储布拉德：美国企业提价没有问题</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">finance.yahoo</strong><span class=\"h-time small\">2021-10-04 23:18</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Reuters) - U.S. businesses are having few problems raising prices on customers for the first time in years, St. Louis Federal Reserve Bank President James Bullard said on Monday, as he warned that inflation could remain elevated for some time to come amid fears higher expectations become entrenched.</p><p><blockquote>（路透社）-圣路易斯联邦储备银行行长詹姆斯·布拉德周一表示，美国企业多年来首次向客户提价几乎没有问题，他警告称，由于担心通胀可能在未来一段时间内保持高位。更高的预期变得根深蒂固。</blockquote></p><p> Bullard's business contacts in his Fed district and around the country \"typically say 'don't worry my company's going to be profitable because I am going to raise prices and we've had no difficulty raising prices in this environment,'\" Bullard said during an event held by the International Economic Forum of the Americas.</p><p><blockquote>布拉德在美联储地区和全国各地的业务联系人“通常会说‘不要担心我的公司会盈利，因为我将提高价格，而在这种环境下我们提高价格没有任何困难，’”布拉德在美洲国际经济论坛举办的一次活动中说道。</blockquote></p><p> Bullard is among the strongest advocates at the U.S. central bank for aggressive moves to combat higher-than-expected inflation and he sees two interest rate hikes needed in 2022. Interest rates remain near zero currently, where they have been since the onset of the COVID-19 pandemic in early 2020.</p><p><blockquote>布拉德是美联储最强烈主张采取积极行动应对高于预期的通胀的人之一，他认为2022年需要加息两次。目前利率仍接近于零，自2020年初COVID-19大流行爆发以来一直如此。</blockquote></p><p> \"I am concerned about the changing mentality, I would say, around prices in the economy and the relative freedom that businesses feel that they can just pass on increased costs easily to their customers. For years, that's not been the case,\" Bullard added.</p><p><blockquote>“我想说，我担心经济中围绕价格的心态不断变化，以及企业认为可以轻松地将增加的成本转嫁给客户的相对自由。多年来，情况并非如此，”布拉德补充道。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/feds-bullard-u-businesses-having-151026032.html\">finance.yahoo</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/feds-bullard-u-businesses-having-151026032.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185304471","content_text":"(Reuters) - U.S. businesses are having few problems raising prices on customers for the first time in years, St. Louis Federal Reserve Bank President James Bullard said on Monday, as he warned that inflation could remain elevated for some time to come amid fears higher expectations become entrenched.\nBullard's business contacts in his Fed district and around the country \"typically say 'don't worry my company's going to be profitable because I am going to raise prices and we've had no difficulty raising prices in this environment,'\" Bullard said during an event held by the International Economic Forum of the Americas.\nBullard is among the strongest advocates at the U.S. central bank for aggressive moves to combat higher-than-expected inflation and he sees two interest rate hikes needed in 2022. Interest rates remain near zero currently, where they have been since the onset of the COVID-19 pandemic in early 2020.\n\"I am concerned about the changing mentality, I would say, around prices in the economy and the relative freedom that businesses feel that they can just pass on increased costs easily to their customers. For years, that's not been the case,\" Bullard added.","news_type":1,"symbols_score_info":{".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":1210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867919618,"gmtCreate":1633184557310,"gmtModify":1633184557600,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/867919618","repostId":"1134305481","repostType":4,"repost":{"id":"1134305481","kind":"news","pubTimestamp":1633152909,"share":"https://www.laohu8.com/m/news/1134305481?lang=zh_CN&edition=full","pubTime":"2021-10-02 13:35","market":"sh","language":"en","title":"3 Stocks That Can Double Again in the Fourth Quarter<blockquote>四季度可以再次翻倍的3只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1134305481","media":"The motley fool","summary":"Key Points\n\nCrocs has jacked up its guidance every quarter this year. It reports again later this mo","content":"<p>Key Points</p><p><blockquote>要点</blockquote></p><p> <ul>  <li>Crocs has jacked up its guidance every quarter this year. It reports again later this month.</li>  <li>AMC would have to double from here to revisit its June highs. Check the upcoming theatrical release slate to know why movie theaters are about to get a whole lot better.</li>  <li>Upstart is revolutionizing the way creditworthiness is determined in consumer loans, and it's laughing all the way to the bank.</li> </ul> </p><p><blockquote><ul><li>Crocs今年每个季度都上调了指引。它将于本月晚些时候再次报道。</li><li>AMC必须在此基础上翻一番才能重温6月份的高点。查看即将上映的影院上映名单，了解为什么电影院会变得更好。</li><li>Upstart正在彻底改变消费贷款中确定信用度的方式，并且一直笑到银行。</li></ul></blockquote></p><p> It's been a volatile year for stocks, but naturally some investments have fared better than others. Over 300 stocks have more than doubled in 2021. Many of those winning investments will be lucky if they can hold those gains through the final three months of the year, but what about the names that have the potential to double again?</p><p><blockquote>对于股市来说，今年是动荡的一年，但自然有些投资的表现比其他投资更好。超过300只股票在2021年上涨了一倍多。如果许多获胜的投资能够在今年最后三个月保持这些收益，那将是幸运的，但那些有潜力再次翻倍的投资呢？</blockquote></p><p> <b>Crocs</b>&nbsp;(NASDAQ:CROX),<b>AMC Entertainment</b>(NYSE:AMC), and<b>Upstart</b>&nbsp;(NASDAQ:UPST)have more than doubled in value through the first nine months of 2021. Let's see why they have what it takes to possibly repeat the feat in the fourth quarter.</p><p><blockquote><b>卡骆驰</b>（纳斯达克：CROX），<b>AMC院线</b>（纽约证券交易所代码：AMC），以及<b>暴发户</b>（纳斯达克：UPST）的价值在2021年前9个月翻了一番多。让我们看看为什么他们有能力在第四季度重复这一壮举。</blockquote></p><p> 1. Crocs</p><p><blockquote>1.Crocs</blockquote></p><p> Remember those bright rubbery shoes with holes in them? They're back in a big way. Crocs sales are booming since the pandemic began, and the stock is following suit with a 129% increase through the first nine months of 2021.</p><p><blockquote>还记得那双有洞的亮色胶鞋吗？他们大举回来了。自疫情爆发以来，Crocs的销量一直在蓬勃发展，该股也紧随其后，在2021年前9个月上涨了129%。</blockquote></p><p> The comfortable resin shoes were already making a comeback before the COVID-19 crisis with double-digit revenue growth in 2019 before repeating the feat in 2020. Momentum is what's really taking Crocs to a higher level in 2021.</p><p><blockquote>舒适的树脂鞋在新冠肺炎危机之前就已经卷土重来，2019年的收入实现了两位数的增长，然后在2020年重复了这一壮举。动力才是真正让Crocs在2021年更上一层楼的原因。</blockquote></p><p> The year began with the footwear maker projecting 20%-to-25% top-line growth for the entire year back in February. Guidance was bumped higher -- to between 40% and 50% growth -- the following quarter. It happened again this summer, with Crocs now targeting a 60%-to-65% surge in revenue for all of 2021. What do you think will happen if those targets get pushed even higher when it reports third-quarter results later this month?</p><p><blockquote>今年年初，这家鞋类制造商在2月份预计全年营收将增长20%至25%。下个季度的指引被上调至40%至50%之间。这种情况在今年夏天再次发生，Crocs现在的目标是2021年全年收入增长60%至65%。如果本月晚些时候公布第三季度业绩时这些目标被推得更高，您认为会发生什么？</blockquote></p><p> Despite a stock that has popped nearly sixfold since the start of 2019, Crocs is reasonably priced given its accelerating growth. It's trading at 21 times this year's earnings and just 17 times next year's target. There's clearly room to increase those multiples, and Wall Street's finally as comfortable with Crocs as an investment as its customers are in its shoes.</p><p><blockquote>尽管自2019年初以来，Crocs的股价已上涨近六倍，但鉴于其加速增长，其定价合理。该公司今年市盈率为21倍，明年目标市盈率仅为17倍。显然还有增加这些市盈率的空间，华尔街终于像客户一样对Crocs作为一项投资感到满意。</blockquote></p><p> 2. AMC Entertainment</p><p><blockquote>2.AMC院线</blockquote></p><p> You may be surprised to find the country's leading multiplex operator on this list, but plot twists are what make movies so good. It's certainly true that AMC Entertainment has appreciated -- in terms of both stock price and a fivefold explosion in shares outstanding -- to the point where its valuation is out of whack relative to its peers'. If you want a pure investing play on the movie theater industry's recovery, you will find more attractively priced stocks toscratchthatitch.</p><p><blockquote>你可能会惊讶地发现这个国家领先的多厅影院运营商在这个名单上，但情节曲折是电影如此优秀的原因。AMC院线确实已经升值——无论是股价还是流通股数量都增长了五倍——以至于其估值相对于同行来说已经不正常了。如果您想对电影院行业的复苏进行纯粹的投资，您会发现价格更具吸引力的股票。</blockquote></p><p> However, as ameme stockand cultural phenomenon it's hard to argue against what AMC has done to translate its popularity among retail investors into a legitimate market share grab in the recovery process. No company has seen its market cap inflate as much as AMC has this year, but this is also a stock that enters the fourth quarter with a stock price that is a little more than half of what it was when it peaked in June. In short, it would have to double from here to revisit its all-time high -- but isn't that always possible with the poster child for 2021 momentum stocks?</p><p><blockquote>然而，作为一种流行的股票和文化现象，很难否认AMC在复苏过程中将其在散户投资者中的受欢迎程度转化为合法的市场份额抢夺。今年没有一家公司的市值像AMC那样膨胀，但这也是一只进入第四季度的股票，股价仅为6月份峰值时的一半多一点。简而言之，它必须在这里翻倍才能重温历史高点——但对于2021年动量股的典型代表来说，这难道不总是可能的吗？</blockquote></p><p> Fundamentally speaking, the catalysts are also there.<i>Shang-Chi and the Legend of the Ten Rings</i>shattered box office records over Labor Day weekend, but the initial excitement fizzled out when subsequent weekends were abysmal. However, it's all about the pipeline. Studios pushed out September releases into October and beyond when the delta variant resulted in a spike in COVID-19 cases. We're now seeing the highly anticipated films start to come back, starting with the new James Bond movie next weekend. The fourth quarter should be a lot stronger for the industry than the naysayers think, and if AMC stock gets back to where it was in early June -- fundamentally earned this time -- it will have to double from here.</p><p><blockquote>从根本上说，催化剂也在。<i>尚气与十环传说</i>劳动节周末打破了票房记录，但最初的兴奋随着随后的周末糟糕透顶而消失。然而，这一切都与管道有关。当德尔塔变异毒株导致新冠肺炎病例激增时，电影公司将9月的上映推迟到10月及以后。我们现在看到备受期待的电影开始回归，从下周末的新詹姆斯·邦德电影开始。该行业第四季度的表现应该比反对者想象的要强劲得多，如果AMC股价回到6月初的水平——这次基本上是盈利的——那么它将不得不在此基础上翻一番。</blockquote></p><p> 3. Upstart</p><p><blockquote>3.暴发户</blockquote></p><p> I love when industries ripe for disruption get upended, and that's what Upstart is doing with the lending industry. Upstart usesartificial intelligenceand machine learning to make better calls on assessing risk profiles and creditworthiness for folks who don't typically get approved for consumer loans.</p><p><blockquote>我喜欢颠覆成熟的行业被颠覆，这就是Upstart在贷款行业所做的事情。Upstart使用人工智能和机器学习来更好地评级评估那些通常不会获得消费贷款批准的人的风险状况和信用度。</blockquote></p><p> Growth is bonkers. Revenue seemed to be decelerating sharply, with slowing growth spurts of 89%, 52%, and 27% in the last three years respectively. Now that consumers are becoming aware of Upstart as a better alternative to payday loans and other predatory lending products, business is skyrocketing. Revenue rose 90% in the first quarter, only to surge 1,018% in its latest report. And no, that's not a typo.</p><p><blockquote>增长是疯狂的。收入似乎正在急剧减速，过去三年的增长分别放缓了89%、52%和27%。现在，消费者开始意识到Upstart是发薪日贷款和其他掠夺性贷款产品的更好替代品，业务正在飙升。第一季度收入增长90%，但在最新报告中却飙升了1,018%。不，这不是错别字。</blockquote></p><p></p><p> With Upstart now expanding into the auto loans market, the potential for its better alternative to stodgy credit scores is just getting started. The stock has been a seven-bagger through the first three quarters of 2021, but the runway is long for this disruptive jet.</p><p><blockquote>随着Upstart现在扩展到汽车贷款市场，其更好的替代乏味信用评分的潜力才刚刚开始。该股在2021年前三个季度已上涨七倍，但对于这款颠覆性喷气式飞机来说，跑道还很长。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks That Can Double Again in the Fourth Quarter<blockquote>四季度可以再次翻倍的3只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks That Can Double Again in the Fourth Quarter<blockquote>四季度可以再次翻倍的3只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The motley fool</strong><span class=\"h-time small\">2021-10-02 13:35</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Key Points</p><p><blockquote>要点</blockquote></p><p> <ul>  <li>Crocs has jacked up its guidance every quarter this year. It reports again later this month.</li>  <li>AMC would have to double from here to revisit its June highs. Check the upcoming theatrical release slate to know why movie theaters are about to get a whole lot better.</li>  <li>Upstart is revolutionizing the way creditworthiness is determined in consumer loans, and it's laughing all the way to the bank.</li> </ul> </p><p><blockquote><ul><li>Crocs今年每个季度都上调了指引。它将于本月晚些时候再次报道。</li><li>AMC必须在此基础上翻一番才能重温6月份的高点。查看即将上映的影院上映名单，了解为什么电影院会变得更好。</li><li>Upstart正在彻底改变消费贷款中确定信用度的方式，并且一直笑到银行。</li></ul></blockquote></p><p> It's been a volatile year for stocks, but naturally some investments have fared better than others. Over 300 stocks have more than doubled in 2021. Many of those winning investments will be lucky if they can hold those gains through the final three months of the year, but what about the names that have the potential to double again?</p><p><blockquote>对于股市来说，今年是动荡的一年，但自然有些投资的表现比其他投资更好。超过300只股票在2021年上涨了一倍多。如果许多获胜的投资能够在今年最后三个月保持这些收益，那将是幸运的，但那些有潜力再次翻倍的投资呢？</blockquote></p><p> <b>Crocs</b>&nbsp;(NASDAQ:CROX),<b>AMC Entertainment</b>(NYSE:AMC), and<b>Upstart</b>&nbsp;(NASDAQ:UPST)have more than doubled in value through the first nine months of 2021. Let's see why they have what it takes to possibly repeat the feat in the fourth quarter.</p><p><blockquote><b>卡骆驰</b>（纳斯达克：CROX），<b>AMC院线</b>（纽约证券交易所代码：AMC），以及<b>暴发户</b>（纳斯达克：UPST）的价值在2021年前9个月翻了一番多。让我们看看为什么他们有能力在第四季度重复这一壮举。</blockquote></p><p> 1. Crocs</p><p><blockquote>1.Crocs</blockquote></p><p> Remember those bright rubbery shoes with holes in them? They're back in a big way. Crocs sales are booming since the pandemic began, and the stock is following suit with a 129% increase through the first nine months of 2021.</p><p><blockquote>还记得那双有洞的亮色胶鞋吗？他们大举回来了。自疫情爆发以来，Crocs的销量一直在蓬勃发展，该股也紧随其后，在2021年前9个月上涨了129%。</blockquote></p><p> The comfortable resin shoes were already making a comeback before the COVID-19 crisis with double-digit revenue growth in 2019 before repeating the feat in 2020. Momentum is what's really taking Crocs to a higher level in 2021.</p><p><blockquote>舒适的树脂鞋在新冠肺炎危机之前就已经卷土重来，2019年的收入实现了两位数的增长，然后在2020年重复了这一壮举。动力才是真正让Crocs在2021年更上一层楼的原因。</blockquote></p><p> The year began with the footwear maker projecting 20%-to-25% top-line growth for the entire year back in February. Guidance was bumped higher -- to between 40% and 50% growth -- the following quarter. It happened again this summer, with Crocs now targeting a 60%-to-65% surge in revenue for all of 2021. What do you think will happen if those targets get pushed even higher when it reports third-quarter results later this month?</p><p><blockquote>今年年初，这家鞋类制造商在2月份预计全年营收将增长20%至25%。下个季度的指引被上调至40%至50%之间。这种情况在今年夏天再次发生，Crocs现在的目标是2021年全年收入增长60%至65%。如果本月晚些时候公布第三季度业绩时这些目标被推得更高，您认为会发生什么？</blockquote></p><p> Despite a stock that has popped nearly sixfold since the start of 2019, Crocs is reasonably priced given its accelerating growth. It's trading at 21 times this year's earnings and just 17 times next year's target. There's clearly room to increase those multiples, and Wall Street's finally as comfortable with Crocs as an investment as its customers are in its shoes.</p><p><blockquote>尽管自2019年初以来，Crocs的股价已上涨近六倍，但鉴于其加速增长，其定价合理。该公司今年市盈率为21倍，明年目标市盈率仅为17倍。显然还有增加这些市盈率的空间，华尔街终于像客户一样对Crocs作为一项投资感到满意。</blockquote></p><p> 2. AMC Entertainment</p><p><blockquote>2.AMC院线</blockquote></p><p> You may be surprised to find the country's leading multiplex operator on this list, but plot twists are what make movies so good. It's certainly true that AMC Entertainment has appreciated -- in terms of both stock price and a fivefold explosion in shares outstanding -- to the point where its valuation is out of whack relative to its peers'. If you want a pure investing play on the movie theater industry's recovery, you will find more attractively priced stocks toscratchthatitch.</p><p><blockquote>你可能会惊讶地发现这个国家领先的多厅影院运营商在这个名单上，但情节曲折是电影如此优秀的原因。AMC院线确实已经升值——无论是股价还是流通股数量都增长了五倍——以至于其估值相对于同行来说已经不正常了。如果您想对电影院行业的复苏进行纯粹的投资，您会发现价格更具吸引力的股票。</blockquote></p><p> However, as ameme stockand cultural phenomenon it's hard to argue against what AMC has done to translate its popularity among retail investors into a legitimate market share grab in the recovery process. No company has seen its market cap inflate as much as AMC has this year, but this is also a stock that enters the fourth quarter with a stock price that is a little more than half of what it was when it peaked in June. In short, it would have to double from here to revisit its all-time high -- but isn't that always possible with the poster child for 2021 momentum stocks?</p><p><blockquote>然而，作为一种流行的股票和文化现象，很难否认AMC在复苏过程中将其在散户投资者中的受欢迎程度转化为合法的市场份额抢夺。今年没有一家公司的市值像AMC那样膨胀，但这也是一只进入第四季度的股票，股价仅为6月份峰值时的一半多一点。简而言之，它必须在这里翻倍才能重温历史高点——但对于2021年动量股的典型代表来说，这难道不总是可能的吗？</blockquote></p><p> Fundamentally speaking, the catalysts are also there.<i>Shang-Chi and the Legend of the Ten Rings</i>shattered box office records over Labor Day weekend, but the initial excitement fizzled out when subsequent weekends were abysmal. However, it's all about the pipeline. Studios pushed out September releases into October and beyond when the delta variant resulted in a spike in COVID-19 cases. We're now seeing the highly anticipated films start to come back, starting with the new James Bond movie next weekend. The fourth quarter should be a lot stronger for the industry than the naysayers think, and if AMC stock gets back to where it was in early June -- fundamentally earned this time -- it will have to double from here.</p><p><blockquote>从根本上说，催化剂也在。<i>尚气与十环传说</i>劳动节周末打破了票房记录，但最初的兴奋随着随后的周末糟糕透顶而消失。然而，这一切都与管道有关。当德尔塔变异毒株导致新冠肺炎病例激增时，电影公司将9月的上映推迟到10月及以后。我们现在看到备受期待的电影开始回归，从下周末的新詹姆斯·邦德电影开始。该行业第四季度的表现应该比反对者想象的要强劲得多，如果AMC股价回到6月初的水平——这次基本上是盈利的——那么它将不得不在此基础上翻一番。</blockquote></p><p> 3. Upstart</p><p><blockquote>3.暴发户</blockquote></p><p> I love when industries ripe for disruption get upended, and that's what Upstart is doing with the lending industry. Upstart usesartificial intelligenceand machine learning to make better calls on assessing risk profiles and creditworthiness for folks who don't typically get approved for consumer loans.</p><p><blockquote>我喜欢颠覆成熟的行业被颠覆，这就是Upstart在贷款行业所做的事情。Upstart使用人工智能和机器学习来更好地评级评估那些通常不会获得消费贷款批准的人的风险状况和信用度。</blockquote></p><p> Growth is bonkers. Revenue seemed to be decelerating sharply, with slowing growth spurts of 89%, 52%, and 27% in the last three years respectively. Now that consumers are becoming aware of Upstart as a better alternative to payday loans and other predatory lending products, business is skyrocketing. Revenue rose 90% in the first quarter, only to surge 1,018% in its latest report. And no, that's not a typo.</p><p><blockquote>增长是疯狂的。收入似乎正在急剧减速，过去三年的增长分别放缓了89%、52%和27%。现在，消费者开始意识到Upstart是发薪日贷款和其他掠夺性贷款产品的更好替代品，业务正在飙升。第一季度收入增长90%，但在最新报告中却飙升了1,018%。不，这不是错别字。</blockquote></p><p></p><p> With Upstart now expanding into the auto loans market, the potential for its better alternative to stodgy credit scores is just getting started. The stock has been a seven-bagger through the first three quarters of 2021, but the runway is long for this disruptive jet.</p><p><blockquote>随着Upstart现在扩展到汽车贷款市场，其更好的替代乏味信用评分的潜力才刚刚开始。该股在2021年前三个季度已上涨七倍，但对于这款颠覆性喷气式飞机来说，跑道还很长。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/10/01/3-stocks-that-can-double-again-in-the-fourth-quart/\">The motley fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","AMC":"AMC院线","CROX":"卡骆驰"},"source_url":"https://www.fool.com/investing/2021/10/01/3-stocks-that-can-double-again-in-the-fourth-quart/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134305481","content_text":"Key Points\n\nCrocs has jacked up its guidance every quarter this year. It reports again later this month.\nAMC would have to double from here to revisit its June highs. Check the upcoming theatrical release slate to know why movie theaters are about to get a whole lot better.\nUpstart is revolutionizing the way creditworthiness is determined in consumer loans, and it's laughing all the way to the bank.\n\n\nIt's been a volatile year for stocks, but naturally some investments have fared better than others. Over 300 stocks have more than doubled in 2021. Many of those winning investments will be lucky if they can hold those gains through the final three months of the year, but what about the names that have the potential to double again?\nCrocs (NASDAQ:CROX),AMC Entertainment(NYSE:AMC), andUpstart (NASDAQ:UPST)have more than doubled in value through the first nine months of 2021. Let's see why they have what it takes to possibly repeat the feat in the fourth quarter.\n1. Crocs\nRemember those bright rubbery shoes with holes in them? They're back in a big way. Crocs sales are booming since the pandemic began, and the stock is following suit with a 129% increase through the first nine months of 2021.\nThe comfortable resin shoes were already making a comeback before the COVID-19 crisis with double-digit revenue growth in 2019 before repeating the feat in 2020. Momentum is what's really taking Crocs to a higher level in 2021.\nThe year began with the footwear maker projecting 20%-to-25% top-line growth for the entire year back in February. Guidance was bumped higher -- to between 40% and 50% growth -- the following quarter. It happened again this summer, with Crocs now targeting a 60%-to-65% surge in revenue for all of 2021. What do you think will happen if those targets get pushed even higher when it reports third-quarter results later this month?\nDespite a stock that has popped nearly sixfold since the start of 2019, Crocs is reasonably priced given its accelerating growth. It's trading at 21 times this year's earnings and just 17 times next year's target. There's clearly room to increase those multiples, and Wall Street's finally as comfortable with Crocs as an investment as its customers are in its shoes.\n2. AMC Entertainment\nYou may be surprised to find the country's leading multiplex operator on this list, but plot twists are what make movies so good. It's certainly true that AMC Entertainment has appreciated -- in terms of both stock price and a fivefold explosion in shares outstanding -- to the point where its valuation is out of whack relative to its peers'. If you want a pure investing play on the movie theater industry's recovery, you will find more attractively priced stocks toscratchthatitch.\nHowever, as ameme stockand cultural phenomenon it's hard to argue against what AMC has done to translate its popularity among retail investors into a legitimate market share grab in the recovery process. No company has seen its market cap inflate as much as AMC has this year, but this is also a stock that enters the fourth quarter with a stock price that is a little more than half of what it was when it peaked in June. In short, it would have to double from here to revisit its all-time high -- but isn't that always possible with the poster child for 2021 momentum stocks?\nFundamentally speaking, the catalysts are also there.Shang-Chi and the Legend of the Ten Ringsshattered box office records over Labor Day weekend, but the initial excitement fizzled out when subsequent weekends were abysmal. However, it's all about the pipeline. Studios pushed out September releases into October and beyond when the delta variant resulted in a spike in COVID-19 cases. We're now seeing the highly anticipated films start to come back, starting with the new James Bond movie next weekend. The fourth quarter should be a lot stronger for the industry than the naysayers think, and if AMC stock gets back to where it was in early June -- fundamentally earned this time -- it will have to double from here.\n3. Upstart\nI love when industries ripe for disruption get upended, and that's what Upstart is doing with the lending industry. Upstart usesartificial intelligenceand machine learning to make better calls on assessing risk profiles and creditworthiness for folks who don't typically get approved for consumer loans.\nGrowth is bonkers. Revenue seemed to be decelerating sharply, with slowing growth spurts of 89%, 52%, and 27% in the last three years respectively. Now that consumers are becoming aware of Upstart as a better alternative to payday loans and other predatory lending products, business is skyrocketing. Revenue rose 90% in the first quarter, only to surge 1,018% in its latest report. And no, that's not a typo.\nWith Upstart now expanding into the auto loans market, the potential for its better alternative to stodgy credit scores is just getting started. The stock has been a seven-bagger through the first three quarters of 2021, but the runway is long for this disruptive jet.","news_type":1,"symbols_score_info":{"CROX":0.9,"AMC":0.9,"UPST":0.9}},"isVote":1,"tweetType":1,"viewCount":998,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865442253,"gmtCreate":1633013712650,"gmtModify":1633013712887,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/865442253","repostId":"1149815025","repostType":4,"repost":{"id":"1149815025","kind":"news","pubTimestamp":1633013380,"share":"https://www.laohu8.com/m/news/1149815025?lang=zh_CN&edition=full","pubTime":"2021-09-30 22:49","market":"us","language":"en","title":"BioNTech: Stock Price Buoyancy Depends On Comirnaty Sales, But Long Term Value On Pipeline<blockquote>BioNTech：股价上涨取决于Comirnaty销售，但长期价值在于管道</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1149815025","media":"Seeking Alpha","summary":"Summary\n\nBioNTech has been a phenomenal success story for investors, delivering a ~1,900% gain on in","content":"<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>BioNTech has been a phenomenal success story for investors, delivering a ~1,900% gain on investment since its 2019 IPO.</li>  <li>Sales of its mRNA vaccine Comirnaty will earn the company in excess of $18bn in 2021, management believes - firmly ahead of expectations.</li>  <li>These revenues are likely not sustainable, however - I expect them to dip below $10bn from 2022.</li>  <li>Nevertheless, BioNTech has never been about a single vaccine and the pipeline excites.</li>  <li>mRNA technology is here to stay and BioNTech's pipeline will soon become the key measure for valuing the company. It may take time but a triple-digit billion valuation is a distinct possibility in my view.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d4c2347e8f25525b37a93f78e0d8ba65\" tg-width=\"1536\" tg-height=\"1092\" width=\"100%\" height=\"auto\"><span>PM Images/DigitalVision via Getty Images</span></p><p><blockquote><ul><li>BioNTech对投资者来说是一个非凡的成功故事，自2019年IPO以来，投资收益约为1,900%。</li><li>管理层相信，2021年其mRNA疫苗Comirnaty的销售额将为该公司带来超过180亿美元的收入，远远超出预期。</li><li>然而，这些收入可能不可持续——我预计从2022年起，它们将降至100亿美元以下。</li><li>尽管如此，BioNTech从来都不是关于单一疫苗，管道令人兴奋。</li><li>mRNA技术将继续存在，BioNTech的产品线将很快成为公司估值的关键指标。这可能需要时间，但在我看来，三位数的估值是一个明显的可能性。</li></ul><p class=\"t-img-caption\"><span>PM Images/DigitalVision来自Getty Images</span></p></blockquote></p><p> <b>Investment Thesis</b></p><p><blockquote><b>投资论文</b></blockquote></p><p> BioNTech (BNTX) shareholders who backed the messenger-RNA pioneer at the time of the Germany based company's IPO, which raised ~$150m at a price of $15, can be well satisfied with a &gt;1,900% gain on investment to date - but is the company still worth backing at current price of $277 per share?</p><p><blockquote>BioNTech(BNTX)股东在这家德国公司首次公开募股时支持这家信使RNA先驱，该公司以15美元的价格筹集了约1.5亿美元，他们对迄今为止超过1,900%的投资收益感到非常满意-但以目前每股277美元的价格，该公司仍然值得支持吗？</blockquote></p><p> When I&nbsp;last covered BioNTech&nbsp;back in February, I set a share price forecast of ~$200 for BioNTech stock, but that was based on sales of its Comirnaty COVID vaccine - jointly developed with Pfizer (PFE) - reaching ~$7.5bn in 2021.</p><p><blockquote>当我上次在2月份报道BioNTech时，我将BioNTech股票的股价预测设定为约200美元，但这是基于其与辉瑞(PFE)联合开发的Comirnaty COVID疫苗的销售额到2021年将达到约75亿美元。</blockquote></p><p> Releasing its&nbsp;Q2'21 results&nbsp;in early August, the company reported 6-month revenues of $8.56bn - shattering my expectations - and its share price reached a stunning peak of $388.</p><p><blockquote>该公司在8月初发布了21年第二季度业绩，报告6个月营收为85.6亿美元，超出了我的预期，股价也达到了388美元的惊人峰值。</blockquote></p><p> At the time of writing, shares have fallen back to a price of $277 - discounted by ~29% from their August peak, but with full-year revenues forecast by management to be in the region of $18.5bn, and net profits perhaps reaching &gt;$13.5bn (if we take 6-month net profit figure of $6.8bn and double it), investors will likely look at a forward price to sales ratio of 4x, and forward price to earnings ratio of ~5x, and feel that BioNTech stock continues to look great value.</p><p><blockquote>截至撰写本文时，股价已回落至277美元，较8月份的峰值折价约29%，但管理层预测全年收入约为185亿美元，净利润可能达到135亿美元以上（如果我们将6个月净利润数字为68亿美元并翻倍），投资者可能会看到4倍的远期市销率和约5倍的远期市盈率，并认为BioNTech股票看起来仍然很有价值。</blockquote></p><p> Essentially, two factors will determine whether BioNTech shares are worth buying at current price, and also how long investors should think about holding them.</p><p><blockquote>从本质上讲，有两个因素将决定BioNTech股票是否值得以当前价格购买，以及投资者应该考虑持有它们多长时间。</blockquote></p><p> The first is the scale of ongoing demand for its COVID vaccine Comirnaty. Sadly, revenues from this source have probably exceeded the market's wildest expectations, with the pandemic refusing to die down, and with booster shots now&nbsp;approved&nbsp;to be administered to over-65's in the US, and to over-50's in the UK, and&nbsp;under consideration&nbsp;for all people over the age of 16 in Europe, there appears to be no set limit to how many Comirnaty shots BioNTech will eventually sell.</p><p><blockquote>首先是对其新冠疫苗Comirnaty的持续需求规模。可悲的是，这一来源的收入可能超出了市场最疯狂的预期，因为疫情拒绝消退，而且加强注射现在被批准用于美国65岁以上的人，在英国50岁以上的人，并且正在考虑针对欧洲所有16岁以上的人，BioNTech最终销售的Comirnaty疫苗数量似乎没有设定限制。</blockquote></p><p> The second is the migration of the use of messenger-RNA technologies into other therapeutic modalities, to target a broad range of diseases, where it can potentially challenge current standards of care on efficacy and safety.</p><p><blockquote>第二个是信使RNA技术的使用迁移到其他治疗模式中，以针对广泛的疾病，在这些疾病中，它可能会在疗效和安全性方面挑战当前的护理标准。</blockquote></p><p> Only in a nightmare scenario will vaccine demand remain at current levels beyond the next 2-3 years, and therefore BioNTech's revenues will not remain at 2021 levels over the long term, unless it can launch new vaccine products targeting e.g. other infectious diseases, oncology, auto-immune, inflammation, regenerative medicines, etc.</p><p><blockquote>只有在噩梦般的情况下，疫苗需求才会在未来2-3年内保持在当前水平，因此BioNTech的收入长期不会保持在2021年的水平，除非它能够推出针对其他传染病、肿瘤学、自身免疫、炎症、再生医学等的新疫苗产品。</blockquote></p><p> To that end, BioNTech recently released a&nbsp;70-slide presentation&nbsp;highlighting its development pipeline, and reporting progress across all the above treatment fields. Not one single mention of its COVID vaccine can be found, illustrating that BioNTech has never, and will never think of itself as a pure COVID vaccine company.</p><p><blockquote>为此，BioNTech最近发布了一份70张幻灯片的演示文稿，重点介绍了其开发管道，并报告了上述所有治疗领域的进展。找不到一处提及其COVID疫苗的地方，这表明BioNTech从来没有也永远不会认为自己是一家纯粹的COVID疫苗公司。</blockquote></p><p> Even so, it will take time to successfully develop new mRNA therapies in other indications, and success is not guaranteed.</p><p><blockquote>即便如此，在其他适应症中成功开发新的mRNA疗法还需要时间，也不能保证成功。</blockquote></p><p> New challengers are emerging in the mRNA field, with strong investor backing and ambitious goals - China-based pharma Abogen Biosciences, for example,recently raised&nbsp;&gt;&nbsp;$700m of funding to develop an mRNA COVID vaccine whilst Sanofi (SNY), the French Pharma company with a &gt;$120bn market cap valuation recently&nbsp;splashed out&nbsp;$3.2bn to acquire Translate Bio, and its messenger RNA Technology targeting Cystic Fibrosis and other genetic diseases.</p><p><blockquote>mRNA领域正在出现新的挑战者，拥有强大的投资者支持和雄心勃勃的目标——例如，中国制药公司Abogen Biosciences最近筹集了超过7亿美元的资金来开发mRNA新冠疫苗，而法国制药公司赛诺菲(SNY)市值超过1200亿美元，最近斥资32亿美元收购了Translate Bio及其针对囊性纤维化和其他遗传疾病的信使RNA技术。</blockquote></p><p> 6 months ago, Moderna (MRNA), BioNTech and CureVac were probably considered the \"Big 3\" mRNA pioneers, but CureVac's failure to successfully develop a COVID vaccine has wiped &gt;50% off of its market value whilst Moderna stock has realized unprecedented highs, trading at a price of $390 at the time of writing, with a market valuation of $157bn.</p><p><blockquote>6个月前，Moderna(MRNA)、BioNTech和CureVac可能被认为是“三大”mRNA先驱，但CureVac未能成功开发新冠疫苗，使其市值蒸发了50%以上，而Moderna股票却实现了前所未有的高点，截至撰写本文时，交易价格为390美元，市值为1570亿美元。</blockquote></p><p></p><p> That is a staggeringly high valuation, but as I argued in my last post on BioNTech and in&nbsp;other posts on Moderna&nbsp;itself, that valuation could potentially double again if the company can prove that mRNA technology will work in any therapeutic setting - as it is striving to do.</p><p><blockquote>这是一个高得惊人的估值，但正如我在关于BioNTech的上一篇文章和关于Moderna本身的其他文章中所指出的那样，如果该公司能够证明mRNA技术可以在任何治疗环境中发挥作用，那么估值可能会再次翻倍——正如它正在努力做的那样。</blockquote></p><p> I would certainly argue that BioNTech has more in common with Moderna than it does with CureVac - the company will earn a similar volume of revenues in FY21 as Moderna, and yet its market cap of $75bn is half that of Moderna's.</p><p><blockquote>我当然认为BioNTech与Moderna的共同点多于与CureVac的共同点——该公司在2021财年的收入将与Moderna相似，但其750亿美元的市值是Moderna的一半。</blockquote></p><p> That may be due firstly to the market's perception that BioNTech owes much of its success to Pfizer, whilst Moderna is not reliant on a Big Pharma partner, and secondly on the strength of Moderna's non-COVID programs.</p><p><blockquote>这可能首先是因为市场认为BioNTech的成功很大程度上归功于辉瑞，而Moderna并不依赖大型制药合作伙伴，其次是因为Moderna的非新冠项目的实力。</blockquote></p><p> In the rest of this post I will take a closer look at BioNTech's Covid earnings, and its longer-term development pipeline in order to highlight the short and long-term investment cases.</p><p><blockquote>在本文的其余部分中，我将仔细研究BioNTech的Covid收益及其长期发展渠道，以强调短期和长期投资案例。</blockquote></p><p> My thesis is that BioNTech is not worth less than half Moderna, and that Moderna itself is potentially undervalued relative to its opportunities to develop mRNA vaccines and therapies in other therapeutic modalities.</p><p><blockquote>我的论点是，BioNTech的价值不低于Moderna的一半，而且相对于其在其他治疗模式中开发mRNA疫苗和疗法的机会，Moderna本身可能被低估。</blockquote></p><p> As such, my feeling is that investors can pick up BioNTech stock at current price and be optimistic of ~30% near-term upside, based on recent developments with Comirnaty, and the introduction of booster shots.</p><p><blockquote>因此，我的感觉是，根据Comirnaty最近的进展以及加强注射的推出，投资者可以以当前价格买入BioNTech股票，并对近期约30%的上涨持乐观态度。</blockquote></p><p> A dip may follow if COVID revenues begin to slide after 2022, which I expect to happen, and be pronounced, but this ought to be offset by pipeline progress, which suggests to me that BioNTech could maintain a &gt;$100bn market cap, which may even be at the lower end of expectations.</p><p><blockquote>如果COVID收入在2022年之后开始下滑（我预计这种情况会发生，并且是明显的），那么收入可能会下降，但这应该会被管道进展所抵消，这在我看来表明BioNTech可以保持超过1000亿美元的市值，这可能甚至处于预期的下限。</blockquote></p><p> <b>Outlook for Comirnaty</b></p><p><blockquote><b>Comirnaty展望</b></blockquote></p><p> Pfizer/BioNTech'sCovid vaccine - now known as Comirnaty, is fully approved by the FDA, and used in &gt;130 countries in the fight against Coronavirus.</p><p><blockquote>辉瑞/BioNTech的COVID疫苗——现在被称为Comirnaty，已获得FDA的完全批准，并在超过130个国家用于对抗冠状病毒。</blockquote></p><p> In the first 6 months of 2021, BioNTech and Pfizer shipped &gt;1bn doses of Comirnaty, signed supply contracts to deliver another 2.2bn doses by the end of the year, and committed to supply a further 2bn doses to low and middle-income nations, according to a summation in BioNTech's Q2'21&nbsp;earnings presentation.</p><p><blockquote>根据BioNTech 21年第二季度财报的总结，2021年前6个月，BioNTech和辉瑞运送了超过10亿剂Comirnaty，签署了到年底再交付22亿剂的供应合同，并承诺向中低收入国家再供应20亿剂。</blockquote></p><p> Alongside an agreement signed with the EU to provide 900m doses, and potentially another 900m - doses that had been earmarked for fulfilment by CureVac before its vaccine&nbsp;failed to achieve&nbsp;the required efficacy in its pivotal trial, with just 47% versus Pfizer / BioNTech's &gt;95% - there are 90m doses going to the US, and potentially 90m more in 2022.</p><p><blockquote>除了与欧盟签署的提供9亿剂疫苗的协议外，还可能再提供9亿剂疫苗——在其疫苗在关键试验中未能达到所需功效之前，CureVac已指定由其履行，仅为47%，而辉瑞/BioNTech的疫苗&gt;95%——美国将有9000万剂疫苗，2022年可能会增加9000万剂。</blockquote></p><p> Since August, however, Comirnaty has&nbsp;received&nbsp;an Emergency Use Authorisation (\"EUA\") for use as a booster vaccine, for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups, based on data suggesting that the vaccine \"elicits high neutralization titers against SARS-CoV-2 and all currently tested variants\".</p><p><blockquote>然而，自8月以来，Comirnaty已获得紧急使用授权（“EUA”），用作加强疫苗，适用于65岁及以上的个人以及某些高危人群中18至64岁的个人，数据表明该疫苗“对新型冠状病毒病毒和所有当前测试的变种产生高中和滴度”。</blockquote></p><p> Covid is simply refusing to go away, with a significant spike in infections, hospitalizations and deaths reported across the past 2 months, according to data from the&nbsp;New York Times.</p><p><blockquote>根据《纽约时报》的数据，Covid根本拒绝消失，过去两个月报告的感染、住院和死亡人数大幅增加。</blockquote></p><p> Just as it was the first vaccine approved in the US for COVID, Comirnaty is now the first to be approved as a booster shot, and it seems logical that, in time, booster shots will be extended to the entire US population, and populations worldwide. Looking further ahead, it also seems likely that annual or biannual shots will be required as COVID becomes an endemic disease.</p><p><blockquote>正如它是美国批准的第一个用于COVID的疫苗一样，Comirnaty现在是第一个被批准作为加强注射的疫苗，随着时间的推移，加强注射将扩展到整个美国人口和世界各地的人口，这似乎是合乎逻辑的。展望未来，随着COVID成为一种地方病，似乎也可能需要每年或每两年注射一次。</blockquote></p><p> With that said, I would argue that it is unlikely that BioNTech will replicate its $18bn of sales - which works out at just under 1bn doses - in 2021 in future years.</p><p><blockquote>话虽如此，我认为BioNTech不太可能在未来几年复制其2021年180亿美元的销售额（即略低于10亿剂）。</blockquote></p><p> At maximum capacity, Pfizer/BioNTech can manufacture ~2bn doses per annum, so we can be fairly sure that each firms' sales are capped at &gt;$20bn per annum, but it is also likely that both companies average selling price will decrease after 2021, as the vaccine rollout switches from developed, to developing nations.</p><p><blockquote>在最大产能下，辉瑞/BioNTech每年可以生产约20亿剂疫苗，因此我们可以相当肯定每家公司的销售额上限为每年200亿美元以上，但两家公司的平均售价也有可能在2021年后下降，随着疫苗的推出从发达国家转向发展中国家。</blockquote></p><p> Arguably, if every global citizen receives 2 vaccinations per annum, there is demand for ~16bn doses per annum, and as a key supplier, BioNTech would have no issues selling 1bn doses per annum. The deals recently done with the EU are not far short of such figures, but they may not be repeatable, and logistically speaking there is little or no chance that any population globally will be able to achieve &gt;50% population vaccination in a single year in my view.</p><p><blockquote>可以说，如果每个全球公民每年接种2次疫苗，每年的需求约为160亿剂，而作为主要供应商，BioNTech每年销售10亿剂疫苗不会有任何问题。最近与欧盟达成的协议与这样的数字相差不远，但它们可能无法重复，从逻辑上讲，在我看来，全球任何人口在一年内实现超过50%的人口疫苗接种的可能性很小或没有。</blockquote></p><p> As such, I would not expect to see BioNTech earn double-digit billions from Comirnaty sales in any year after 2021, and its profit margins may well narrow after this year - the near 80% profit margin achieved across the first 6 months of 2021 is also simply unsustainable from an economic or ethical viewpoint.</p><p><blockquote>因此，我预计BioNTech在2021年之后的任何一年都不会从Comirnaty销售额中赚取两位数的数十亿美元，而且其利润率在今年之后很可能会收窄——2021年前6个月实现的近80%的利润率也是从经济或伦理的角度来看根本是不可持续的。</blockquote></p><p> I would put forward an average figure of ~$8bn per annum for BioNTech's earnings from Comirnaty between 2022 - 2025, for the reasons discussed above, and a profit margin average of ~50%.</p><p><blockquote>出于上述原因，我认为BioNTech在2022年至2025年间从Comirnaty获得的平均收益约为每年80亿美元，平均利润率约为50%。</blockquote></p><p></p><p> That gives me a price to sales ratio of ~9.4x and price to earnings ratio of ~19x - not especially attractive, but realistic, and for a company with as much promise as BioNTech, perhaps a strong value proposition, given what may come from its pipeline.</p><p><blockquote>这给了我约9.4倍的市销率和约19倍的市盈率——不是特别有吸引力，但很现实，对于像BioNTech这样有前途的公司来说，考虑到可能来自它的管道。</blockquote></p><p> <b>Outlook for Pipeline</b></p><p><blockquote><b>管道展望</b></blockquote></p><p> When we think about the fact that neither BioNTech nor Moderna can realistically rely on revenues or profit margins from its COVID vaccine sales being sustained over the long term at current levels, their valuations - $75bn and $153bn respectively - may look too high.</p><p><blockquote>当我们想到BioNTech和Moderna都无法真正依赖其新冠疫苗销售的收入或利润率长期维持在当前水平时，它们的估值（分别为750亿美元和1530亿美元）可能看起来太高了。</blockquote></p><p> But believers in mRNA technology - and why wouldn't anyone be excited by a technology as powerful as mRNA, which can effectively instruct cells to manufacture literally any protein - may feel that both companies are significantly undervalued.</p><p><blockquote>但mRNA技术的信徒——以及为什么没有人会对mRNA这样强大的技术感到兴奋，这种技术可以有效地指导细胞制造任何蛋白质——可能会觉得这两家公司的价值都被严重低估了。</blockquote></p><p> The key question, however, is whether each company is able to deliver the hoped for revolution in medicine - personalized vaccines for many/all disease types, tailored to the patients' specific genetic profile - how long it will take, what the risk of failure is, and what will happen to each company's share price in the interim period.</p><p><blockquote>然而，关键问题是每家公司是否能够提供人们所希望的医学革命——针对许多/所有疾病类型的个性化疫苗，根据患者的特定基因特征量身定制——这需要多长时间，失败的风险是什么，以及在此期间每家公司的股价会发生什么变化。</blockquote></p><p> The first and most obvious targets are infectious diseases - then oncology, CAR-T cell therapy, immuno-therapies, and then expansion into multiple modalities, covering most disease types that any investor can care to think of.</p><p><blockquote>第一个也是最明显的目标是传染病——然后是肿瘤学、CAR-T细胞疗法、免疫疗法，然后扩展到多种模式，涵盖任何投资者能想到的大多数疾病类型。</blockquote></p><p> 12 months ago even, BioNTech's infectious disease pipeline went largely under the radar but emboldened by its success with Comirnaty, BioNTech now boasts vaccines in development for Malaria, Tuberculosis and HIV, 10 mRNA vaccines in clinical development targeting infectious diseases, and an influenza vaccine, jointly developed with Pfizer, which implies that the 2 companies are willing to work together over the long term - perhaps a merger is even a possibility.</p><p><blockquote>甚至在12个月前，BioNTech的传染病产品线在很大程度上还没有引起人们的注意，但由于Comirnaty的成功，BioNTech现在拥有正在开发的疟疾、结核病和艾滋病毒疫苗，10种针对传染病的mRNA疫苗正在临床开发中，以及一种流感疫苗，与辉瑞联合开发，这意味着两家公司愿意长期合作——也许合并甚至是可能的。</blockquote></p><p> By the end of this year, BioNTech will deliver 5 trial updates from vaccines targeting solid tumors, leveraging bi-specifics, CD40, and CAR-T cell therapy, and largely targeting solid tumors, initiate 3 Phase 2 trials, targeting melanoma, head and neck cancer, and colorectal cancer, as well as 7 Phase 1 trials, including its influenza vaccine program.</p><p><blockquote>到今年年底，BioNTech将提供5项针对实体瘤的疫苗的试验更新，利用双特异性、CD40和CAR-T细胞疗法，并主要针对实体瘤，启动3项2期试验，针对黑色素瘤、头颈癌和结直肠癌，以及7项1期试验，包括其流感疫苗计划。</blockquote></p><p> All of the company's plans are laid out in its latest&nbsp;investor presentation- collaborations with Pharma powerhouses such as Regeneron (REGN), Genentech (a Roche subsidiary), and Sanofi, as well as Pfizer.</p><p><blockquote>该公司的所有计划都在其最新的投资者演示中进行了阐述——与再生元(REGN)、基因泰克（罗氏子公司）、赛诺菲以及辉瑞等制药巨头的合作。</blockquote></p><p> There are 15 oncology programs in total, 6 infectious disease vaccines (admittedly still at the preclinical stage), therapies targeting PD-1 / PDL1, the targets of cancer blockbuster drugs such as Bristol Myers Squibb's (BMY) Opdivo and Merck's (MRK) Keytruda, cell therapies, and cytokine inhibitors.</p><p><blockquote>总共有15个肿瘤学项目、6个传染病疫苗（诚然仍处于临床前阶段）、靶向PD-1/PDL1的疗法、百时美施贵宝（BMY）Opdivo和默克（MRK）Keytruda等癌症重磅药物的靶点、细胞疗法和细胞因子抑制剂。</blockquote></p><p> <b>Conclusion</b></p><p><blockquote><b>结论</b></blockquote></p><p> My point in relation to both BioNTech and Moderna is that both are increasingly beginning to behave more and more like Big Pharma firms - anticipating that their revenue-generating assets may not have a lengthy shelf life, and understanding that they must deliver new medicines in order to support current valuations over the longer term.</p><p><blockquote>我对BioNTech和Moderna的看法是，两者的行为越来越像大型制药公司——预计他们的创收资产可能没有很长的保质期，并明白他们必须提供新药才能长期支持当前估值。</blockquote></p><p> Reviewing BioNtech's latest investor presentation - which I encourage all prospective investors to do - I was struck by the amount of progress BioNTech has made in a single year, and not just from a development perspective - the company has always had grand ambitions - but from an organisational, and PR perspective also.</p><p><blockquote>回顾BioNTech最新的投资者演示文稿（我鼓励所有潜在投资者这样做），我对BioNTech在一年内取得的进步感到震惊，不仅从发展的角度来看——该公司一直有远大的抱负——而且从组织和公关的角度来看。</blockquote></p><p> There's no question in my mind that the market still values BioNTech as if it were a pure COVID vaccine play, and any company with a single, $18bn per annum selling asset is highly unlikely to be able to distract investor's attention away from that asset.</p><p><blockquote>在我看来，毫无疑问，市场仍然将BioNTech视为纯粹的新冠疫苗业务，任何每年出售180亿美元资产的公司都不太可能将投资者的注意力从该资产上转移开。</blockquote></p><p> But BioNtech and its management team are smarter than most, in my view, just like their technology, and it is planning for the long term.</p><p><blockquote>但在我看来，BioNtech及其管理团队比大多数人都聪明，就像他们的技术一样，并且正在进行长期规划。</blockquote></p><p> Data readouts in oncology - and there ought to be 5 before the end of this year - and progress towards commercialisation of a new infectious disease vaccine - will rapidly become the key yardsticks for assessing the true value of BioNTech shares.</p><p><blockquote>肿瘤学数据（今年年底前应该会有5个）以及新型传染病疫苗商业化的进展将迅速成为评估BioNTech股票真实价值的关键标准。</blockquote></p><p> There is currently no need for investors to be concerned about BioNtech's share price crashing on negative data readouts from these programs - when there are double-digit billion annual revenues in play - but these programs will increasingly replace Comirnaty sales as the stock markets' weighing machine, and that ought to be good news for fans of mRNA science - of which I am one.</p><p><blockquote>目前，投资者没有必要担心BioNtech的股价因这些项目的负面数据而暴跌（当年收入达到两位数十亿美元时），但这些项目将越来越多地取代Comirnaty sales成为股市的称重机器，这对于mRNA科学的粉丝来说应该是个好消息——我就是其中之一。</blockquote></p><p> It may take time, but BioNTech represents an exciting buy and hold opportunity for biotech enthusiasts, in my view.</p><p><blockquote>这可能需要时间，但在我看来，BioNTech对于生物技术爱好者来说是一个令人兴奋的买入并持有机会。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech: Stock Price Buoyancy Depends On Comirnaty Sales, But Long Term Value On Pipeline<blockquote>BioNTech：股价上涨取决于Comirnaty销售，但长期价值在于管道</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech: Stock Price Buoyancy Depends On Comirnaty Sales, But Long Term Value On Pipeline<blockquote>BioNTech：股价上涨取决于Comirnaty销售，但长期价值在于管道</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-09-30 22:49</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>BioNTech has been a phenomenal success story for investors, delivering a ~1,900% gain on investment since its 2019 IPO.</li>  <li>Sales of its mRNA vaccine Comirnaty will earn the company in excess of $18bn in 2021, management believes - firmly ahead of expectations.</li>  <li>These revenues are likely not sustainable, however - I expect them to dip below $10bn from 2022.</li>  <li>Nevertheless, BioNTech has never been about a single vaccine and the pipeline excites.</li>  <li>mRNA technology is here to stay and BioNTech's pipeline will soon become the key measure for valuing the company. It may take time but a triple-digit billion valuation is a distinct possibility in my view.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d4c2347e8f25525b37a93f78e0d8ba65\" tg-width=\"1536\" tg-height=\"1092\" width=\"100%\" height=\"auto\"><span>PM Images/DigitalVision via Getty Images</span></p><p><blockquote><ul><li>BioNTech对投资者来说是一个非凡的成功故事，自2019年IPO以来，投资收益约为1,900%。</li><li>管理层相信，2021年其mRNA疫苗Comirnaty的销售额将为该公司带来超过180亿美元的收入，远远超出预期。</li><li>然而，这些收入可能不可持续——我预计从2022年起，它们将降至100亿美元以下。</li><li>尽管如此，BioNTech从来都不是关于单一疫苗，管道令人兴奋。</li><li>mRNA技术将继续存在，BioNTech的产品线将很快成为公司估值的关键指标。这可能需要时间，但在我看来，三位数的估值是一个明显的可能性。</li></ul><p class=\"t-img-caption\"><span>PM Images/DigitalVision来自Getty Images</span></p></blockquote></p><p> <b>Investment Thesis</b></p><p><blockquote><b>投资论文</b></blockquote></p><p> BioNTech (BNTX) shareholders who backed the messenger-RNA pioneer at the time of the Germany based company's IPO, which raised ~$150m at a price of $15, can be well satisfied with a &gt;1,900% gain on investment to date - but is the company still worth backing at current price of $277 per share?</p><p><blockquote>BioNTech(BNTX)股东在这家德国公司首次公开募股时支持这家信使RNA先驱，该公司以15美元的价格筹集了约1.5亿美元，他们对迄今为止超过1,900%的投资收益感到非常满意-但以目前每股277美元的价格，该公司仍然值得支持吗？</blockquote></p><p> When I&nbsp;last covered BioNTech&nbsp;back in February, I set a share price forecast of ~$200 for BioNTech stock, but that was based on sales of its Comirnaty COVID vaccine - jointly developed with Pfizer (PFE) - reaching ~$7.5bn in 2021.</p><p><blockquote>当我上次在2月份报道BioNTech时，我将BioNTech股票的股价预测设定为约200美元，但这是基于其与辉瑞(PFE)联合开发的Comirnaty COVID疫苗的销售额到2021年将达到约75亿美元。</blockquote></p><p> Releasing its&nbsp;Q2'21 results&nbsp;in early August, the company reported 6-month revenues of $8.56bn - shattering my expectations - and its share price reached a stunning peak of $388.</p><p><blockquote>该公司在8月初发布了21年第二季度业绩，报告6个月营收为85.6亿美元，超出了我的预期，股价也达到了388美元的惊人峰值。</blockquote></p><p> At the time of writing, shares have fallen back to a price of $277 - discounted by ~29% from their August peak, but with full-year revenues forecast by management to be in the region of $18.5bn, and net profits perhaps reaching &gt;$13.5bn (if we take 6-month net profit figure of $6.8bn and double it), investors will likely look at a forward price to sales ratio of 4x, and forward price to earnings ratio of ~5x, and feel that BioNTech stock continues to look great value.</p><p><blockquote>截至撰写本文时，股价已回落至277美元，较8月份的峰值折价约29%，但管理层预测全年收入约为185亿美元，净利润可能达到135亿美元以上（如果我们将6个月净利润数字为68亿美元并翻倍），投资者可能会看到4倍的远期市销率和约5倍的远期市盈率，并认为BioNTech股票看起来仍然很有价值。</blockquote></p><p> Essentially, two factors will determine whether BioNTech shares are worth buying at current price, and also how long investors should think about holding them.</p><p><blockquote>从本质上讲，有两个因素将决定BioNTech股票是否值得以当前价格购买，以及投资者应该考虑持有它们多长时间。</blockquote></p><p> The first is the scale of ongoing demand for its COVID vaccine Comirnaty. Sadly, revenues from this source have probably exceeded the market's wildest expectations, with the pandemic refusing to die down, and with booster shots now&nbsp;approved&nbsp;to be administered to over-65's in the US, and to over-50's in the UK, and&nbsp;under consideration&nbsp;for all people over the age of 16 in Europe, there appears to be no set limit to how many Comirnaty shots BioNTech will eventually sell.</p><p><blockquote>首先是对其新冠疫苗Comirnaty的持续需求规模。可悲的是，这一来源的收入可能超出了市场最疯狂的预期，因为疫情拒绝消退，而且加强注射现在被批准用于美国65岁以上的人，在英国50岁以上的人，并且正在考虑针对欧洲所有16岁以上的人，BioNTech最终销售的Comirnaty疫苗数量似乎没有设定限制。</blockquote></p><p> The second is the migration of the use of messenger-RNA technologies into other therapeutic modalities, to target a broad range of diseases, where it can potentially challenge current standards of care on efficacy and safety.</p><p><blockquote>第二个是信使RNA技术的使用迁移到其他治疗模式中，以针对广泛的疾病，在这些疾病中，它可能会在疗效和安全性方面挑战当前的护理标准。</blockquote></p><p> Only in a nightmare scenario will vaccine demand remain at current levels beyond the next 2-3 years, and therefore BioNTech's revenues will not remain at 2021 levels over the long term, unless it can launch new vaccine products targeting e.g. other infectious diseases, oncology, auto-immune, inflammation, regenerative medicines, etc.</p><p><blockquote>只有在噩梦般的情况下，疫苗需求才会在未来2-3年内保持在当前水平，因此BioNTech的收入长期不会保持在2021年的水平，除非它能够推出针对其他传染病、肿瘤学、自身免疫、炎症、再生医学等的新疫苗产品。</blockquote></p><p> To that end, BioNTech recently released a&nbsp;70-slide presentation&nbsp;highlighting its development pipeline, and reporting progress across all the above treatment fields. Not one single mention of its COVID vaccine can be found, illustrating that BioNTech has never, and will never think of itself as a pure COVID vaccine company.</p><p><blockquote>为此，BioNTech最近发布了一份70张幻灯片的演示文稿，重点介绍了其开发管道，并报告了上述所有治疗领域的进展。找不到一处提及其COVID疫苗的地方，这表明BioNTech从来没有也永远不会认为自己是一家纯粹的COVID疫苗公司。</blockquote></p><p> Even so, it will take time to successfully develop new mRNA therapies in other indications, and success is not guaranteed.</p><p><blockquote>即便如此，在其他适应症中成功开发新的mRNA疗法还需要时间，也不能保证成功。</blockquote></p><p> New challengers are emerging in the mRNA field, with strong investor backing and ambitious goals - China-based pharma Abogen Biosciences, for example,recently raised&nbsp;&gt;&nbsp;$700m of funding to develop an mRNA COVID vaccine whilst Sanofi (SNY), the French Pharma company with a &gt;$120bn market cap valuation recently&nbsp;splashed out&nbsp;$3.2bn to acquire Translate Bio, and its messenger RNA Technology targeting Cystic Fibrosis and other genetic diseases.</p><p><blockquote>mRNA领域正在出现新的挑战者，拥有强大的投资者支持和雄心勃勃的目标——例如，中国制药公司Abogen Biosciences最近筹集了超过7亿美元的资金来开发mRNA新冠疫苗，而法国制药公司赛诺菲(SNY)市值超过1200亿美元，最近斥资32亿美元收购了Translate Bio及其针对囊性纤维化和其他遗传疾病的信使RNA技术。</blockquote></p><p> 6 months ago, Moderna (MRNA), BioNTech and CureVac were probably considered the \"Big 3\" mRNA pioneers, but CureVac's failure to successfully develop a COVID vaccine has wiped &gt;50% off of its market value whilst Moderna stock has realized unprecedented highs, trading at a price of $390 at the time of writing, with a market valuation of $157bn.</p><p><blockquote>6个月前，Moderna(MRNA)、BioNTech和CureVac可能被认为是“三大”mRNA先驱，但CureVac未能成功开发新冠疫苗，使其市值蒸发了50%以上，而Moderna股票却实现了前所未有的高点，截至撰写本文时，交易价格为390美元，市值为1570亿美元。</blockquote></p><p></p><p> That is a staggeringly high valuation, but as I argued in my last post on BioNTech and in&nbsp;other posts on Moderna&nbsp;itself, that valuation could potentially double again if the company can prove that mRNA technology will work in any therapeutic setting - as it is striving to do.</p><p><blockquote>这是一个高得惊人的估值，但正如我在关于BioNTech的上一篇文章和关于Moderna本身的其他文章中所指出的那样，如果该公司能够证明mRNA技术可以在任何治疗环境中发挥作用，那么估值可能会再次翻倍——正如它正在努力做的那样。</blockquote></p><p> I would certainly argue that BioNTech has more in common with Moderna than it does with CureVac - the company will earn a similar volume of revenues in FY21 as Moderna, and yet its market cap of $75bn is half that of Moderna's.</p><p><blockquote>我当然认为BioNTech与Moderna的共同点多于与CureVac的共同点——该公司在2021财年的收入将与Moderna相似，但其750亿美元的市值是Moderna的一半。</blockquote></p><p> That may be due firstly to the market's perception that BioNTech owes much of its success to Pfizer, whilst Moderna is not reliant on a Big Pharma partner, and secondly on the strength of Moderna's non-COVID programs.</p><p><blockquote>这可能首先是因为市场认为BioNTech的成功很大程度上归功于辉瑞，而Moderna并不依赖大型制药合作伙伴，其次是因为Moderna的非新冠项目的实力。</blockquote></p><p> In the rest of this post I will take a closer look at BioNTech's Covid earnings, and its longer-term development pipeline in order to highlight the short and long-term investment cases.</p><p><blockquote>在本文的其余部分中，我将仔细研究BioNTech的Covid收益及其长期发展渠道，以强调短期和长期投资案例。</blockquote></p><p> My thesis is that BioNTech is not worth less than half Moderna, and that Moderna itself is potentially undervalued relative to its opportunities to develop mRNA vaccines and therapies in other therapeutic modalities.</p><p><blockquote>我的论点是，BioNTech的价值不低于Moderna的一半，而且相对于其在其他治疗模式中开发mRNA疫苗和疗法的机会，Moderna本身可能被低估。</blockquote></p><p> As such, my feeling is that investors can pick up BioNTech stock at current price and be optimistic of ~30% near-term upside, based on recent developments with Comirnaty, and the introduction of booster shots.</p><p><blockquote>因此，我的感觉是，根据Comirnaty最近的进展以及加强注射的推出，投资者可以以当前价格买入BioNTech股票，并对近期约30%的上涨持乐观态度。</blockquote></p><p> A dip may follow if COVID revenues begin to slide after 2022, which I expect to happen, and be pronounced, but this ought to be offset by pipeline progress, which suggests to me that BioNTech could maintain a &gt;$100bn market cap, which may even be at the lower end of expectations.</p><p><blockquote>如果COVID收入在2022年之后开始下滑（我预计这种情况会发生，并且是明显的），那么收入可能会下降，但这应该会被管道进展所抵消，这在我看来表明BioNTech可以保持超过1000亿美元的市值，这可能甚至处于预期的下限。</blockquote></p><p> <b>Outlook for Comirnaty</b></p><p><blockquote><b>Comirnaty展望</b></blockquote></p><p> Pfizer/BioNTech'sCovid vaccine - now known as Comirnaty, is fully approved by the FDA, and used in &gt;130 countries in the fight against Coronavirus.</p><p><blockquote>辉瑞/BioNTech的COVID疫苗——现在被称为Comirnaty，已获得FDA的完全批准，并在超过130个国家用于对抗冠状病毒。</blockquote></p><p> In the first 6 months of 2021, BioNTech and Pfizer shipped &gt;1bn doses of Comirnaty, signed supply contracts to deliver another 2.2bn doses by the end of the year, and committed to supply a further 2bn doses to low and middle-income nations, according to a summation in BioNTech's Q2'21&nbsp;earnings presentation.</p><p><blockquote>根据BioNTech 21年第二季度财报的总结，2021年前6个月，BioNTech和辉瑞运送了超过10亿剂Comirnaty，签署了到年底再交付22亿剂的供应合同，并承诺向中低收入国家再供应20亿剂。</blockquote></p><p> Alongside an agreement signed with the EU to provide 900m doses, and potentially another 900m - doses that had been earmarked for fulfilment by CureVac before its vaccine&nbsp;failed to achieve&nbsp;the required efficacy in its pivotal trial, with just 47% versus Pfizer / BioNTech's &gt;95% - there are 90m doses going to the US, and potentially 90m more in 2022.</p><p><blockquote>除了与欧盟签署的提供9亿剂疫苗的协议外，还可能再提供9亿剂疫苗——在其疫苗在关键试验中未能达到所需功效之前，CureVac已指定由其履行，仅为47%，而辉瑞/BioNTech的疫苗&gt;95%——美国将有9000万剂疫苗，2022年可能会增加9000万剂。</blockquote></p><p> Since August, however, Comirnaty has&nbsp;received&nbsp;an Emergency Use Authorisation (\"EUA\") for use as a booster vaccine, for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups, based on data suggesting that the vaccine \"elicits high neutralization titers against SARS-CoV-2 and all currently tested variants\".</p><p><blockquote>然而，自8月以来，Comirnaty已获得紧急使用授权（“EUA”），用作加强疫苗，适用于65岁及以上的个人以及某些高危人群中18至64岁的个人，数据表明该疫苗“对新型冠状病毒病毒和所有当前测试的变种产生高中和滴度”。</blockquote></p><p> Covid is simply refusing to go away, with a significant spike in infections, hospitalizations and deaths reported across the past 2 months, according to data from the&nbsp;New York Times.</p><p><blockquote>根据《纽约时报》的数据，Covid根本拒绝消失，过去两个月报告的感染、住院和死亡人数大幅增加。</blockquote></p><p> Just as it was the first vaccine approved in the US for COVID, Comirnaty is now the first to be approved as a booster shot, and it seems logical that, in time, booster shots will be extended to the entire US population, and populations worldwide. Looking further ahead, it also seems likely that annual or biannual shots will be required as COVID becomes an endemic disease.</p><p><blockquote>正如它是美国批准的第一个用于COVID的疫苗一样，Comirnaty现在是第一个被批准作为加强注射的疫苗，随着时间的推移，加强注射将扩展到整个美国人口和世界各地的人口，这似乎是合乎逻辑的。展望未来，随着COVID成为一种地方病，似乎也可能需要每年或每两年注射一次。</blockquote></p><p> With that said, I would argue that it is unlikely that BioNTech will replicate its $18bn of sales - which works out at just under 1bn doses - in 2021 in future years.</p><p><blockquote>话虽如此，我认为BioNTech不太可能在未来几年复制其2021年180亿美元的销售额（即略低于10亿剂）。</blockquote></p><p> At maximum capacity, Pfizer/BioNTech can manufacture ~2bn doses per annum, so we can be fairly sure that each firms' sales are capped at &gt;$20bn per annum, but it is also likely that both companies average selling price will decrease after 2021, as the vaccine rollout switches from developed, to developing nations.</p><p><blockquote>在最大产能下，辉瑞/BioNTech每年可以生产约20亿剂疫苗，因此我们可以相当肯定每家公司的销售额上限为每年200亿美元以上，但两家公司的平均售价也有可能在2021年后下降，随着疫苗的推出从发达国家转向发展中国家。</blockquote></p><p> Arguably, if every global citizen receives 2 vaccinations per annum, there is demand for ~16bn doses per annum, and as a key supplier, BioNTech would have no issues selling 1bn doses per annum. The deals recently done with the EU are not far short of such figures, but they may not be repeatable, and logistically speaking there is little or no chance that any population globally will be able to achieve &gt;50% population vaccination in a single year in my view.</p><p><blockquote>可以说，如果每个全球公民每年接种2次疫苗，每年的需求约为160亿剂，而作为主要供应商，BioNTech每年销售10亿剂疫苗不会有任何问题。最近与欧盟达成的协议与这样的数字相差不远，但它们可能无法重复，从逻辑上讲，在我看来，全球任何人口在一年内实现超过50%的人口疫苗接种的可能性很小或没有。</blockquote></p><p> As such, I would not expect to see BioNTech earn double-digit billions from Comirnaty sales in any year after 2021, and its profit margins may well narrow after this year - the near 80% profit margin achieved across the first 6 months of 2021 is also simply unsustainable from an economic or ethical viewpoint.</p><p><blockquote>因此，我预计BioNTech在2021年之后的任何一年都不会从Comirnaty销售额中赚取两位数的数十亿美元，而且其利润率在今年之后很可能会收窄——2021年前6个月实现的近80%的利润率也是从经济或伦理的角度来看根本是不可持续的。</blockquote></p><p> I would put forward an average figure of ~$8bn per annum for BioNTech's earnings from Comirnaty between 2022 - 2025, for the reasons discussed above, and a profit margin average of ~50%.</p><p><blockquote>出于上述原因，我认为BioNTech在2022年至2025年间从Comirnaty获得的平均收益约为每年80亿美元，平均利润率约为50%。</blockquote></p><p></p><p> That gives me a price to sales ratio of ~9.4x and price to earnings ratio of ~19x - not especially attractive, but realistic, and for a company with as much promise as BioNTech, perhaps a strong value proposition, given what may come from its pipeline.</p><p><blockquote>这给了我约9.4倍的市销率和约19倍的市盈率——不是特别有吸引力，但很现实，对于像BioNTech这样有前途的公司来说，考虑到可能来自它的管道。</blockquote></p><p> <b>Outlook for Pipeline</b></p><p><blockquote><b>管道展望</b></blockquote></p><p> When we think about the fact that neither BioNTech nor Moderna can realistically rely on revenues or profit margins from its COVID vaccine sales being sustained over the long term at current levels, their valuations - $75bn and $153bn respectively - may look too high.</p><p><blockquote>当我们想到BioNTech和Moderna都无法真正依赖其新冠疫苗销售的收入或利润率长期维持在当前水平时，它们的估值（分别为750亿美元和1530亿美元）可能看起来太高了。</blockquote></p><p> But believers in mRNA technology - and why wouldn't anyone be excited by a technology as powerful as mRNA, which can effectively instruct cells to manufacture literally any protein - may feel that both companies are significantly undervalued.</p><p><blockquote>但mRNA技术的信徒——以及为什么没有人会对mRNA这样强大的技术感到兴奋，这种技术可以有效地指导细胞制造任何蛋白质——可能会觉得这两家公司的价值都被严重低估了。</blockquote></p><p> The key question, however, is whether each company is able to deliver the hoped for revolution in medicine - personalized vaccines for many/all disease types, tailored to the patients' specific genetic profile - how long it will take, what the risk of failure is, and what will happen to each company's share price in the interim period.</p><p><blockquote>然而，关键问题是每家公司是否能够提供人们所希望的医学革命——针对许多/所有疾病类型的个性化疫苗，根据患者的特定基因特征量身定制——这需要多长时间，失败的风险是什么，以及在此期间每家公司的股价会发生什么变化。</blockquote></p><p> The first and most obvious targets are infectious diseases - then oncology, CAR-T cell therapy, immuno-therapies, and then expansion into multiple modalities, covering most disease types that any investor can care to think of.</p><p><blockquote>第一个也是最明显的目标是传染病——然后是肿瘤学、CAR-T细胞疗法、免疫疗法，然后扩展到多种模式，涵盖任何投资者能想到的大多数疾病类型。</blockquote></p><p> 12 months ago even, BioNTech's infectious disease pipeline went largely under the radar but emboldened by its success with Comirnaty, BioNTech now boasts vaccines in development for Malaria, Tuberculosis and HIV, 10 mRNA vaccines in clinical development targeting infectious diseases, and an influenza vaccine, jointly developed with Pfizer, which implies that the 2 companies are willing to work together over the long term - perhaps a merger is even a possibility.</p><p><blockquote>甚至在12个月前，BioNTech的传染病产品线在很大程度上还没有引起人们的注意，但由于Comirnaty的成功，BioNTech现在拥有正在开发的疟疾、结核病和艾滋病毒疫苗，10种针对传染病的mRNA疫苗正在临床开发中，以及一种流感疫苗，与辉瑞联合开发，这意味着两家公司愿意长期合作——也许合并甚至是可能的。</blockquote></p><p> By the end of this year, BioNTech will deliver 5 trial updates from vaccines targeting solid tumors, leveraging bi-specifics, CD40, and CAR-T cell therapy, and largely targeting solid tumors, initiate 3 Phase 2 trials, targeting melanoma, head and neck cancer, and colorectal cancer, as well as 7 Phase 1 trials, including its influenza vaccine program.</p><p><blockquote>到今年年底，BioNTech将提供5项针对实体瘤的疫苗的试验更新，利用双特异性、CD40和CAR-T细胞疗法，并主要针对实体瘤，启动3项2期试验，针对黑色素瘤、头颈癌和结直肠癌，以及7项1期试验，包括其流感疫苗计划。</blockquote></p><p> All of the company's plans are laid out in its latest&nbsp;investor presentation- collaborations with Pharma powerhouses such as Regeneron (REGN), Genentech (a Roche subsidiary), and Sanofi, as well as Pfizer.</p><p><blockquote>该公司的所有计划都在其最新的投资者演示中进行了阐述——与再生元(REGN)、基因泰克（罗氏子公司）、赛诺菲以及辉瑞等制药巨头的合作。</blockquote></p><p> There are 15 oncology programs in total, 6 infectious disease vaccines (admittedly still at the preclinical stage), therapies targeting PD-1 / PDL1, the targets of cancer blockbuster drugs such as Bristol Myers Squibb's (BMY) Opdivo and Merck's (MRK) Keytruda, cell therapies, and cytokine inhibitors.</p><p><blockquote>总共有15个肿瘤学项目、6个传染病疫苗（诚然仍处于临床前阶段）、靶向PD-1/PDL1的疗法、百时美施贵宝（BMY）Opdivo和默克（MRK）Keytruda等癌症重磅药物的靶点、细胞疗法和细胞因子抑制剂。</blockquote></p><p> <b>Conclusion</b></p><p><blockquote><b>结论</b></blockquote></p><p> My point in relation to both BioNTech and Moderna is that both are increasingly beginning to behave more and more like Big Pharma firms - anticipating that their revenue-generating assets may not have a lengthy shelf life, and understanding that they must deliver new medicines in order to support current valuations over the longer term.</p><p><blockquote>我对BioNTech和Moderna的看法是，两者的行为越来越像大型制药公司——预计他们的创收资产可能没有很长的保质期，并明白他们必须提供新药才能长期支持当前估值。</blockquote></p><p> Reviewing BioNtech's latest investor presentation - which I encourage all prospective investors to do - I was struck by the amount of progress BioNTech has made in a single year, and not just from a development perspective - the company has always had grand ambitions - but from an organisational, and PR perspective also.</p><p><blockquote>回顾BioNTech最新的投资者演示文稿（我鼓励所有潜在投资者这样做），我对BioNTech在一年内取得的进步感到震惊，不仅从发展的角度来看——该公司一直有远大的抱负——而且从组织和公关的角度来看。</blockquote></p><p> There's no question in my mind that the market still values BioNTech as if it were a pure COVID vaccine play, and any company with a single, $18bn per annum selling asset is highly unlikely to be able to distract investor's attention away from that asset.</p><p><blockquote>在我看来，毫无疑问，市场仍然将BioNTech视为纯粹的新冠疫苗业务，任何每年出售180亿美元资产的公司都不太可能将投资者的注意力从该资产上转移开。</blockquote></p><p> But BioNtech and its management team are smarter than most, in my view, just like their technology, and it is planning for the long term.</p><p><blockquote>但在我看来，BioNtech及其管理团队比大多数人都聪明，就像他们的技术一样，并且正在进行长期规划。</blockquote></p><p> Data readouts in oncology - and there ought to be 5 before the end of this year - and progress towards commercialisation of a new infectious disease vaccine - will rapidly become the key yardsticks for assessing the true value of BioNTech shares.</p><p><blockquote>肿瘤学数据（今年年底前应该会有5个）以及新型传染病疫苗商业化的进展将迅速成为评估BioNTech股票真实价值的关键标准。</blockquote></p><p> There is currently no need for investors to be concerned about BioNtech's share price crashing on negative data readouts from these programs - when there are double-digit billion annual revenues in play - but these programs will increasingly replace Comirnaty sales as the stock markets' weighing machine, and that ought to be good news for fans of mRNA science - of which I am one.</p><p><blockquote>目前，投资者没有必要担心BioNtech的股价因这些项目的负面数据而暴跌（当年收入达到两位数十亿美元时），但这些项目将越来越多地取代Comirnaty sales成为股市的称重机器，这对于mRNA科学的粉丝来说应该是个好消息——我就是其中之一。</blockquote></p><p> It may take time, but BioNTech represents an exciting buy and hold opportunity for biotech enthusiasts, in my view.</p><p><blockquote>这可能需要时间，但在我看来，BioNTech对于生物技术爱好者来说是一个令人兴奋的买入并持有机会。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/article/4457813-biontech-stock-price-buoyancy-depends-on-comirnaty-sales-but-long-term-value-on-pipeline-bntx\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/article/4457813-biontech-stock-price-buoyancy-depends-on-comirnaty-sales-but-long-term-value-on-pipeline-bntx","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149815025","content_text":"Summary\n\nBioNTech has been a phenomenal success story for investors, delivering a ~1,900% gain on investment since its 2019 IPO.\nSales of its mRNA vaccine Comirnaty will earn the company in excess of $18bn in 2021, management believes - firmly ahead of expectations.\nThese revenues are likely not sustainable, however - I expect them to dip below $10bn from 2022.\nNevertheless, BioNTech has never been about a single vaccine and the pipeline excites.\nmRNA technology is here to stay and BioNTech's pipeline will soon become the key measure for valuing the company. It may take time but a triple-digit billion valuation is a distinct possibility in my view.\n\nPM Images/DigitalVision via Getty Images\nInvestment Thesis\nBioNTech (BNTX) shareholders who backed the messenger-RNA pioneer at the time of the Germany based company's IPO, which raised ~$150m at a price of $15, can be well satisfied with a >1,900% gain on investment to date - but is the company still worth backing at current price of $277 per share?\nWhen I last covered BioNTech back in February, I set a share price forecast of ~$200 for BioNTech stock, but that was based on sales of its Comirnaty COVID vaccine - jointly developed with Pfizer (PFE) - reaching ~$7.5bn in 2021.\nReleasing its Q2'21 results in early August, the company reported 6-month revenues of $8.56bn - shattering my expectations - and its share price reached a stunning peak of $388.\nAt the time of writing, shares have fallen back to a price of $277 - discounted by ~29% from their August peak, but with full-year revenues forecast by management to be in the region of $18.5bn, and net profits perhaps reaching >$13.5bn (if we take 6-month net profit figure of $6.8bn and double it), investors will likely look at a forward price to sales ratio of 4x, and forward price to earnings ratio of ~5x, and feel that BioNTech stock continues to look great value.\nEssentially, two factors will determine whether BioNTech shares are worth buying at current price, and also how long investors should think about holding them.\nThe first is the scale of ongoing demand for its COVID vaccine Comirnaty. Sadly, revenues from this source have probably exceeded the market's wildest expectations, with the pandemic refusing to die down, and with booster shots now approved to be administered to over-65's in the US, and to over-50's in the UK, and under consideration for all people over the age of 16 in Europe, there appears to be no set limit to how many Comirnaty shots BioNTech will eventually sell.\nThe second is the migration of the use of messenger-RNA technologies into other therapeutic modalities, to target a broad range of diseases, where it can potentially challenge current standards of care on efficacy and safety.\nOnly in a nightmare scenario will vaccine demand remain at current levels beyond the next 2-3 years, and therefore BioNTech's revenues will not remain at 2021 levels over the long term, unless it can launch new vaccine products targeting e.g. other infectious diseases, oncology, auto-immune, inflammation, regenerative medicines, etc.\nTo that end, BioNTech recently released a 70-slide presentation highlighting its development pipeline, and reporting progress across all the above treatment fields. Not one single mention of its COVID vaccine can be found, illustrating that BioNTech has never, and will never think of itself as a pure COVID vaccine company.\nEven so, it will take time to successfully develop new mRNA therapies in other indications, and success is not guaranteed.\nNew challengers are emerging in the mRNA field, with strong investor backing and ambitious goals - China-based pharma Abogen Biosciences, for example,recently raised > $700m of funding to develop an mRNA COVID vaccine whilst Sanofi (SNY), the French Pharma company with a >$120bn market cap valuation recently splashed out $3.2bn to acquire Translate Bio, and its messenger RNA Technology targeting Cystic Fibrosis and other genetic diseases.\n6 months ago, Moderna (MRNA), BioNTech and CureVac were probably considered the \"Big 3\" mRNA pioneers, but CureVac's failure to successfully develop a COVID vaccine has wiped >50% off of its market value whilst Moderna stock has realized unprecedented highs, trading at a price of $390 at the time of writing, with a market valuation of $157bn.\nThat is a staggeringly high valuation, but as I argued in my last post on BioNTech and in other posts on Moderna itself, that valuation could potentially double again if the company can prove that mRNA technology will work in any therapeutic setting - as it is striving to do.\nI would certainly argue that BioNTech has more in common with Moderna than it does with CureVac - the company will earn a similar volume of revenues in FY21 as Moderna, and yet its market cap of $75bn is half that of Moderna's.\nThat may be due firstly to the market's perception that BioNTech owes much of its success to Pfizer, whilst Moderna is not reliant on a Big Pharma partner, and secondly on the strength of Moderna's non-COVID programs.\nIn the rest of this post I will take a closer look at BioNTech's Covid earnings, and its longer-term development pipeline in order to highlight the short and long-term investment cases.\nMy thesis is that BioNTech is not worth less than half Moderna, and that Moderna itself is potentially undervalued relative to its opportunities to develop mRNA vaccines and therapies in other therapeutic modalities.\nAs such, my feeling is that investors can pick up BioNTech stock at current price and be optimistic of ~30% near-term upside, based on recent developments with Comirnaty, and the introduction of booster shots.\nA dip may follow if COVID revenues begin to slide after 2022, which I expect to happen, and be pronounced, but this ought to be offset by pipeline progress, which suggests to me that BioNTech could maintain a >$100bn market cap, which may even be at the lower end of expectations.\nOutlook for Comirnaty\nPfizer/BioNTech'sCovid vaccine - now known as Comirnaty, is fully approved by the FDA, and used in >130 countries in the fight against Coronavirus.\nIn the first 6 months of 2021, BioNTech and Pfizer shipped >1bn doses of Comirnaty, signed supply contracts to deliver another 2.2bn doses by the end of the year, and committed to supply a further 2bn doses to low and middle-income nations, according to a summation in BioNTech's Q2'21 earnings presentation.\nAlongside an agreement signed with the EU to provide 900m doses, and potentially another 900m - doses that had been earmarked for fulfilment by CureVac before its vaccine failed to achieve the required efficacy in its pivotal trial, with just 47% versus Pfizer / BioNTech's >95% - there are 90m doses going to the US, and potentially 90m more in 2022.\nSince August, however, Comirnaty has received an Emergency Use Authorisation (\"EUA\") for use as a booster vaccine, for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups, based on data suggesting that the vaccine \"elicits high neutralization titers against SARS-CoV-2 and all currently tested variants\".\nCovid is simply refusing to go away, with a significant spike in infections, hospitalizations and deaths reported across the past 2 months, according to data from the New York Times.\nJust as it was the first vaccine approved in the US for COVID, Comirnaty is now the first to be approved as a booster shot, and it seems logical that, in time, booster shots will be extended to the entire US population, and populations worldwide. Looking further ahead, it also seems likely that annual or biannual shots will be required as COVID becomes an endemic disease.\nWith that said, I would argue that it is unlikely that BioNTech will replicate its $18bn of sales - which works out at just under 1bn doses - in 2021 in future years.\nAt maximum capacity, Pfizer/BioNTech can manufacture ~2bn doses per annum, so we can be fairly sure that each firms' sales are capped at >$20bn per annum, but it is also likely that both companies average selling price will decrease after 2021, as the vaccine rollout switches from developed, to developing nations.\nArguably, if every global citizen receives 2 vaccinations per annum, there is demand for ~16bn doses per annum, and as a key supplier, BioNTech would have no issues selling 1bn doses per annum. The deals recently done with the EU are not far short of such figures, but they may not be repeatable, and logistically speaking there is little or no chance that any population globally will be able to achieve >50% population vaccination in a single year in my view.\nAs such, I would not expect to see BioNTech earn double-digit billions from Comirnaty sales in any year after 2021, and its profit margins may well narrow after this year - the near 80% profit margin achieved across the first 6 months of 2021 is also simply unsustainable from an economic or ethical viewpoint.\nI would put forward an average figure of ~$8bn per annum for BioNTech's earnings from Comirnaty between 2022 - 2025, for the reasons discussed above, and a profit margin average of ~50%.\nThat gives me a price to sales ratio of ~9.4x and price to earnings ratio of ~19x - not especially attractive, but realistic, and for a company with as much promise as BioNTech, perhaps a strong value proposition, given what may come from its pipeline.\nOutlook for Pipeline\nWhen we think about the fact that neither BioNTech nor Moderna can realistically rely on revenues or profit margins from its COVID vaccine sales being sustained over the long term at current levels, their valuations - $75bn and $153bn respectively - may look too high.\nBut believers in mRNA technology - and why wouldn't anyone be excited by a technology as powerful as mRNA, which can effectively instruct cells to manufacture literally any protein - may feel that both companies are significantly undervalued.\nThe key question, however, is whether each company is able to deliver the hoped for revolution in medicine - personalized vaccines for many/all disease types, tailored to the patients' specific genetic profile - how long it will take, what the risk of failure is, and what will happen to each company's share price in the interim period.\nThe first and most obvious targets are infectious diseases - then oncology, CAR-T cell therapy, immuno-therapies, and then expansion into multiple modalities, covering most disease types that any investor can care to think of.\n12 months ago even, BioNTech's infectious disease pipeline went largely under the radar but emboldened by its success with Comirnaty, BioNTech now boasts vaccines in development for Malaria, Tuberculosis and HIV, 10 mRNA vaccines in clinical development targeting infectious diseases, and an influenza vaccine, jointly developed with Pfizer, which implies that the 2 companies are willing to work together over the long term - perhaps a merger is even a possibility.\nBy the end of this year, BioNTech will deliver 5 trial updates from vaccines targeting solid tumors, leveraging bi-specifics, CD40, and CAR-T cell therapy, and largely targeting solid tumors, initiate 3 Phase 2 trials, targeting melanoma, head and neck cancer, and colorectal cancer, as well as 7 Phase 1 trials, including its influenza vaccine program.\nAll of the company's plans are laid out in its latest investor presentation- collaborations with Pharma powerhouses such as Regeneron (REGN), Genentech (a Roche subsidiary), and Sanofi, as well as Pfizer.\nThere are 15 oncology programs in total, 6 infectious disease vaccines (admittedly still at the preclinical stage), therapies targeting PD-1 / PDL1, the targets of cancer blockbuster drugs such as Bristol Myers Squibb's (BMY) Opdivo and Merck's (MRK) Keytruda, cell therapies, and cytokine inhibitors.\nConclusion\nMy point in relation to both BioNTech and Moderna is that both are increasingly beginning to behave more and more like Big Pharma firms - anticipating that their revenue-generating assets may not have a lengthy shelf life, and understanding that they must deliver new medicines in order to support current valuations over the longer term.\nReviewing BioNtech's latest investor presentation - which I encourage all prospective investors to do - I was struck by the amount of progress BioNTech has made in a single year, and not just from a development perspective - the company has always had grand ambitions - but from an organisational, and PR perspective also.\nThere's no question in my mind that the market still values BioNTech as if it were a pure COVID vaccine play, and any company with a single, $18bn per annum selling asset is highly unlikely to be able to distract investor's attention away from that asset.\nBut BioNtech and its management team are smarter than most, in my view, just like their technology, and it is planning for the long term.\nData readouts in oncology - and there ought to be 5 before the end of this year - and progress towards commercialisation of a new infectious disease vaccine - will rapidly become the key yardsticks for assessing the true value of BioNTech shares.\nThere is currently no need for investors to be concerned about BioNtech's share price crashing on negative data readouts from these programs - when there are double-digit billion annual revenues in play - but these programs will increasingly replace Comirnaty sales as the stock markets' weighing machine, and that ought to be good news for fans of mRNA science - of which I am one.\nIt may take time, but BioNTech represents an exciting buy and hold opportunity for biotech enthusiasts, in my view.","news_type":1,"symbols_score_info":{"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":1041,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865054353,"gmtCreate":1632926008796,"gmtModify":1632926008994,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/865054353","repostId":"1190233990","repostType":4,"repost":{"id":"1190233990","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632925635,"share":"https://www.laohu8.com/m/news/1190233990?lang=zh_CN&edition=full","pubTime":"2021-09-29 22:27","market":"us","language":"en","title":"Pharmaceutical stocks rallied in morning trading<blockquote>医药股早盘上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1190233990","media":"Tiger Newspress","summary":"Pharmaceutical stocks rallied in morning trading.Pfizer,BioNTech SE,Eli Lilly,Merck,Moderna,AstraZen","content":"<p>Pharmaceutical stocks rallied in morning trading.Pfizer,BioNTech SE,Eli Lilly,Merck,Moderna,AstraZeneca&nbsp;and&nbsp;Sanofi&nbsp;climbed&nbsp;between 0.5% and 3%.</p><p><blockquote>医药股早盘上涨。辉瑞、BioNTech SE、礼来公司、默克、Moderna、阿斯利康和赛诺菲上涨0.5%至3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/30e27c112e85fc577e71ea58a8ac6216\" tg-width=\"407\" tg-height=\"716\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Pfizer’s covid-19 vaccine for kids may not be FDA authorized before november.</p><p><blockquote>辉瑞公司的儿童新冠肺炎疫苗可能不会在11月之前获得FDA的授权。</blockquote></p><p> Citi analyst Andrew Baum upgraded shares of Ely Lilly and Co&nbsp;to Buy and raised the price target.</p><p><blockquote>花旗分析师安德鲁·鲍姆将伊利礼来公司的股票评级上调至买入，并上调了目标价。</blockquote></p><p> Merck says its covid-19 antiviral pill is cctive against variants.</p><p><blockquote>默克公司表示，其新冠肺炎抗病毒药物对变种有效。</blockquote></p><p> AstraZeneca buys rare disease drugmaker Caelum in potential $500 mln deal.</p><p><blockquote>阿斯利康以5亿美元的潜在交易收购罕见病制药商Caelum。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaceutical stocks rallied in morning trading<blockquote>医药股早盘上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaceutical stocks rallied in morning trading<blockquote>医药股早盘上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-29 22:27</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pharmaceutical stocks rallied in morning trading.Pfizer,BioNTech SE,Eli Lilly,Merck,Moderna,AstraZeneca&nbsp;and&nbsp;Sanofi&nbsp;climbed&nbsp;between 0.5% and 3%.</p><p><blockquote>医药股早盘上涨。辉瑞、BioNTech SE、礼来公司、默克、Moderna、阿斯利康和赛诺菲上涨0.5%至3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/30e27c112e85fc577e71ea58a8ac6216\" tg-width=\"407\" tg-height=\"716\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Pfizer’s covid-19 vaccine for kids may not be FDA authorized before november.</p><p><blockquote>辉瑞公司的儿童新冠肺炎疫苗可能不会在11月之前获得FDA的授权。</blockquote></p><p> Citi analyst Andrew Baum upgraded shares of Ely Lilly and Co&nbsp;to Buy and raised the price target.</p><p><blockquote>花旗分析师安德鲁·鲍姆将伊利礼来公司的股票评级上调至买入，并上调了目标价。</blockquote></p><p> Merck says its covid-19 antiviral pill is cctive against variants.</p><p><blockquote>默克公司表示，其新冠肺炎抗病毒药物对变种有效。</blockquote></p><p> AstraZeneca buys rare disease drugmaker Caelum in potential $500 mln deal.</p><p><blockquote>阿斯利康以5亿美元的潜在交易收购罕见病制药商Caelum。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190233990","content_text":"Pharmaceutical stocks rallied in morning trading.Pfizer,BioNTech SE,Eli Lilly,Merck,Moderna,AstraZeneca and Sanofi climbed between 0.5% and 3%.\n\nPfizer’s covid-19 vaccine for kids may not be FDA authorized before november.\nCiti analyst Andrew Baum upgraded shares of Ely Lilly and Co to Buy and raised the price target.\nMerck says its covid-19 antiviral pill is cctive against variants.\nAstraZeneca buys rare disease drugmaker Caelum in potential $500 mln deal.","news_type":1,"symbols_score_info":{"BNTX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":104281718,"gmtCreate":1620393921634,"gmtModify":1634205564111,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Pls like &amp; comment Thank you","listText":"Pls like &amp; comment Thank you","text":"Pls like & comment Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":10,"repostSize":0,"link":"https://laohu8.com/post/104281718","repostId":"2133520488","repostType":4,"isVote":1,"tweetType":1,"viewCount":699,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377326329,"gmtCreate":1619498671861,"gmtModify":1634212252854,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Boom.!","listText":"Boom.!","text":"Boom.!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/377326329","repostId":"1190086074","repostType":4,"repost":{"id":"1190086074","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619480390,"share":"https://www.laohu8.com/m/news/1190086074?lang=zh_CN&edition=full","pubTime":"2021-04-27 07:39","market":"us","language":"en","title":"Tesla posts record net income of $438 million, revenue surges by 74%<blockquote>特斯拉净利润创纪录4.38亿美元营收暴增74%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1190086074","media":"Tiger Newspress","summary":"Tesla reported record net income of $438 million during the quarter, as well as earnings of 93 cents per share on $10.39 billion in revenue.In its earnings release, the company said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.”On an earnings call, CEO Elon Musk said the delayed new version of the company’s Model S sedan will be deliv","content":"<p><b>KEY POINTS</b></p><p><blockquote><b>要点</b></blockquote></p><p><ul><li>Tesla reported record net income of $438 million during the quarter, as well as earnings of 93 cents per share on $10.39 billion in revenue.</li><li>In its earnings release, the company said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.”</li><li>On an earnings call, CEO Elon Musk said the delayed new version of the company’s Model S sedan will be delivered starting in May 2021, and Model X deliveries will begin in the third quarter of the year.</li></ul>Tesla&nbsp;reported first-quarter results after the bell on Monday. The company beat expectations handily, buoyed by sales of bitcoin and regulatory credits, but the stock dipped as much as 2.5% after hours as investors digested the numbers.</p><p><blockquote><ul><li>特斯拉报告本季度净利润达到创纪录的4.38亿美元，每股收益为93美分，营收为103.9亿美元。</li><li>该公司在财报中表示，通过“极快地转向新的微控制器，同时为新供应商制造的新芯片开发固件”，它已经度过了困扰汽车行业的芯片短缺问题。</li><li>在财报看涨期权上，首席执行官Elon Musk表示，该公司推迟的新版Model S轿车将于2021年5月开始交付，Model X将于今年第三季度开始交付。</li></ul>特斯拉周一盘后公布了第一季度业绩。在比特币销售和监管信贷的提振下，该公司轻松超出预期，但随着投资者消化这些数据，该股盘后下跌2.5%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/fec5c52f391c1077b749edc13b7b3417\" tg-width=\"1302\" tg-height=\"833\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>Here’s how the company fared in the quarter, compared with analyst estimates compiled by Refinitiv:</p><p><blockquote>以下是该公司本季度的表现，与Refinitiv编制的分析师预期相比：</blockquote></p><p><ul><li><b>Earnings:</b>93 cents per share vs. 79 cents per share expected</li><li><b>Revenue:</b>$10.39 billion vs. $10.29 billion expected, up 74% from a year ago</li></ul>Net profit reached a quarterly record of $438 million on a GAAP basis, and the company recorded $518 million in revenue from sales of regulatory credits during the period. It also recorded a $101 million positive impact from&nbsp;sales of bitcoin&nbsp;during the quarter.</p><p><blockquote><ul><li><b>收益：</b>每股93美分，预期每股79美分</li><li><b>收入：</b>103.9亿美元，预期为102.9亿美元，同比增长74%</li></ul>按GAAP计算，净利润达到季度创纪录的4.38亿美元，该公司在此期间从监管信贷销售中获得了5.18亿美元的收入。本季度比特币销售还带来了1.01亿美元的积极影响。</blockquote></p><p><img src=\"https://static.tigerbbs.com/107ab1e725bed375ea106bdf3024ec6a\" tg-width=\"1910\" tg-height=\"1097\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>CEO Elon Musk’s electric vehicle business reported in the first quarter&nbsp;vehicle deliveries of 184,800&nbsp;Model 3 and Model Y cars, beating expectations and setting a record for Tesla. However, the company also said it produced none of its higher-end Model S sedans or Model X SUVs for the period ending March. It delivered2,020 older Model S sedans and Model X SUVs from inventory.</p><p><blockquote>首席执行官Elon Musk的电动汽车业务报告称，第一季度Model 3和Model Y汽车交付量为18.48万辆，超出预期，创下了特斯拉的纪录。不过，该公司还表示，截至3月份，该公司没有生产任何高端Model S轿车或Model X SUV。它从库存中交付了2,020辆旧款Model S轿车和Model X SUV。</blockquote></p><p>On Monday’s earnings call, Musk said the new version of the company’s Model S sedans will finally be delivered to customers starting in May 2021, with Model X deliveries to begin in the third quarter of the year. Musk and CFO Zachary Kirkhorn both said supply chain issues are likely to remain a challenge for Tesla this year.</p><p><blockquote>在周一的财报看涨期权上，Musk表示，该公司新版Model S轿车最终将于2021年5月开始向客户交付，Model X将于今年第三季度开始交付。Musk和CFO Zachary Kirkhorn均表示，供应链问题可能仍是特斯拉今年面临的挑战。</blockquote></p><p>In January 2021 (during a fourth-quarter 2020 earnings update) Musk had said that the Model S Plaid was already in production would be delivered starting in February 2021. But he admitted on Monday, “There were more challenges than expected,” in producing the refreshed version of these vehicles. He did not elaborate.</p><p><blockquote>2021年1月（在2020年第四季度财报更新期间），马斯克曾表示Model S Plaid已经投入生产，并将于2021年2月开始交付。但他周一承认，在生产这些车辆的更新版本时，“存在比预期更多的挑战”。他没有详细说明。</blockquote></p><p>Tesla is now aiming to produce 2,000 Model S and X vehicles per week later this year.</p><p><blockquote>特斯拉目前的目标是在今年晚些时候每周生产2,000辆Model S和X汽车。</blockquote></p><p>The company said Monday it expects more than 50% vehicle delivery growth in 2021 overall, which implies minimum deliveries around 750,000 vehicles this year.</p><p><blockquote>该公司周一表示，预计2021年汽车交付量总体增长将超过50%，这意味着今年的最低交付量约为75万辆。</blockquote></p><p>The fact Tesla grew vehicle unit sales by more than 100% year over year but grew service centers by only 28% and its mobile service fleet by only 22% explains why some Tesla customers face frustratingly long wait times for repairs. Service expansion is not keeping pace with the volume of vehicles sold.</p><p><blockquote>事实上，特斯拉的汽车销量同比增长超过100%，但服务中心仅增长28%，移动服务车队仅增长22%，这解释了为什么一些特斯拉客户面临令人沮丧的漫长维修等待时间。服务扩张跟不上车辆销量的步伐。</blockquote></p><p>Tesla said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.” It did not disclose the names of its new suppliers.</p><p><blockquote>特斯拉表示，它通过“极快地转向新的微控制器，同时为新供应商制造的新芯片开发固件”，部分克服了困扰汽车行业的芯片短缺问题。它没有透露新供应商的名称。</blockquote></p><p>It also reiterated Musk’s frequent claim that cameras, not radar, are a better path toward autonomous vehicles. “Our AI-based software architecture has been increasingly reliant on cameras, to the point where radar is becoming unnecessary earlier than expected. As a result, our FSD [Full Self-Driving] team is fully focused on evolving to a vision-based autonomous system and we are nearly ready to switch the US market to Tesla Vision,” the company said in its earnings release.</p><p><blockquote>它还重申了马斯克经常声称的摄像头而不是雷达是自动驾驶汽车的更好途径。“我们基于人工智能的软件架构越来越依赖摄像头，以至于雷达比预期更早变得不必要。因此，我们的FSD（全自动驾驶）团队完全专注于向基于视觉的自动驾驶系统发展，我们几乎准备好将美国市场转向特斯拉视觉，”该公司在财报中表示。</blockquote></p><p>Revenue for its energy generation and storage business nearly doubled for Tesla versus the same period in 2020, when Musk said Covid, then an emerging pandemic, had slowed its energy business to a crawl. But energy revenue declined from $787 million in the fourth quarter to $595 million in the first quarter of 2021.</p><p><blockquote>与2020年同期相比，特斯拉能源发电和存储业务的收入几乎翻了一番，当时马斯克表示，当时新冠疫情是一种新兴流行病，导致其能源业务放缓。但能源收入从第四季度的7.87亿美元下降至2021年第一季度的5.95亿美元。</blockquote></p><p>Recently, Tesla increased prices for its solar rooftops by 50%, and now requires anyone ordering solar photovoltaics (including Tesla solar roof tiles) to also order the Powerwall, Tesla’s home energy storage system. The sudden price change applied retroactively to some&nbsp;vexed customers.</p><p><blockquote>最近，特斯拉将其太阳能屋顶的价格提高了50%，现在要求任何订购太阳能光伏（包括特斯拉太阳能屋顶瓦片）的人也必须订购特斯拉的家庭储能系统Powerwall。突然的价格变化追溯适用于一些恼怒的顾客。</blockquote></p><p>Musk said on the Q1 2021 call that he is aiming for homes with solar rooftops and batteries from Tesla to function as a “giant distributed utility” that can help incumbent electrical utilities supply customers with all the electricity they need as demand and extreme weather events increase.</p><p><blockquote>马斯克在2021年第一季度看涨期权上表示，他的目标是让拥有太阳能屋顶和特斯拉电池的家庭成为“巨型分布式公用事业公司”，可以帮助现有电力公司在需求和极端天气事件增加时为客户提供所需的所有电力。</blockquote></p><p></p><p>Executives did not say how they would change their production or mix of battery cells from suppliers in order to make a higher volume of vehicles and energy storage products in 2021.</p><p><blockquote>高管们没有透露他们将如何改变供应商的电池生产或组合，以便在2021年生产更多的汽车和储能产品。</blockquote></p><p>Musk said the company’s 4680 cells, which it developed independently and makes at a pilot plant in Fremont, California, are not yet reliable enough to be shipped in Tesla vehicles. He said Tesla would probably “achieve volume production” of these cells in 12 to 18 months.</p><p><blockquote>Musk表示，该公司自主开发并在加州Fremont的一家试点工厂生产的4680电池还不够可靠，无法用特斯拉汽车运输。他表示，特斯拉可能会在12至18个月内“实现批量生产”这些电池。</blockquote></p><p>The company revealed in February it purchased&nbsp;$1.5 billion in bitcoin&nbsp;and would potentially invest in other cryptocurrencies in the future. By April, bitcoin rose to record levels before pulling back. In its statement of cash flows, Tesla revealed that it had sold $272 million worth of “digital assets,” presumably bitcoin, during the quarter.</p><p><blockquote>该公司在2月份透露，它购买了15亿美元的比特币，并可能在未来投资其他加密货币。到4月份，比特币升至创纪录水平，然后回落。特斯拉在其现金流量表中透露，该公司在本季度出售了价值2.72亿美元的“数字资产”，可能是比特币。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla posts record net income of $438 million, revenue surges by 74%<blockquote>特斯拉净利润创纪录4.38亿美元营收暴增74%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla posts record net income of $438 million, revenue surges by 74%<blockquote>特斯拉净利润创纪录4.38亿美元营收暴增74%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-04-27 07:39</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><b>KEY POINTS</b></p><p><blockquote><b>要点</b></blockquote></p><p><ul><li>Tesla reported record net income of $438 million during the quarter, as well as earnings of 93 cents per share on $10.39 billion in revenue.</li><li>In its earnings release, the company said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.”</li><li>On an earnings call, CEO Elon Musk said the delayed new version of the company’s Model S sedan will be delivered starting in May 2021, and Model X deliveries will begin in the third quarter of the year.</li></ul>Tesla&nbsp;reported first-quarter results after the bell on Monday. The company beat expectations handily, buoyed by sales of bitcoin and regulatory credits, but the stock dipped as much as 2.5% after hours as investors digested the numbers.</p><p><blockquote><ul><li>特斯拉报告本季度净利润达到创纪录的4.38亿美元，每股收益为93美分，营收为103.9亿美元。</li><li>该公司在财报中表示，通过“极快地转向新的微控制器，同时为新供应商制造的新芯片开发固件”，它已经度过了困扰汽车行业的芯片短缺问题。</li><li>在财报看涨期权上，首席执行官Elon Musk表示，该公司推迟的新版Model S轿车将于2021年5月开始交付，Model X将于今年第三季度开始交付。</li></ul>特斯拉周一盘后公布了第一季度业绩。在比特币销售和监管信贷的提振下，该公司轻松超出预期，但随着投资者消化这些数据，该股盘后下跌2.5%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/fec5c52f391c1077b749edc13b7b3417\" tg-width=\"1302\" tg-height=\"833\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>Here’s how the company fared in the quarter, compared with analyst estimates compiled by Refinitiv:</p><p><blockquote>以下是该公司本季度的表现，与Refinitiv编制的分析师预期相比：</blockquote></p><p><ul><li><b>Earnings:</b>93 cents per share vs. 79 cents per share expected</li><li><b>Revenue:</b>$10.39 billion vs. $10.29 billion expected, up 74% from a year ago</li></ul>Net profit reached a quarterly record of $438 million on a GAAP basis, and the company recorded $518 million in revenue from sales of regulatory credits during the period. It also recorded a $101 million positive impact from&nbsp;sales of bitcoin&nbsp;during the quarter.</p><p><blockquote><ul><li><b>收益：</b>每股93美分，预期每股79美分</li><li><b>收入：</b>103.9亿美元，预期为102.9亿美元，同比增长74%</li></ul>按GAAP计算，净利润达到季度创纪录的4.38亿美元，该公司在此期间从监管信贷销售中获得了5.18亿美元的收入。本季度比特币销售还带来了1.01亿美元的积极影响。</blockquote></p><p><img src=\"https://static.tigerbbs.com/107ab1e725bed375ea106bdf3024ec6a\" tg-width=\"1910\" tg-height=\"1097\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>CEO Elon Musk’s electric vehicle business reported in the first quarter&nbsp;vehicle deliveries of 184,800&nbsp;Model 3 and Model Y cars, beating expectations and setting a record for Tesla. However, the company also said it produced none of its higher-end Model S sedans or Model X SUVs for the period ending March. It delivered2,020 older Model S sedans and Model X SUVs from inventory.</p><p><blockquote>首席执行官Elon Musk的电动汽车业务报告称，第一季度Model 3和Model Y汽车交付量为18.48万辆，超出预期，创下了特斯拉的纪录。不过，该公司还表示，截至3月份，该公司没有生产任何高端Model S轿车或Model X SUV。它从库存中交付了2,020辆旧款Model S轿车和Model X SUV。</blockquote></p><p>On Monday’s earnings call, Musk said the new version of the company’s Model S sedans will finally be delivered to customers starting in May 2021, with Model X deliveries to begin in the third quarter of the year. Musk and CFO Zachary Kirkhorn both said supply chain issues are likely to remain a challenge for Tesla this year.</p><p><blockquote>在周一的财报看涨期权上，Musk表示，该公司新版Model S轿车最终将于2021年5月开始向客户交付，Model X将于今年第三季度开始交付。Musk和CFO Zachary Kirkhorn均表示，供应链问题可能仍是特斯拉今年面临的挑战。</blockquote></p><p>In January 2021 (during a fourth-quarter 2020 earnings update) Musk had said that the Model S Plaid was already in production would be delivered starting in February 2021. But he admitted on Monday, “There were more challenges than expected,” in producing the refreshed version of these vehicles. He did not elaborate.</p><p><blockquote>2021年1月（在2020年第四季度财报更新期间），马斯克曾表示Model S Plaid已经投入生产，并将于2021年2月开始交付。但他周一承认，在生产这些车辆的更新版本时，“存在比预期更多的挑战”。他没有详细说明。</blockquote></p><p>Tesla is now aiming to produce 2,000 Model S and X vehicles per week later this year.</p><p><blockquote>特斯拉目前的目标是在今年晚些时候每周生产2,000辆Model S和X汽车。</blockquote></p><p>The company said Monday it expects more than 50% vehicle delivery growth in 2021 overall, which implies minimum deliveries around 750,000 vehicles this year.</p><p><blockquote>该公司周一表示，预计2021年汽车交付量总体增长将超过50%，这意味着今年的最低交付量约为75万辆。</blockquote></p><p>The fact Tesla grew vehicle unit sales by more than 100% year over year but grew service centers by only 28% and its mobile service fleet by only 22% explains why some Tesla customers face frustratingly long wait times for repairs. Service expansion is not keeping pace with the volume of vehicles sold.</p><p><blockquote>事实上，特斯拉的汽车销量同比增长超过100%，但服务中心仅增长28%，移动服务车队仅增长22%，这解释了为什么一些特斯拉客户面临令人沮丧的漫长维修等待时间。服务扩张跟不上车辆销量的步伐。</blockquote></p><p>Tesla said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.” It did not disclose the names of its new suppliers.</p><p><blockquote>特斯拉表示，它通过“极快地转向新的微控制器，同时为新供应商制造的新芯片开发固件”，部分克服了困扰汽车行业的芯片短缺问题。它没有透露新供应商的名称。</blockquote></p><p>It also reiterated Musk’s frequent claim that cameras, not radar, are a better path toward autonomous vehicles. “Our AI-based software architecture has been increasingly reliant on cameras, to the point where radar is becoming unnecessary earlier than expected. As a result, our FSD [Full Self-Driving] team is fully focused on evolving to a vision-based autonomous system and we are nearly ready to switch the US market to Tesla Vision,” the company said in its earnings release.</p><p><blockquote>它还重申了马斯克经常声称的摄像头而不是雷达是自动驾驶汽车的更好途径。“我们基于人工智能的软件架构越来越依赖摄像头，以至于雷达比预期更早变得不必要。因此，我们的FSD（全自动驾驶）团队完全专注于向基于视觉的自动驾驶系统发展，我们几乎准备好将美国市场转向特斯拉视觉，”该公司在财报中表示。</blockquote></p><p>Revenue for its energy generation and storage business nearly doubled for Tesla versus the same period in 2020, when Musk said Covid, then an emerging pandemic, had slowed its energy business to a crawl. But energy revenue declined from $787 million in the fourth quarter to $595 million in the first quarter of 2021.</p><p><blockquote>与2020年同期相比，特斯拉能源发电和存储业务的收入几乎翻了一番，当时马斯克表示，当时新冠疫情是一种新兴流行病，导致其能源业务放缓。但能源收入从第四季度的7.87亿美元下降至2021年第一季度的5.95亿美元。</blockquote></p><p>Recently, Tesla increased prices for its solar rooftops by 50%, and now requires anyone ordering solar photovoltaics (including Tesla solar roof tiles) to also order the Powerwall, Tesla’s home energy storage system. The sudden price change applied retroactively to some&nbsp;vexed customers.</p><p><blockquote>最近，特斯拉将其太阳能屋顶的价格提高了50%，现在要求任何订购太阳能光伏（包括特斯拉太阳能屋顶瓦片）的人也必须订购特斯拉的家庭储能系统Powerwall。突然的价格变化追溯适用于一些恼怒的顾客。</blockquote></p><p>Musk said on the Q1 2021 call that he is aiming for homes with solar rooftops and batteries from Tesla to function as a “giant distributed utility” that can help incumbent electrical utilities supply customers with all the electricity they need as demand and extreme weather events increase.</p><p><blockquote>马斯克在2021年第一季度看涨期权上表示，他的目标是让拥有太阳能屋顶和特斯拉电池的家庭成为“巨型分布式公用事业公司”，可以帮助现有电力公司在需求和极端天气事件增加时为客户提供所需的所有电力。</blockquote></p><p></p><p>Executives did not say how they would change their production or mix of battery cells from suppliers in order to make a higher volume of vehicles and energy storage products in 2021.</p><p><blockquote>高管们没有透露他们将如何改变供应商的电池生产或组合，以便在2021年生产更多的汽车和储能产品。</blockquote></p><p>Musk said the company’s 4680 cells, which it developed independently and makes at a pilot plant in Fremont, California, are not yet reliable enough to be shipped in Tesla vehicles. He said Tesla would probably “achieve volume production” of these cells in 12 to 18 months.</p><p><blockquote>Musk表示，该公司自主开发并在加州Fremont的一家试点工厂生产的4680电池还不够可靠，无法用特斯拉汽车运输。他表示，特斯拉可能会在12至18个月内“实现批量生产”这些电池。</blockquote></p><p>The company revealed in February it purchased&nbsp;$1.5 billion in bitcoin&nbsp;and would potentially invest in other cryptocurrencies in the future. By April, bitcoin rose to record levels before pulling back. In its statement of cash flows, Tesla revealed that it had sold $272 million worth of “digital assets,” presumably bitcoin, during the quarter.</p><p><blockquote>该公司在2月份透露，它购买了15亿美元的比特币，并可能在未来投资其他加密货币。到4月份，比特币升至创纪录水平，然后回落。特斯拉在其现金流量表中透露，该公司在本季度出售了价值2.72亿美元的“数字资产”，可能是比特币。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190086074","content_text":"KEY POINTSTesla reported record net income of $438 million during the quarter, as well as earnings of 93 cents per share on $10.39 billion in revenue.In its earnings release, the company said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.”On an earnings call, CEO Elon Musk said the delayed new version of the company’s Model S sedan will be delivered starting in May 2021, and Model X deliveries will begin in the third quarter of the year.Tesla reported first-quarter results after the bell on Monday. The company beat expectations handily, buoyed by sales of bitcoin and regulatory credits, but the stock dipped as much as 2.5% after hours as investors digested the numbers.Here’s how the company fared in the quarter, compared with analyst estimates compiled by Refinitiv:Earnings:93 cents per share vs. 79 cents per share expectedRevenue:$10.39 billion vs. $10.29 billion expected, up 74% from a year agoNet profit reached a quarterly record of $438 million on a GAAP basis, and the company recorded $518 million in revenue from sales of regulatory credits during the period. It also recorded a $101 million positive impact from sales of bitcoin during the quarter.CEO Elon Musk’s electric vehicle business reported in the first quarter vehicle deliveries of 184,800 Model 3 and Model Y cars, beating expectations and setting a record for Tesla. However, the company also said it produced none of its higher-end Model S sedans or Model X SUVs for the period ending March. It delivered2,020 older Model S sedans and Model X SUVs from inventory.On Monday’s earnings call, Musk said the new version of the company’s Model S sedans will finally be delivered to customers starting in May 2021, with Model X deliveries to begin in the third quarter of the year. Musk and CFO Zachary Kirkhorn both said supply chain issues are likely to remain a challenge for Tesla this year.In January 2021 (during a fourth-quarter 2020 earnings update) Musk had said that the Model S Plaid was already in production would be delivered starting in February 2021. But he admitted on Monday, “There were more challenges than expected,” in producing the refreshed version of these vehicles. He did not elaborate.Tesla is now aiming to produce 2,000 Model S and X vehicles per week later this year.The company said Monday it expects more than 50% vehicle delivery growth in 2021 overall, which implies minimum deliveries around 750,000 vehicles this year.The fact Tesla grew vehicle unit sales by more than 100% year over year but grew service centers by only 28% and its mobile service fleet by only 22% explains why some Tesla customers face frustratingly long wait times for repairs. Service expansion is not keeping pace with the volume of vehicles sold.Tesla said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.” It did not disclose the names of its new suppliers.It also reiterated Musk’s frequent claim that cameras, not radar, are a better path toward autonomous vehicles. “Our AI-based software architecture has been increasingly reliant on cameras, to the point where radar is becoming unnecessary earlier than expected. As a result, our FSD [Full Self-Driving] team is fully focused on evolving to a vision-based autonomous system and we are nearly ready to switch the US market to Tesla Vision,” the company said in its earnings release.Revenue for its energy generation and storage business nearly doubled for Tesla versus the same period in 2020, when Musk said Covid, then an emerging pandemic, had slowed its energy business to a crawl. But energy revenue declined from $787 million in the fourth quarter to $595 million in the first quarter of 2021.Recently, Tesla increased prices for its solar rooftops by 50%, and now requires anyone ordering solar photovoltaics (including Tesla solar roof tiles) to also order the Powerwall, Tesla’s home energy storage system. The sudden price change applied retroactively to some vexed customers.Musk said on the Q1 2021 call that he is aiming for homes with solar rooftops and batteries from Tesla to function as a “giant distributed utility” that can help incumbent electrical utilities supply customers with all the electricity they need as demand and extreme weather events increase.Executives did not say how they would change their production or mix of battery cells from suppliers in order to make a higher volume of vehicles and energy storage products in 2021.Musk said the company’s 4680 cells, which it developed independently and makes at a pilot plant in Fremont, California, are not yet reliable enough to be shipped in Tesla vehicles. He said Tesla would probably “achieve volume production” of these cells in 12 to 18 months.The company revealed in February it purchased $1.5 billion in bitcoin and would potentially invest in other cryptocurrencies in the future. By April, bitcoin rose to record levels before pulling back. In its statement of cash flows, Tesla revealed that it had sold $272 million worth of “digital assets,” presumably bitcoin, during the quarter.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":426,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166475181,"gmtCreate":1624024072343,"gmtModify":1631887210343,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Get your post featured? What’s that means.?","listText":"Get your post featured? What’s that means.?","text":"Get your post featured? What’s that means.?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/166475181","repostId":"1118271544","repostType":4,"repost":{"id":"1118271544","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624023029,"share":"https://www.laohu8.com/m/news/1118271544?lang=zh_CN&edition=full","pubTime":"2021-06-18 21:30","market":"us","language":"en","title":"Dow drops 400 points at the open, extending losses in its worst week since January<blockquote>道琼斯指数开盘下跌400点，延续1月份以来最糟糕的一周跌幅</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1118271544","media":"Tiger Newspress","summary":"U.S. stocks fell on Friday with the Dow Jones Industrial Average on pace to post its worst week sinc","content":"<p>U.S. stocks fell on Friday with the Dow Jones Industrial Average on pace to post its worst week since January, as bank shares led the market sell-off after the Federal Reserve's latest policy update.</p><p><blockquote>美国股市周五下跌，道琼斯工业平均指数有望创下1月份以来最糟糕的一周，美联储最新政策更新后，银行股领跌市场。</blockquote></p><p> The blue-chip average dropped 400 points, bringing its week-to-date losses to 2.8% The S&amp;P 500 fell 0.8%, pushing its loss this week to more than 1%. The tech-heavy Nasdaq Composite dipped 0.5%.</p><p><blockquote>蓝筹股平均指数下跌400点，本周迄今跌幅达到2.8%。标普500下跌0.8%，本周跌幅超过1%。以科技股为主的纳斯达克综合指数下跌0.5%。</blockquote></p><p> Stocks extended their losses asSt. Louis Fed President Jim Bullard said on CNBCthat it was natural for the Fed to tilt a little \"hawkish\" this week and that the first rate increase from the central bank would likely come in 2022.</p><p><blockquote>股市扩大跌幅。路易斯联储主席Jim Bullard在CNBC上表示，美联储本周倾向于稍微“鹰派”是很自然的，央行首次加息可能会在2022年进行。</blockquote></p><p> Wall Street registered losses as the Federal Reserve on Wednesday afternoon added two rate hikes to its 2023 forecast and increased its inflation projection for the year.</p><p><blockquote>周三下午，美联储在2023年预测中增加了两次加息，并上调了今年的通胀预测，华尔街出现下跌。</blockquote></p><p> The decline in stocks came as the Fed's actions caused a drastic flattening of the so-called Treasury yield curve&nbsp;where the yields of shorter-duration Treasurys, like the&nbsp;2-year note, rose, while longer duration yields, such as the benchmark 10-year, fell.&nbsp;The retreat in long-dated bonds reflects less optimism toward economic growth, while the jump in short-end yields shows the expectations of the Fed raising rates.</p><p><blockquote>股市下跌之际，美联储的行动导致所谓的国债收益率曲线急剧变平，2年期国债等短期国债收益率上升，而基准10年期国债等长期国债收益率下降。长期债券的回落反映了对经济增长的不太乐观，而短端收益率的跃升则显示了对美联储加息的预期。</blockquote></p><p> This phenomenon is hurting bank stocks particularly as bank earnings could take a hit when the spread between short-term and long-term rates narrows. Goldman Sachs shares fell more than 1% Friday, while JPMorgan and Morgan Stanley also traded in the red.</p><p><blockquote>这种现象正在损害银行股，特别是当短期和长期利率之间的利差缩小时，银行盈利可能会受到打击。高盛股价周五下跌超过1%，摩根大通和摩根士丹利也出现亏损。</blockquote></p><p> Fed Chairman Jerome Powell said on Wednesday that officials have discussed tapering bond buying and would at some point begin slowing the asset purchases.</p><p><blockquote>美联储主席鲍威尔周三表示，官员们已经讨论了缩减债券购买，并将在某个时候开始放缓资产购买。</blockquote></p><p> \"Investors may be interpreting the Fed's hawkish tilt Wednesday as a sign that an extended US post-pandemic economic expansion may be a bit harder to achieve in a potentially emerging environment of less accommodative monetary policy,\" said Goldman Sachs' Chris Hussey in a note.</p><p><blockquote>高盛(Goldman Sachs)的克里斯·赫西(Chris Hussey)在一份报告中表示：“投资者可能将美联储周三的鹰派倾向解读为一个迹象，表明在可能出现的货币政策不太宽松的环境下，美国大流行后经济扩张可能更难实现。”</blockquote></p><p> Most commodities prices rebounded a bit on Friday followingsharp declines this week&nbsp;as China attempts to cool rising prices and the U.S. dollar strengthens. Futures prices for copper, gold, and platinum rebounded Friday, but were still down big for the week.</p><p><blockquote>由于中国试图冷却不断上涨的物价和美元走强，大多数大宗商品价格在本周大幅下跌后，周五略有反弹。铜、黄金和铂的期货价格周五反弹，但本周仍大幅下跌。</blockquote></p><p> Chip stocks, which have had a good week, looked set to continue their run on Friday with shares of Nvidia higher by about 1%.</p><p><blockquote>本周表现良好的芯片股周五似乎将继续上涨，英伟达股价上涨约1%。</blockquote></p><p> Adobe shares gained about 3% after earnings and revenue topped estimates.</p><p><blockquote>盈利和收入超出预期后，Adobe股价上涨约3%。</blockquote></p><p> Friday also coincides with the quarterly \"quadruple witching\" where options and futures on indexes and equities expire. Many expect trading to be more volatile in light of this event.</p><p><blockquote>周五也恰逢季度“四重巫术”，指数和股票的期权和期货到期。许多人预计，鉴于这一事件，交易将更加波动。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow drops 400 points at the open, extending losses in its worst week since January<blockquote>道琼斯指数开盘下跌400点，延续1月份以来最糟糕的一周跌幅</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow drops 400 points at the open, extending losses in its worst week since January<blockquote>道琼斯指数开盘下跌400点，延续1月份以来最糟糕的一周跌幅</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-06-18 21:30</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S. stocks fell on Friday with the Dow Jones Industrial Average on pace to post its worst week since January, as bank shares led the market sell-off after the Federal Reserve's latest policy update.</p><p><blockquote>美国股市周五下跌，道琼斯工业平均指数有望创下1月份以来最糟糕的一周，美联储最新政策更新后，银行股领跌市场。</blockquote></p><p> The blue-chip average dropped 400 points, bringing its week-to-date losses to 2.8% The S&amp;P 500 fell 0.8%, pushing its loss this week to more than 1%. The tech-heavy Nasdaq Composite dipped 0.5%.</p><p><blockquote>蓝筹股平均指数下跌400点，本周迄今跌幅达到2.8%。标普500下跌0.8%，本周跌幅超过1%。以科技股为主的纳斯达克综合指数下跌0.5%。</blockquote></p><p> Stocks extended their losses asSt. Louis Fed President Jim Bullard said on CNBCthat it was natural for the Fed to tilt a little \"hawkish\" this week and that the first rate increase from the central bank would likely come in 2022.</p><p><blockquote>股市扩大跌幅。路易斯联储主席Jim Bullard在CNBC上表示，美联储本周倾向于稍微“鹰派”是很自然的，央行首次加息可能会在2022年进行。</blockquote></p><p> Wall Street registered losses as the Federal Reserve on Wednesday afternoon added two rate hikes to its 2023 forecast and increased its inflation projection for the year.</p><p><blockquote>周三下午，美联储在2023年预测中增加了两次加息，并上调了今年的通胀预测，华尔街出现下跌。</blockquote></p><p> The decline in stocks came as the Fed's actions caused a drastic flattening of the so-called Treasury yield curve&nbsp;where the yields of shorter-duration Treasurys, like the&nbsp;2-year note, rose, while longer duration yields, such as the benchmark 10-year, fell.&nbsp;The retreat in long-dated bonds reflects less optimism toward economic growth, while the jump in short-end yields shows the expectations of the Fed raising rates.</p><p><blockquote>股市下跌之际，美联储的行动导致所谓的国债收益率曲线急剧变平，2年期国债等短期国债收益率上升，而基准10年期国债等长期国债收益率下降。长期债券的回落反映了对经济增长的不太乐观，而短端收益率的跃升则显示了对美联储加息的预期。</blockquote></p><p> This phenomenon is hurting bank stocks particularly as bank earnings could take a hit when the spread between short-term and long-term rates narrows. Goldman Sachs shares fell more than 1% Friday, while JPMorgan and Morgan Stanley also traded in the red.</p><p><blockquote>这种现象正在损害银行股，特别是当短期和长期利率之间的利差缩小时，银行盈利可能会受到打击。高盛股价周五下跌超过1%，摩根大通和摩根士丹利也出现亏损。</blockquote></p><p> Fed Chairman Jerome Powell said on Wednesday that officials have discussed tapering bond buying and would at some point begin slowing the asset purchases.</p><p><blockquote>美联储主席鲍威尔周三表示，官员们已经讨论了缩减债券购买，并将在某个时候开始放缓资产购买。</blockquote></p><p> \"Investors may be interpreting the Fed's hawkish tilt Wednesday as a sign that an extended US post-pandemic economic expansion may be a bit harder to achieve in a potentially emerging environment of less accommodative monetary policy,\" said Goldman Sachs' Chris Hussey in a note.</p><p><blockquote>高盛(Goldman Sachs)的克里斯·赫西(Chris Hussey)在一份报告中表示：“投资者可能将美联储周三的鹰派倾向解读为一个迹象，表明在可能出现的货币政策不太宽松的环境下，美国大流行后经济扩张可能更难实现。”</blockquote></p><p> Most commodities prices rebounded a bit on Friday followingsharp declines this week&nbsp;as China attempts to cool rising prices and the U.S. dollar strengthens. Futures prices for copper, gold, and platinum rebounded Friday, but were still down big for the week.</p><p><blockquote>由于中国试图冷却不断上涨的物价和美元走强，大多数大宗商品价格在本周大幅下跌后，周五略有反弹。铜、黄金和铂的期货价格周五反弹，但本周仍大幅下跌。</blockquote></p><p> Chip stocks, which have had a good week, looked set to continue their run on Friday with shares of Nvidia higher by about 1%.</p><p><blockquote>本周表现良好的芯片股周五似乎将继续上涨，英伟达股价上涨约1%。</blockquote></p><p> Adobe shares gained about 3% after earnings and revenue topped estimates.</p><p><blockquote>盈利和收入超出预期后，Adobe股价上涨约3%。</blockquote></p><p> Friday also coincides with the quarterly \"quadruple witching\" where options and futures on indexes and equities expire. Many expect trading to be more volatile in light of this event.</p><p><blockquote>周五也恰逢季度“四重巫术”，指数和股票的期权和期货到期。许多人预计，鉴于这一事件，交易将更加波动。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118271544","content_text":"U.S. stocks fell on Friday with the Dow Jones Industrial Average on pace to post its worst week since January, as bank shares led the market sell-off after the Federal Reserve's latest policy update.\nThe blue-chip average dropped 400 points, bringing its week-to-date losses to 2.8% The S&P 500 fell 0.8%, pushing its loss this week to more than 1%. The tech-heavy Nasdaq Composite dipped 0.5%.\nStocks extended their losses asSt. Louis Fed President Jim Bullard said on CNBCthat it was natural for the Fed to tilt a little \"hawkish\" this week and that the first rate increase from the central bank would likely come in 2022.\nWall Street registered losses as the Federal Reserve on Wednesday afternoon added two rate hikes to its 2023 forecast and increased its inflation projection for the year.\nThe decline in stocks came as the Fed's actions caused a drastic flattening of the so-called Treasury yield curve where the yields of shorter-duration Treasurys, like the 2-year note, rose, while longer duration yields, such as the benchmark 10-year, fell. The retreat in long-dated bonds reflects less optimism toward economic growth, while the jump in short-end yields shows the expectations of the Fed raising rates.\nThis phenomenon is hurting bank stocks particularly as bank earnings could take a hit when the spread between short-term and long-term rates narrows. Goldman Sachs shares fell more than 1% Friday, while JPMorgan and Morgan Stanley also traded in the red.\nFed Chairman Jerome Powell said on Wednesday that officials have discussed tapering bond buying and would at some point begin slowing the asset purchases.\n\"Investors may be interpreting the Fed's hawkish tilt Wednesday as a sign that an extended US post-pandemic economic expansion may be a bit harder to achieve in a potentially emerging environment of less accommodative monetary policy,\" said Goldman Sachs' Chris Hussey in a note.\nMost commodities prices rebounded a bit on Friday followingsharp declines this week as China attempts to cool rising prices and the U.S. dollar strengthens. Futures prices for copper, gold, and platinum rebounded Friday, but were still down big for the week.\nChip stocks, which have had a good week, looked set to continue their run on Friday with shares of Nvidia higher by about 1%.\nAdobe shares gained about 3% after earnings and revenue topped estimates.\nFriday also coincides with the quarterly \"quadruple witching\" where options and futures on indexes and equities expire. Many expect trading to be more volatile in light of this event.","news_type":1,"symbols_score_info":{".DJI":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":639,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":196915679,"gmtCreate":1621004490291,"gmtModify":1634194608009,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Buy buy buy","listText":"Buy buy buy","text":"Buy buy buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/196915679","repostId":"1185220705","repostType":4,"isVote":1,"tweetType":1,"viewCount":552,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109577559,"gmtCreate":1619707492371,"gmtModify":1634210534329,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Need ur like &amp; comment","listText":"Need ur like &amp; comment","text":"Need ur like & comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/109577559","repostId":"1183966356","repostType":4,"repost":{"id":"1183966356","kind":"news","pubTimestamp":1619665696,"share":"https://www.laohu8.com/m/news/1183966356?lang=zh_CN&edition=full","pubTime":"2021-04-29 11:08","market":"us","language":"en","title":"NIO Q1 2021 Earnings Report Preview: What to Look For<blockquote>蔚来2021年第一季度收益报告预览：寻找什么</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1183966356","media":"InvestoPedia","summary":"Analysts estimate earnings per ADS of -0.72 yuan vs. -1.66 yuan in Q1 FY 2020.Revenue is expected to soar on expanding vehicle sales.NIO Inc. , like many other automakers, was forced to halt production this year due to the global semiconductor shortage. Semiconductor chips, widely used in smartphones, computers, and other electronic devices, are especially important to NIO, a maker of premium electric vehicles . NIO's production stoppage in late March had little impact on the company's record ve","content":"<p>Focus on NIO vehicle deliveries</p><p><blockquote>聚焦蔚来汽车交付</blockquote></p><p> <b>KEY TAKEAWAYS</b></p><p><blockquote><b>关键要点</b></blockquote></p><p> <ul>  <li>Analysts estimate earnings per ADS of -0.72 yuan vs. -1.66 yuan in Q1 FY 2020.</li>  <li>Vehicle deliveries, already announced, rose dramatically YOY.</li>  <li>Revenue is expected to soar on expanding vehicle sales.</li> </ul> NIO Inc. (NIO), like many other automakers, was forced to halt production this year due to the global semiconductor shortage. Semiconductor chips, widely used in smartphones, computers, and other electronic devices, are especially important to NIO, a maker of premium electric vehicles (EVs). NIO's production stoppage in late March had little impact on the company's record vehicle deliveries in Q1, but it could affect future production numbers.</p><p><blockquote><ul><li>分析师预计2020财年第一季度每股美国存托凭证收益为-0.72元，而2020财年第一季度为-1.66元。</li><li>已经宣布的车辆交付量同比大幅增长。</li><li>随着汽车销量的扩大，收入预计将飙升。</li></ul>蔚来（蔚来）和许多其他汽车制造商一样，由于全球半导体短缺，今年被迫停产。广泛用于智能手机、计算机和其他电子设备的半导体芯片对于高端电动汽车(EV)制造商蔚来尤为重要。蔚来3月下旬的停产对该公司第一季度创纪录的汽车交付量影响不大，但可能会影响未来的产量。</blockquote></p><p> Investors will focus on how these forces affect NIO's immediate results, as well as its financial outlook, when the company reports earnings on April 29, 2021 for Q1 FY 2021.Analysts are expecting the company's loss per American depositary share (ADS) to narrow significantly as revenue expands at a rapid pace.</p><p><blockquote>当蔚来于2021年4月29日公布2021财年第一季度收益时，投资者将关注这些力量如何影响该公司的近期业绩及其财务前景。分析师预计该公司每股美国存托股(ADS)亏损将随着收入快速扩张而显着收窄。</blockquote></p><p> Vehicle deliveries are another key metric investors watch in order to gauge the company's productive capacity. NIO already reported vehicle deliveries for the first quarter earlier this month, achieving a new quarterly record despite total deliveries coming in slightly below expectations.</p><p><blockquote>车辆交付量是投资者关注的另一个关键指标，以衡量公司的生产能力。蔚来本月早些时候已经公布了第一季度的汽车交付量，尽管总交付量略低于预期，但仍创下了新的季度纪录。</blockquote></p><p> Shares of NIO have dramatically outperformed the broader market over the past year. But after reaching all-time highs earlier this year, the stock has fallen considerably and has been trading mostly sideways since early March. NIO's shares have provided investors with an astronomic total return of 1,171.9% over the past year, well above the S&amp;P 500's total return of 45.5%.</p><p><blockquote>过去一年，蔚来的股价大幅跑赢大盘。但在今年早些时候达到历史高点后，该股大幅下跌，自3月初以来一直横盘整理。过去一年，蔚来的股票为投资者带来了1,171.9%的天文数字总回报率，远高于标普500 45.5%的总回报率。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a11e1a915810ccbc7f07ec2adf16865b\" tg-width=\"3004\" tg-height=\"1798\"><span>Source: TradingView.</span></p><p><blockquote><p class=\"t-img-caption\"><span>资料来源：TradingView。</span></p></blockquote></p><p> <b>NIO Earnings History</b></p><p><blockquote><b>蔚来盈利历史</b></blockquote></p><p> The stock, which had been gathering downward momentum after peaking around mid-February, plunged following NIO's&nbsp;Q4 FY 2020 earnings&nbsp;report released at the beginning of March. The company reported a much larger loss per ADS than analysts expected and revenue also missed estimates. However, NIO's loss narrowed considerably compared to the year-ago quarter and revenue was still up 133.2%.The company was optimistic about its performance, noting that its&nbsp;gross margin&nbsp;rose to 17.2% compared to negative 8.9% in the year-ago quarter.</p><p><blockquote>该股在2月中旬左右见顶后一直在积聚下行动力，在蔚来3月初发布2020财年第四季度收益报告后暴跌。该公司报告的每股美国存托凭证亏损远高于分析师预期，收入也低于预期。不过，蔚来的亏损较去年同期大幅收窄，营收仍增长133.2%。该公司对其业绩持乐观态度，指出其毛利率升至17.2%，而去年同期为负8.9%。</blockquote></p><p> In Q3 FY 2020, NIO posted a loss per ADS of 0.98 yuan ($0.15 as of the CNY/USD exchange rate on April 27, 2021).It was the smallest loss in at least 11 quarters. Revenue rose 146.4%, maintaining the pace of growth achieved in the second quarter.NIO said it delivered a record number of vehicles and saw improvements in its average selling price. The company also said that it was the second straight quarter of positive cash flow from operating activities.</p><p><blockquote>2020财年第三季度，蔚来每ADS亏损0.98元人民币（按2021年4月27日人民币/美元汇率计算为0.15美元）。这是至少11个季度以来的最小亏损。收入增长146.4%，保持了第二季度的增长速度。蔚来表示，其交付的车辆数量创历史新高，平均售价也有所提高。该公司还表示，这是连续第二个季度经营活动现金流为正。</blockquote></p><p> Analysts expect continued improvement in NIO's financial results in Q1 FY 2021. While NIO is still expected to post another loss per ADS, it is estimated to be the lowest in at least 14 quarters. Revenue for the quarter is forecast to rise 446.1%, which would be the fastest pace since Q2 FY 2019. For full-year FY 2021, analysts are currently expecting NIO to achieve a loss of 2.72 yuan per ADS, which would be the smallest loss in at least five years. Revenue is expected to rise 109.7%, a faster pace than in each of the last two years.</p><p><blockquote>分析师预计蔚来2021财年第一季度的财务业绩将持续改善。虽然蔚来预计仍将再次出现每股美国存托凭证亏损，但估计将是至少14个季度以来的最低水平。该季度收入预计将增长446.1%，这将是自2019财年第二季度以来的最快增速。对于2021财年全年，分析师目前预计蔚来将实现每股ADS亏损2.72元，这将是至少五年来的最小亏损。收入预计将增长109.7%，增速快于过去两年的每年。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d412a9c0aea28621f713f5afbfba444c\" tg-width=\"885\" tg-height=\"352\"><span>Source: Visible Alpha; NIO Inc.</span></p><p><blockquote><p class=\"t-img-caption\"><span>来源：可见阿尔法；蔚来</span></p></blockquote></p><p> <b>The Key Metric</b></p><p><blockquote><b>关键指标</b></blockquote></p><p> As mentioned above, investors are also watching the number of vehicles NIO delivers each quarter. NIO generates some revenue from various services it provides, but the majority of revenue is derived from vehicle sales.Currently, the company makes deliveries of three types of vehicles: the ES8, the company's 6-seater and 7-seater flagship premium smart electric SUV; the ES6, the company’s 5-seater high-performance premium smart electric SUV; and the EC6, the company’s 5-seater premium electric coupe SUV.The number of vehicle deliveries provides an indication of the demand for NIO's vehicles as well as the company's ability to scale production.</p><p><blockquote>如上所述，投资者也在关注蔚来每个季度交付的汽车数量。蔚来从其提供的各种服务中获得一些收入，但大部分收入来自汽车销售。目前，该公司交付三种类型的车辆：ES8，该公司的6座和7座旗舰高端智能电动SUV；该公司的5座高性能高级智能电动SUV ES6；以及该公司的5座高级电动轿跑车SUV EC6。汽车交付数量表明了对蔚来汽车的需求以及该公司扩大生产的能力。</blockquote></p><p></p><p> NIO has significantly ramped up its production over the past few years. The company delivered 11,350 vehicles in FY 2018. In FY 2020, it had nearly quadrupled that figure, delivering 43,730 vehicles. Despite a slowdown in Q1 FY 2020 amid the COVID-19 pandemic, NIO quickly made up for the Q1 drop in deliveries with a 190.8% year-over-year increase in Q2 FY 2020. Total vehicle delivery growth decelerated to 154.3% in Q3 and then to 111.0% in Q4. However, vehicle deliveries rose 423.0% in Q1 FY 2021, hitting a new quarterly record, as mentioned above. For full-year FY 2021, analysts are forecasting NIO to deliver 88,280 vehicles, which would be more than double last year's total deliveries. However, NIO warned investors in early March that the global chip shortage is likely to cut its production capacity, at least in the second quarter.</p><p><blockquote>蔚来在过去几年中大幅提高了产量。该公司在2018财年交付了11,350辆汽车。2020财年，这一数字几乎翻了两番，交付了43,730辆汽车。尽管2020财年第一季度因COVID-19大流行而放缓，但蔚来很快弥补了第一季度交付量的下降，2020财年第二季度同比增长190.8%。第三季度车辆交付总量增速放缓至154.3%，第四季度放缓至111.0%。然而，如上所述，2021财年第一季度的车辆交付量增长了423.0%，创下了新的季度纪录。对于2021财年全年，分析师预测蔚来将交付88,280辆汽车，这将是去年总交付量的两倍多。然而，蔚来在3月初警告投资者，全球芯片短缺很可能会削减其产能，至少在第二季度是这样。</blockquote></p><p></p>","source":"lsy1606203311635","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO Q1 2021 Earnings Report Preview: What to Look For<blockquote>蔚来2021年第一季度收益报告预览：寻找什么</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO Q1 2021 Earnings Report Preview: What to Look For<blockquote>蔚来2021年第一季度收益报告预览：寻找什么</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">InvestoPedia</strong><span class=\"h-time small\">2021-04-29 11:08</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Focus on NIO vehicle deliveries</p><p><blockquote>聚焦蔚来汽车交付</blockquote></p><p> <b>KEY TAKEAWAYS</b></p><p><blockquote><b>关键要点</b></blockquote></p><p> <ul>  <li>Analysts estimate earnings per ADS of -0.72 yuan vs. -1.66 yuan in Q1 FY 2020.</li>  <li>Vehicle deliveries, already announced, rose dramatically YOY.</li>  <li>Revenue is expected to soar on expanding vehicle sales.</li> </ul> NIO Inc. (NIO), like many other automakers, was forced to halt production this year due to the global semiconductor shortage. Semiconductor chips, widely used in smartphones, computers, and other electronic devices, are especially important to NIO, a maker of premium electric vehicles (EVs). NIO's production stoppage in late March had little impact on the company's record vehicle deliveries in Q1, but it could affect future production numbers.</p><p><blockquote><ul><li>分析师预计2020财年第一季度每股美国存托凭证收益为-0.72元，而2020财年第一季度为-1.66元。</li><li>已经宣布的车辆交付量同比大幅增长。</li><li>随着汽车销量的扩大，收入预计将飙升。</li></ul>蔚来（蔚来）和许多其他汽车制造商一样，由于全球半导体短缺，今年被迫停产。广泛用于智能手机、计算机和其他电子设备的半导体芯片对于高端电动汽车(EV)制造商蔚来尤为重要。蔚来3月下旬的停产对该公司第一季度创纪录的汽车交付量影响不大，但可能会影响未来的产量。</blockquote></p><p> Investors will focus on how these forces affect NIO's immediate results, as well as its financial outlook, when the company reports earnings on April 29, 2021 for Q1 FY 2021.Analysts are expecting the company's loss per American depositary share (ADS) to narrow significantly as revenue expands at a rapid pace.</p><p><blockquote>当蔚来于2021年4月29日公布2021财年第一季度收益时，投资者将关注这些力量如何影响该公司的近期业绩及其财务前景。分析师预计该公司每股美国存托股(ADS)亏损将随着收入快速扩张而显着收窄。</blockquote></p><p> Vehicle deliveries are another key metric investors watch in order to gauge the company's productive capacity. NIO already reported vehicle deliveries for the first quarter earlier this month, achieving a new quarterly record despite total deliveries coming in slightly below expectations.</p><p><blockquote>车辆交付量是投资者关注的另一个关键指标，以衡量公司的生产能力。蔚来本月早些时候已经公布了第一季度的汽车交付量，尽管总交付量略低于预期，但仍创下了新的季度纪录。</blockquote></p><p> Shares of NIO have dramatically outperformed the broader market over the past year. But after reaching all-time highs earlier this year, the stock has fallen considerably and has been trading mostly sideways since early March. NIO's shares have provided investors with an astronomic total return of 1,171.9% over the past year, well above the S&amp;P 500's total return of 45.5%.</p><p><blockquote>过去一年，蔚来的股价大幅跑赢大盘。但在今年早些时候达到历史高点后，该股大幅下跌，自3月初以来一直横盘整理。过去一年，蔚来的股票为投资者带来了1,171.9%的天文数字总回报率，远高于标普500 45.5%的总回报率。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a11e1a915810ccbc7f07ec2adf16865b\" tg-width=\"3004\" tg-height=\"1798\"><span>Source: TradingView.</span></p><p><blockquote><p class=\"t-img-caption\"><span>资料来源：TradingView。</span></p></blockquote></p><p> <b>NIO Earnings History</b></p><p><blockquote><b>蔚来盈利历史</b></blockquote></p><p> The stock, which had been gathering downward momentum after peaking around mid-February, plunged following NIO's&nbsp;Q4 FY 2020 earnings&nbsp;report released at the beginning of March. The company reported a much larger loss per ADS than analysts expected and revenue also missed estimates. However, NIO's loss narrowed considerably compared to the year-ago quarter and revenue was still up 133.2%.The company was optimistic about its performance, noting that its&nbsp;gross margin&nbsp;rose to 17.2% compared to negative 8.9% in the year-ago quarter.</p><p><blockquote>该股在2月中旬左右见顶后一直在积聚下行动力，在蔚来3月初发布2020财年第四季度收益报告后暴跌。该公司报告的每股美国存托凭证亏损远高于分析师预期，收入也低于预期。不过，蔚来的亏损较去年同期大幅收窄，营收仍增长133.2%。该公司对其业绩持乐观态度，指出其毛利率升至17.2%，而去年同期为负8.9%。</blockquote></p><p> In Q3 FY 2020, NIO posted a loss per ADS of 0.98 yuan ($0.15 as of the CNY/USD exchange rate on April 27, 2021).It was the smallest loss in at least 11 quarters. Revenue rose 146.4%, maintaining the pace of growth achieved in the second quarter.NIO said it delivered a record number of vehicles and saw improvements in its average selling price. The company also said that it was the second straight quarter of positive cash flow from operating activities.</p><p><blockquote>2020财年第三季度，蔚来每ADS亏损0.98元人民币（按2021年4月27日人民币/美元汇率计算为0.15美元）。这是至少11个季度以来的最小亏损。收入增长146.4%，保持了第二季度的增长速度。蔚来表示，其交付的车辆数量创历史新高，平均售价也有所提高。该公司还表示，这是连续第二个季度经营活动现金流为正。</blockquote></p><p> Analysts expect continued improvement in NIO's financial results in Q1 FY 2021. While NIO is still expected to post another loss per ADS, it is estimated to be the lowest in at least 14 quarters. Revenue for the quarter is forecast to rise 446.1%, which would be the fastest pace since Q2 FY 2019. For full-year FY 2021, analysts are currently expecting NIO to achieve a loss of 2.72 yuan per ADS, which would be the smallest loss in at least five years. Revenue is expected to rise 109.7%, a faster pace than in each of the last two years.</p><p><blockquote>分析师预计蔚来2021财年第一季度的财务业绩将持续改善。虽然蔚来预计仍将再次出现每股美国存托凭证亏损，但估计将是至少14个季度以来的最低水平。该季度收入预计将增长446.1%，这将是自2019财年第二季度以来的最快增速。对于2021财年全年，分析师目前预计蔚来将实现每股ADS亏损2.72元，这将是至少五年来的最小亏损。收入预计将增长109.7%，增速快于过去两年的每年。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d412a9c0aea28621f713f5afbfba444c\" tg-width=\"885\" tg-height=\"352\"><span>Source: Visible Alpha; NIO Inc.</span></p><p><blockquote><p class=\"t-img-caption\"><span>来源：可见阿尔法；蔚来</span></p></blockquote></p><p> <b>The Key Metric</b></p><p><blockquote><b>关键指标</b></blockquote></p><p> As mentioned above, investors are also watching the number of vehicles NIO delivers each quarter. NIO generates some revenue from various services it provides, but the majority of revenue is derived from vehicle sales.Currently, the company makes deliveries of three types of vehicles: the ES8, the company's 6-seater and 7-seater flagship premium smart electric SUV; the ES6, the company’s 5-seater high-performance premium smart electric SUV; and the EC6, the company’s 5-seater premium electric coupe SUV.The number of vehicle deliveries provides an indication of the demand for NIO's vehicles as well as the company's ability to scale production.</p><p><blockquote>如上所述，投资者也在关注蔚来每个季度交付的汽车数量。蔚来从其提供的各种服务中获得一些收入，但大部分收入来自汽车销售。目前，该公司交付三种类型的车辆：ES8，该公司的6座和7座旗舰高端智能电动SUV；该公司的5座高性能高级智能电动SUV ES6；以及该公司的5座高级电动轿跑车SUV EC6。汽车交付数量表明了对蔚来汽车的需求以及该公司扩大生产的能力。</blockquote></p><p></p><p> NIO has significantly ramped up its production over the past few years. The company delivered 11,350 vehicles in FY 2018. In FY 2020, it had nearly quadrupled that figure, delivering 43,730 vehicles. Despite a slowdown in Q1 FY 2020 amid the COVID-19 pandemic, NIO quickly made up for the Q1 drop in deliveries with a 190.8% year-over-year increase in Q2 FY 2020. Total vehicle delivery growth decelerated to 154.3% in Q3 and then to 111.0% in Q4. However, vehicle deliveries rose 423.0% in Q1 FY 2021, hitting a new quarterly record, as mentioned above. For full-year FY 2021, analysts are forecasting NIO to deliver 88,280 vehicles, which would be more than double last year's total deliveries. However, NIO warned investors in early March that the global chip shortage is likely to cut its production capacity, at least in the second quarter.</p><p><blockquote>蔚来在过去几年中大幅提高了产量。该公司在2018财年交付了11,350辆汽车。2020财年，这一数字几乎翻了两番，交付了43,730辆汽车。尽管2020财年第一季度因COVID-19大流行而放缓，但蔚来很快弥补了第一季度交付量的下降，2020财年第二季度同比增长190.8%。第三季度车辆交付总量增速放缓至154.3%，第四季度放缓至111.0%。然而，如上所述，2021财年第一季度的车辆交付量增长了423.0%，创下了新的季度纪录。对于2021财年全年，分析师预测蔚来将交付88,280辆汽车，这将是去年总交付量的两倍多。然而，蔚来在3月初警告投资者，全球芯片短缺很可能会削减其产能，至少在第二季度是这样。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.investopedia.com/nio-q1-2021-earnings-report-preview-5180991\">InvestoPedia</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"source_url":"https://www.investopedia.com/nio-q1-2021-earnings-report-preview-5180991","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183966356","content_text":"Focus on NIO vehicle deliveries\nKEY TAKEAWAYS\n\nAnalysts estimate earnings per ADS of -0.72 yuan vs. -1.66 yuan in Q1 FY 2020.\nVehicle deliveries, already announced, rose dramatically YOY.\nRevenue is expected to soar on expanding vehicle sales.\n\nNIO Inc. (NIO), like many other automakers, was forced to halt production this year due to the global semiconductor shortage. Semiconductor chips, widely used in smartphones, computers, and other electronic devices, are especially important to NIO, a maker of premium electric vehicles (EVs). NIO's production stoppage in late March had little impact on the company's record vehicle deliveries in Q1, but it could affect future production numbers.\nInvestors will focus on how these forces affect NIO's immediate results, as well as its financial outlook, when the company reports earnings on April 29, 2021 for Q1 FY 2021.Analysts are expecting the company's loss per American depositary share (ADS) to narrow significantly as revenue expands at a rapid pace.\nVehicle deliveries are another key metric investors watch in order to gauge the company's productive capacity. NIO already reported vehicle deliveries for the first quarter earlier this month, achieving a new quarterly record despite total deliveries coming in slightly below expectations.\nShares of NIO have dramatically outperformed the broader market over the past year. But after reaching all-time highs earlier this year, the stock has fallen considerably and has been trading mostly sideways since early March. NIO's shares have provided investors with an astronomic total return of 1,171.9% over the past year, well above the S&P 500's total return of 45.5%.\nSource: TradingView.\nNIO Earnings History\nThe stock, which had been gathering downward momentum after peaking around mid-February, plunged following NIO's Q4 FY 2020 earnings report released at the beginning of March. The company reported a much larger loss per ADS than analysts expected and revenue also missed estimates. However, NIO's loss narrowed considerably compared to the year-ago quarter and revenue was still up 133.2%.The company was optimistic about its performance, noting that its gross margin rose to 17.2% compared to negative 8.9% in the year-ago quarter.\nIn Q3 FY 2020, NIO posted a loss per ADS of 0.98 yuan ($0.15 as of the CNY/USD exchange rate on April 27, 2021).It was the smallest loss in at least 11 quarters. Revenue rose 146.4%, maintaining the pace of growth achieved in the second quarter.NIO said it delivered a record number of vehicles and saw improvements in its average selling price. The company also said that it was the second straight quarter of positive cash flow from operating activities.\nAnalysts expect continued improvement in NIO's financial results in Q1 FY 2021. While NIO is still expected to post another loss per ADS, it is estimated to be the lowest in at least 14 quarters. Revenue for the quarter is forecast to rise 446.1%, which would be the fastest pace since Q2 FY 2019. For full-year FY 2021, analysts are currently expecting NIO to achieve a loss of 2.72 yuan per ADS, which would be the smallest loss in at least five years. Revenue is expected to rise 109.7%, a faster pace than in each of the last two years.\nSource: Visible Alpha; NIO Inc.\nThe Key Metric\nAs mentioned above, investors are also watching the number of vehicles NIO delivers each quarter. NIO generates some revenue from various services it provides, but the majority of revenue is derived from vehicle sales.Currently, the company makes deliveries of three types of vehicles: the ES8, the company's 6-seater and 7-seater flagship premium smart electric SUV; the ES6, the company’s 5-seater high-performance premium smart electric SUV; and the EC6, the company’s 5-seater premium electric coupe SUV.The number of vehicle deliveries provides an indication of the demand for NIO's vehicles as well as the company's ability to scale production.\nNIO has significantly ramped up its production over the past few years. The company delivered 11,350 vehicles in FY 2018. In FY 2020, it had nearly quadrupled that figure, delivering 43,730 vehicles. Despite a slowdown in Q1 FY 2020 amid the COVID-19 pandemic, NIO quickly made up for the Q1 drop in deliveries with a 190.8% year-over-year increase in Q2 FY 2020. Total vehicle delivery growth decelerated to 154.3% in Q3 and then to 111.0% in Q4. However, vehicle deliveries rose 423.0% in Q1 FY 2021, hitting a new quarterly record, as mentioned above. For full-year FY 2021, analysts are forecasting NIO to deliver 88,280 vehicles, which would be more than double last year's total deliveries. However, NIO warned investors in early March that the global chip shortage is likely to cut its production capacity, at least in the second quarter.","news_type":1,"symbols_score_info":{"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":634,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":600765168,"gmtCreate":1638198782315,"gmtModify":1638198822415,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600765168","repostId":"1180693909","repostType":4,"repost":{"id":"1180693909","kind":"news","pubTimestamp":1638198357,"share":"https://www.laohu8.com/m/news/1180693909?lang=zh_CN&edition=full","pubTime":"2021-11-29 23:05","market":"us","language":"en","title":"Spotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify股票：逢低买入10月初的水平？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1180693909","media":"TheStreet","summary":"Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the","content":"<p>Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the move as bearish, while others could find it an opportunity to buy SPOT cheaper.</p><p><blockquote>继第三季度后盈利飙升后，Spotify股价在11月份失去了大量动力。一些人可能认为此举是看跌的，而另一些人可能会发现这是一个以更便宜的价格购买现货的机会。</blockquote></p><p> In late October, Spotify&nbsp;announced third quarter results. The numbers excited investors and sent Spotify stock&nbsp;up nearly 15% quickly. The key metric supporting bullishness was the large increase in the platform's MAUs (monthly active users) over the previous year, followed by an almost 30% YoY growth in revenue.</p><p><blockquote>10月下旬，Spotify公布了第三季度业绩。这些数字令投资者兴奋不已，并使Spotify股价迅速上涨近15%。支持看涨的关键指标是该平台的MAU（月活跃用户）较上一年大幅增长，随后收入同比增长近30%。</blockquote></p><p> However, almost a month after the earnings announcement, shares have dipped 10% and returned to the same levels of early October. Today, MavenFlix tries to make sense of what is happening with SPOT, and debates whether the recent drop can be considered a buying opportunity.</p><p><blockquote>然而，财报公布近一个月后，股价已下跌10%，回到10月初的水平。今天，MavenFlix试图了解SPOT的情况，并讨论最近的下跌是否可以被视为买入机会。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1a76b6dc048e3702eb0b6ef48bbc0409\" tg-width=\"1240\" tg-height=\"698\" width=\"100%\" height=\"auto\"><span>Figure 1: Spotify app icon.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：Spotify应用程序图标。</span></p></blockquote></p><p> <b>Recent downfall and a future opportunity</b></p><p><blockquote><b>最近的失败和未来的机会</b></blockquote></p><p> SPOT hit $205 per share in August and, since then, embarked on a strong bullish ride to six-month highs. However, in November, not long after the announcement of the company's third quarter results, Spotify stock dropped from a high of $300 to less than $250.</p><p><blockquote>现货在8月份触及每股205美元，此后开始强劲看涨，升至六个月高点。然而，11月，在公司第三季度业绩公布后不久，Spotify股票就从300美元的高点跌至250美元以下。</blockquote></p><p> One of the possible causes for such decline is profit taking. If so, an opportunity to buy the dip could exist for those who like the fundamentals of the company, but that believed SPOT may have been too expensive or overvalued. Today, Spotify is trading at the lowest price in the last 3 months.</p><p><blockquote>这种下跌的可能原因之一是获利了结。如果是这样的话，对于那些喜欢该公司基本面但认为现货可能太贵或估值过高的人来说，可能存在逢低买入的机会。今天，Spotify的交易价格是过去3个月来的最低价格。</blockquote></p><p> <b>Podcast growth and ad revenue</b></p><p><blockquote><b>播客增长和广告收入</b></blockquote></p><p> Unlike what many might think, Spotify is not merely a music platform, but an audio one. Therefore, one should not only consider growth in the music streaming space when calculating the fair value of the stock.</p><p><blockquote>与许多人的想法不同，Spotify不仅仅是一个音乐平台，还是一个音频平台。因此，在计算股票的公允价值时，不应只考虑音乐流媒体领域的增长。</blockquote></p><p> As we discussed in “Spotify Earnings: Why The Stock Spiked On Q3 Results”, one of the most relevant growth drivers for Spotify today is podcast. This sub-segment of streaming audio is expanding fast and could become a substantial part of the company's P&amp;L in the foreseeable future.</p><p><blockquote>正如我们在“Spotify收益：为什么该股在第三季度业绩中飙升”中讨论的那样，当今Spotify最相关的增长动力之一是播客。流媒体音频的这一细分市场正在快速扩张，在可预见的未来可能成为公司损益的重要组成部分。</blockquote></p><p> With ad-supported accounts growing at the same rate as paid users, monetizing on podcasts is a key next step for Spotify. We think that this could be a catalyst pushing Spotify stock higher in the future – even if not in the next few weeks or months.</p><p><blockquote>随着广告支持的账户以与付费用户相同的速度增长，通过播客赚钱是Spotify的下一步关键。我们认为这可能是未来推高Spotify股价的催化剂——即使不是在未来几周或几个月内。</blockquote></p><p> <b>Spotify dominates audio streaming</b></p><p><blockquote><b>Spotify主导音频流</b></blockquote></p><p> Spotify has one of the largest music libraries. However, we do not think that this sets the company apart from its competitors. Apple and Amazon, for example, continue to invest their bottomless piles of cash to boost their platforms’ content offerings as well.</p><p><blockquote>Spotify拥有最大的音乐库之一。然而，我们并不认为这使该公司从竞争对手中脱颖而出。例如，苹果和亚马逊也继续投入大量现金来增加其平台的内容产品。</blockquote></p><p> What makes Spotify stand out, in our view, is its footprint in audio streaming. Despite the growth prospects, the market is still concentrated in the hands of few players, unlike what happens in video streaming. Spotify has clear market dominance, as the chart below depicts.</p><p><blockquote>在我们看来，Spotify之所以脱颖而出，是因为它在音频流领域的足迹。尽管有增长前景，但市场仍然集中在少数玩家手中，这与视频流媒体的情况不同。如下图所示，Spotify拥有明显的市场主导地位。</blockquote></p><p> The investments in podcasts should only help Spotify to establish itself at the top for years to come. Currently, there are about 2.6 million podcast titles available on the platform.</p><p><blockquote>对播客的投资应该只会帮助Spotify在未来几年确立自己的地位。目前，该平台上大约有260万个播客标题。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ab561adf751b756fe06b8fa8d2bff0ee\" tg-width=\"609\" tg-height=\"458\" width=\"100%\" height=\"auto\"><span>Figure 2: Music streaming market share.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：音乐流媒体市场份额。</span></p></blockquote></p><p> <b>Our view</b></p><p><blockquote><b>我们的观点</b></blockquote></p><p> After Spotify stock dropped more than 10% since the beginning of November, a window of opportunity may have opened for those who appreciate Spotify's business model. Buying SPOT today, however, may only prove to be a good long-term strategy, since volatility in the short term in unlikely to subside.</p><p><blockquote>自11月初以来，Spotify股价下跌超过10%，对于那些欣赏Spotify商业模式的人来说，机会之窗可能已经打开。然而，今天购买现货可能只是一个很好的长期策略，因为短期内的波动不太可能消退。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Spotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify股票：逢低买入10月初的水平？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSpotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify股票：逢低买入10月初的水平？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-11-29 23:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the move as bearish, while others could find it an opportunity to buy SPOT cheaper.</p><p><blockquote>继第三季度后盈利飙升后，Spotify股价在11月份失去了大量动力。一些人可能认为此举是看跌的，而另一些人可能会发现这是一个以更便宜的价格购买现货的机会。</blockquote></p><p> In late October, Spotify&nbsp;announced third quarter results. The numbers excited investors and sent Spotify stock&nbsp;up nearly 15% quickly. The key metric supporting bullishness was the large increase in the platform's MAUs (monthly active users) over the previous year, followed by an almost 30% YoY growth in revenue.</p><p><blockquote>10月下旬，Spotify公布了第三季度业绩。这些数字令投资者兴奋不已，并使Spotify股价迅速上涨近15%。支持看涨的关键指标是该平台的MAU（月活跃用户）较上一年大幅增长，随后收入同比增长近30%。</blockquote></p><p> However, almost a month after the earnings announcement, shares have dipped 10% and returned to the same levels of early October. Today, MavenFlix tries to make sense of what is happening with SPOT, and debates whether the recent drop can be considered a buying opportunity.</p><p><blockquote>然而，财报公布近一个月后，股价已下跌10%，回到10月初的水平。今天，MavenFlix试图了解SPOT的情况，并讨论最近的下跌是否可以被视为买入机会。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1a76b6dc048e3702eb0b6ef48bbc0409\" tg-width=\"1240\" tg-height=\"698\" width=\"100%\" height=\"auto\"><span>Figure 1: Spotify app icon.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：Spotify应用程序图标。</span></p></blockquote></p><p> <b>Recent downfall and a future opportunity</b></p><p><blockquote><b>最近的失败和未来的机会</b></blockquote></p><p> SPOT hit $205 per share in August and, since then, embarked on a strong bullish ride to six-month highs. However, in November, not long after the announcement of the company's third quarter results, Spotify stock dropped from a high of $300 to less than $250.</p><p><blockquote>现货在8月份触及每股205美元，此后开始强劲看涨，升至六个月高点。然而，11月，在公司第三季度业绩公布后不久，Spotify股票就从300美元的高点跌至250美元以下。</blockquote></p><p> One of the possible causes for such decline is profit taking. If so, an opportunity to buy the dip could exist for those who like the fundamentals of the company, but that believed SPOT may have been too expensive or overvalued. Today, Spotify is trading at the lowest price in the last 3 months.</p><p><blockquote>这种下跌的可能原因之一是获利了结。如果是这样的话，对于那些喜欢该公司基本面但认为现货可能太贵或估值过高的人来说，可能存在逢低买入的机会。今天，Spotify的交易价格是过去3个月来的最低价格。</blockquote></p><p> <b>Podcast growth and ad revenue</b></p><p><blockquote><b>播客增长和广告收入</b></blockquote></p><p> Unlike what many might think, Spotify is not merely a music platform, but an audio one. Therefore, one should not only consider growth in the music streaming space when calculating the fair value of the stock.</p><p><blockquote>与许多人的想法不同，Spotify不仅仅是一个音乐平台，还是一个音频平台。因此，在计算股票的公允价值时，不应只考虑音乐流媒体领域的增长。</blockquote></p><p> As we discussed in “Spotify Earnings: Why The Stock Spiked On Q3 Results”, one of the most relevant growth drivers for Spotify today is podcast. This sub-segment of streaming audio is expanding fast and could become a substantial part of the company's P&amp;L in the foreseeable future.</p><p><blockquote>正如我们在“Spotify收益：为什么该股在第三季度业绩中飙升”中讨论的那样，当今Spotify最相关的增长动力之一是播客。流媒体音频的这一细分市场正在快速扩张，在可预见的未来可能成为公司损益的重要组成部分。</blockquote></p><p> With ad-supported accounts growing at the same rate as paid users, monetizing on podcasts is a key next step for Spotify. We think that this could be a catalyst pushing Spotify stock higher in the future – even if not in the next few weeks or months.</p><p><blockquote>随着广告支持的账户以与付费用户相同的速度增长，通过播客赚钱是Spotify的下一步关键。我们认为这可能是未来推高Spotify股价的催化剂——即使不是在未来几周或几个月内。</blockquote></p><p> <b>Spotify dominates audio streaming</b></p><p><blockquote><b>Spotify主导音频流</b></blockquote></p><p> Spotify has one of the largest music libraries. However, we do not think that this sets the company apart from its competitors. Apple and Amazon, for example, continue to invest their bottomless piles of cash to boost their platforms’ content offerings as well.</p><p><blockquote>Spotify拥有最大的音乐库之一。然而，我们并不认为这使该公司从竞争对手中脱颖而出。例如，苹果和亚马逊也继续投入大量现金来增加其平台的内容产品。</blockquote></p><p> What makes Spotify stand out, in our view, is its footprint in audio streaming. Despite the growth prospects, the market is still concentrated in the hands of few players, unlike what happens in video streaming. Spotify has clear market dominance, as the chart below depicts.</p><p><blockquote>在我们看来，Spotify之所以脱颖而出，是因为它在音频流领域的足迹。尽管有增长前景，但市场仍然集中在少数玩家手中，这与视频流媒体的情况不同。如下图所示，Spotify拥有明显的市场主导地位。</blockquote></p><p> The investments in podcasts should only help Spotify to establish itself at the top for years to come. Currently, there are about 2.6 million podcast titles available on the platform.</p><p><blockquote>对播客的投资应该只会帮助Spotify在未来几年确立自己的地位。目前，该平台上大约有260万个播客标题。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ab561adf751b756fe06b8fa8d2bff0ee\" tg-width=\"609\" tg-height=\"458\" width=\"100%\" height=\"auto\"><span>Figure 2: Music streaming market share.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：音乐流媒体市场份额。</span></p></blockquote></p><p> <b>Our view</b></p><p><blockquote><b>我们的观点</b></blockquote></p><p> After Spotify stock dropped more than 10% since the beginning of November, a window of opportunity may have opened for those who appreciate Spotify's business model. Buying SPOT today, however, may only prove to be a good long-term strategy, since volatility in the short term in unlikely to subside.</p><p><blockquote>自11月初以来，Spotify股价下跌超过10%，对于那些欣赏Spotify商业模式的人来说，机会之窗可能已经打开。然而，今天购买现货可能只是一个很好的长期策略，因为短期内的波动不太可能消退。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/streaming/spot/buy-spotify-stock-at-pre-q3-earnings-levels\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPOT":"Spotify Technology S.A."},"source_url":"https://www.thestreet.com/streaming/spot/buy-spotify-stock-at-pre-q3-earnings-levels","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180693909","content_text":"Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the move as bearish, while others could find it an opportunity to buy SPOT cheaper.\nIn late October, Spotify announced third quarter results. The numbers excited investors and sent Spotify stock up nearly 15% quickly. The key metric supporting bullishness was the large increase in the platform's MAUs (monthly active users) over the previous year, followed by an almost 30% YoY growth in revenue.\nHowever, almost a month after the earnings announcement, shares have dipped 10% and returned to the same levels of early October. Today, MavenFlix tries to make sense of what is happening with SPOT, and debates whether the recent drop can be considered a buying opportunity.\nFigure 1: Spotify app icon.\nRecent downfall and a future opportunity\nSPOT hit $205 per share in August and, since then, embarked on a strong bullish ride to six-month highs. However, in November, not long after the announcement of the company's third quarter results, Spotify stock dropped from a high of $300 to less than $250.\nOne of the possible causes for such decline is profit taking. If so, an opportunity to buy the dip could exist for those who like the fundamentals of the company, but that believed SPOT may have been too expensive or overvalued. Today, Spotify is trading at the lowest price in the last 3 months.\nPodcast growth and ad revenue\nUnlike what many might think, Spotify is not merely a music platform, but an audio one. Therefore, one should not only consider growth in the music streaming space when calculating the fair value of the stock.\nAs we discussed in “Spotify Earnings: Why The Stock Spiked On Q3 Results”, one of the most relevant growth drivers for Spotify today is podcast. This sub-segment of streaming audio is expanding fast and could become a substantial part of the company's P&L in the foreseeable future.\nWith ad-supported accounts growing at the same rate as paid users, monetizing on podcasts is a key next step for Spotify. We think that this could be a catalyst pushing Spotify stock higher in the future – even if not in the next few weeks or months.\nSpotify dominates audio streaming\nSpotify has one of the largest music libraries. However, we do not think that this sets the company apart from its competitors. Apple and Amazon, for example, continue to invest their bottomless piles of cash to boost their platforms’ content offerings as well.\nWhat makes Spotify stand out, in our view, is its footprint in audio streaming. Despite the growth prospects, the market is still concentrated in the hands of few players, unlike what happens in video streaming. Spotify has clear market dominance, as the chart below depicts.\nThe investments in podcasts should only help Spotify to establish itself at the top for years to come. Currently, there are about 2.6 million podcast titles available on the platform.\nFigure 2: Music streaming market share.\nOur view\nAfter Spotify stock dropped more than 10% since the beginning of November, a window of opportunity may have opened for those who appreciate Spotify's business model. Buying SPOT today, however, may only prove to be a good long-term strategy, since volatility in the short term in unlikely to subside.","news_type":1,"symbols_score_info":{"SPOT":0.9}},"isVote":1,"tweetType":1,"viewCount":4273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866693672,"gmtCreate":1632758526196,"gmtModify":1632798023770,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/866693672","repostId":"1143307489","repostType":4,"repost":{"id":"1143307489","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632757396,"share":"https://www.laohu8.com/m/news/1143307489?lang=zh_CN&edition=full","pubTime":"2021-09-27 23:43","market":"us","language":"en","title":"Cannabis stocks jumped in Monday morning trading<blockquote>大麻股周一早盘上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1143307489","media":"Tiger Newspress","summary":"Cannabis stocks jumped in Monday morning trading as U.S. House approved bill to ease banking for can","content":"<p>Cannabis stocks jumped in Monday morning trading&nbsp;as&nbsp;U.S. House approved bill to ease banking for cannabis companies.Canopy Growth,Tilray, Aurora Cannabis, Cronos, Sundial Growers&nbsp;and&nbsp;OrganiGram&nbsp;climbed between 2% and 6%.</p><p><blockquote>大麻股在周一早盘交易中上涨，因为美国。众议院批准了放宽大麻公司银行业务的法案。Canopy Growth、Tilray、Aurora Cannabis、Cronos、Sundial Growers和OrganiGram股价上涨2%至6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b7d7c6db300ed6a9e7a2699a1884e853\" tg-width=\"399\" tg-height=\"417\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The U.S. House of Representatives late last&nbsp;Tuesday night approved a bill that would let banks to do business with cannabis companies without fear of penalty, giving traction to the least-disputed reform sought by the growing industry.</p><p><blockquote>美国众议院上周二晚间批准了一项法案，允许银行与大麻公司开展业务，而不必担心受到处罚，这为不断增长的行业寻求的争议最小的改革提供了动力。</blockquote></p><p> The so-called SAFE Banking Act, which is the least disputed reform sought by the growing industry, got picked up as part of broader legislation, and its inclusion in the National Defense Authorization Act was approved by voice vote late Tuesday. It remains to be seen whether the bill will pass the Senate, but the House action gives it a better shot.</p><p><blockquote>所谓的《安全银行法》是这个不断发展的行业所寻求的争议最少的改革，被作为更广泛立法的一部分，并于周二晚些时候以口头投票方式批准将其纳入《国防授权法》。该法案是否会在参议院获得通过还有待观察，但众议院的行动给了它一个更好的机会。</blockquote></p><p> The act would be a boon for marijuana companies, which have so far been stymied by the need to deal in cash because of federal restrictions. That has meant they have extra security costs and logistical problems, even as marijuana increasingly becomes legal. Some three dozen states now allow medical or recreational use, according to New Frontier Data, a cannabis research firm.</p><p><blockquote>该法案对大麻公司来说将是一个福音，由于联邦限制，大麻公司迄今为止一直因需要现金交易而受到阻碍。这意味着他们有额外的安全成本和后勤问题，即使大麻越来越合法。根据大麻研究公司New Frontier Data的数据，现在大约有36个州允许医疗或娱乐用途。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/94634a1c93ee67a96440d95391009461\" tg-width=\"748\" tg-height=\"663\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Representative Ed Perlmutter, a Colorado Democrat, who had re-introduced the bill,has said&nbsp;that allowing cannabis businesses to access the banking system would bring more money into the economy and offer the opportunity to create good-paying jobs. The American cannabis industry had $20.3 billion in legal sales in 2020, according New Frontier Data.</p><p><blockquote>重新提出该法案的科罗拉多州民主党众议员埃德·佩尔穆特表示，允许大麻企业进入银行系统将为经济带来更多资金，并提供创造高薪就业机会的机会。根据New Frontier的数据，2020年美国大麻行业的合法销售额为203亿美元。</blockquote></p><p> The initiative, which has been passed by the House before with bipartisan support but never advanced to the Senate, is still a far cry from the wish list of legal reforms sought by the industry, which include all-out legalization and relief from tax burdens.</p><p><blockquote>该倡议此前已在两党支持下在众议院获得通过，但从未提交参议院，与该行业寻求的法律改革愿望清单（包括全面合法化和减轻税收负担）仍相去甚远。</blockquote></p><p> The U.S. Cannabis Council, a trade group, called the current rules that require marijuana firms to be all-cash a security hazard.</p><p><blockquote>贸易组织美国大麻委员会称，目前要求大麻公司全现金的规定存在安全隐患。</blockquote></p><p> “Over $17 billion in legal cannabis was sold in the United States last year, overwhelmingly through cash transactions. Forcing legitimate, well-regulated cannabis businesses to conduct most of their business in cash is anachronistic and a clear threat to public safety,” the council’s chief executive officer, Steven Hawkins, said in a statement before the bill passed.</p><p><blockquote>“去年，美国销售了超过170亿美元的合法大麻，其中绝大多数是通过现金交易。强迫合法、监管良好的大麻企业以现金开展大部分业务是不合时宜的，也是对公共安全的明显威胁，”该委员会首席执行官史蒂文·霍金斯在该法案通过前的一份声明中表示。</blockquote></p><p> “Every step forward is a positive one for the cannabis industry,”BTIGanalyst Camilo Lyon said in a research note Wednesday. He said it isn’t clear whether Senator Chuck Schumer will include the act in the Senate NDAA bill.</p><p><blockquote>BTIGA分析师卡米洛·里昂(Camilo Lyon)在周三的一份研究报告中表示：“每向前迈出一步对大麻行业来说都是积极的一步。”他说，尚不清楚参议员查克·舒默是否会将该法案纳入参议院国防授权法案。</blockquote></p><p> “Discussions with our D.C. contacts suggest it has an easier pathway of getting through the Senate, largely because no senator wants to be viewed as holding up the massive 1,700 page must-pass NDAA simply because of SAFE banking,” Lyon wrote.</p><p><blockquote>里昂写道：“与我们在华盛顿的联系人进行的讨论表明，它有一个更容易通过参议院的途径，很大程度上是因为没有参议员希望仅仅因为银行业安全而被视为搁置1700页的必须通过的国防授权法案。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cannabis stocks jumped in Monday morning trading<blockquote>大麻股周一早盘上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCannabis stocks jumped in Monday morning trading<blockquote>大麻股周一早盘上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-27 23:43</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Cannabis stocks jumped in Monday morning trading&nbsp;as&nbsp;U.S. House approved bill to ease banking for cannabis companies.Canopy Growth,Tilray, Aurora Cannabis, Cronos, Sundial Growers&nbsp;and&nbsp;OrganiGram&nbsp;climbed between 2% and 6%.</p><p><blockquote>大麻股在周一早盘交易中上涨，因为美国。众议院批准了放宽大麻公司银行业务的法案。Canopy Growth、Tilray、Aurora Cannabis、Cronos、Sundial Growers和OrganiGram股价上涨2%至6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b7d7c6db300ed6a9e7a2699a1884e853\" tg-width=\"399\" tg-height=\"417\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The U.S. House of Representatives late last&nbsp;Tuesday night approved a bill that would let banks to do business with cannabis companies without fear of penalty, giving traction to the least-disputed reform sought by the growing industry.</p><p><blockquote>美国众议院上周二晚间批准了一项法案，允许银行与大麻公司开展业务，而不必担心受到处罚，这为不断增长的行业寻求的争议最小的改革提供了动力。</blockquote></p><p> The so-called SAFE Banking Act, which is the least disputed reform sought by the growing industry, got picked up as part of broader legislation, and its inclusion in the National Defense Authorization Act was approved by voice vote late Tuesday. It remains to be seen whether the bill will pass the Senate, but the House action gives it a better shot.</p><p><blockquote>所谓的《安全银行法》是这个不断发展的行业所寻求的争议最少的改革，被作为更广泛立法的一部分，并于周二晚些时候以口头投票方式批准将其纳入《国防授权法》。该法案是否会在参议院获得通过还有待观察，但众议院的行动给了它一个更好的机会。</blockquote></p><p> The act would be a boon for marijuana companies, which have so far been stymied by the need to deal in cash because of federal restrictions. That has meant they have extra security costs and logistical problems, even as marijuana increasingly becomes legal. Some three dozen states now allow medical or recreational use, according to New Frontier Data, a cannabis research firm.</p><p><blockquote>该法案对大麻公司来说将是一个福音，由于联邦限制，大麻公司迄今为止一直因需要现金交易而受到阻碍。这意味着他们有额外的安全成本和后勤问题，即使大麻越来越合法。根据大麻研究公司New Frontier Data的数据，现在大约有36个州允许医疗或娱乐用途。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/94634a1c93ee67a96440d95391009461\" tg-width=\"748\" tg-height=\"663\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Representative Ed Perlmutter, a Colorado Democrat, who had re-introduced the bill,has said&nbsp;that allowing cannabis businesses to access the banking system would bring more money into the economy and offer the opportunity to create good-paying jobs. The American cannabis industry had $20.3 billion in legal sales in 2020, according New Frontier Data.</p><p><blockquote>重新提出该法案的科罗拉多州民主党众议员埃德·佩尔穆特表示，允许大麻企业进入银行系统将为经济带来更多资金，并提供创造高薪就业机会的机会。根据New Frontier的数据，2020年美国大麻行业的合法销售额为203亿美元。</blockquote></p><p> The initiative, which has been passed by the House before with bipartisan support but never advanced to the Senate, is still a far cry from the wish list of legal reforms sought by the industry, which include all-out legalization and relief from tax burdens.</p><p><blockquote>该倡议此前已在两党支持下在众议院获得通过，但从未提交参议院，与该行业寻求的法律改革愿望清单（包括全面合法化和减轻税收负担）仍相去甚远。</blockquote></p><p> The U.S. Cannabis Council, a trade group, called the current rules that require marijuana firms to be all-cash a security hazard.</p><p><blockquote>贸易组织美国大麻委员会称，目前要求大麻公司全现金的规定存在安全隐患。</blockquote></p><p> “Over $17 billion in legal cannabis was sold in the United States last year, overwhelmingly through cash transactions. Forcing legitimate, well-regulated cannabis businesses to conduct most of their business in cash is anachronistic and a clear threat to public safety,” the council’s chief executive officer, Steven Hawkins, said in a statement before the bill passed.</p><p><blockquote>“去年，美国销售了超过170亿美元的合法大麻，其中绝大多数是通过现金交易。强迫合法、监管良好的大麻企业以现金开展大部分业务是不合时宜的，也是对公共安全的明显威胁，”该委员会首席执行官史蒂文·霍金斯在该法案通过前的一份声明中表示。</blockquote></p><p> “Every step forward is a positive one for the cannabis industry,”BTIGanalyst Camilo Lyon said in a research note Wednesday. He said it isn’t clear whether Senator Chuck Schumer will include the act in the Senate NDAA bill.</p><p><blockquote>BTIGA分析师卡米洛·里昂(Camilo Lyon)在周三的一份研究报告中表示：“每向前迈出一步对大麻行业来说都是积极的一步。”他说，尚不清楚参议员查克·舒默是否会将该法案纳入参议院国防授权法案。</blockquote></p><p> “Discussions with our D.C. contacts suggest it has an easier pathway of getting through the Senate, largely because no senator wants to be viewed as holding up the massive 1,700 page must-pass NDAA simply because of SAFE banking,” Lyon wrote.</p><p><blockquote>里昂写道：“与我们在华盛顿的联系人进行的讨论表明，它有一个更容易通过参议院的途径，很大程度上是因为没有参议员希望仅仅因为银行业安全而被视为搁置1700页的必须通过的国防授权法案。”</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRON":"Cronos Group Inc.","SNDL":"SNDL Inc.","ACB":"奥罗拉大麻公司","TLRY":"Tilray Inc.","OGI":"ORGANIGRAM HOLD","CGC":"Canopy Growth Corporation","MJ":"Amplify Alternative Harvest ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143307489","content_text":"Cannabis stocks jumped in Monday morning trading as U.S. House approved bill to ease banking for cannabis companies.Canopy Growth,Tilray, Aurora Cannabis, Cronos, Sundial Growers and OrganiGram climbed between 2% and 6%.\n\nThe U.S. House of Representatives late last Tuesday night approved a bill that would let banks to do business with cannabis companies without fear of penalty, giving traction to the least-disputed reform sought by the growing industry.\nThe so-called SAFE Banking Act, which is the least disputed reform sought by the growing industry, got picked up as part of broader legislation, and its inclusion in the National Defense Authorization Act was approved by voice vote late Tuesday. It remains to be seen whether the bill will pass the Senate, but the House action gives it a better shot.\nThe act would be a boon for marijuana companies, which have so far been stymied by the need to deal in cash because of federal restrictions. That has meant they have extra security costs and logistical problems, even as marijuana increasingly becomes legal. Some three dozen states now allow medical or recreational use, according to New Frontier Data, a cannabis research firm.\n\nRepresentative Ed Perlmutter, a Colorado Democrat, who had re-introduced the bill,has said that allowing cannabis businesses to access the banking system would bring more money into the economy and offer the opportunity to create good-paying jobs. The American cannabis industry had $20.3 billion in legal sales in 2020, according New Frontier Data.\nThe initiative, which has been passed by the House before with bipartisan support but never advanced to the Senate, is still a far cry from the wish list of legal reforms sought by the industry, which include all-out legalization and relief from tax burdens.\nThe U.S. Cannabis Council, a trade group, called the current rules that require marijuana firms to be all-cash a security hazard.\n“Over $17 billion in legal cannabis was sold in the United States last year, overwhelmingly through cash transactions. Forcing legitimate, well-regulated cannabis businesses to conduct most of their business in cash is anachronistic and a clear threat to public safety,” the council’s chief executive officer, Steven Hawkins, said in a statement before the bill passed.\n“Every step forward is a positive one for the cannabis industry,”BTIGanalyst Camilo Lyon said in a research note Wednesday. He said it isn’t clear whether Senator Chuck Schumer will include the act in the Senate NDAA bill.\n“Discussions with our D.C. contacts suggest it has an easier pathway of getting through the Senate, largely because no senator wants to be viewed as holding up the massive 1,700 page must-pass NDAA simply because of SAFE banking,” Lyon wrote.","news_type":1,"symbols_score_info":{"OGI":0.9,"SNDL":0.9,"MJ":0.9,"CRON":0.9,"ACB":0.9,"TLRY":0.9,"CGC":0.9}},"isVote":1,"tweetType":1,"viewCount":779,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":196212133,"gmtCreate":1621056356122,"gmtModify":1634194222243,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Pls like &amp; comment","listText":"Pls like &amp; comment","text":"Pls like & comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/196212133","repostId":"1163454382","repostType":4,"repost":{"id":"1163454382","kind":"news","pubTimestamp":1621004581,"share":"https://www.laohu8.com/m/news/1163454382?lang=zh_CN&edition=full","pubTime":"2021-05-14 23:03","market":"us","language":"en","title":"Why AMC Entertainment Stock Jumped Again Friday<blockquote>为什么AMC院线股价周五再次上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1163454382","media":"Motley Fool","summary":"AMC investors have reason for more optimism on the heels of another capital raise.Yesterday's jump came after the company announcedit raised $428 million. First, the Centers for Disease Control and Prevention  issued a new statement on current health and safety protocols saying that fully vaccinated people can resume activities without wearing a mask or physically distancing, including indoors.This should allow theaters to open back up at full capacity and be a desirable destination for vaccinat","content":"<p>  <b>AMC investors have reason for more optimism on the heels of another capital raise.</b>  <b>What happened</b></p><p><blockquote><b>在再次融资后，AMC投资者有理由更加乐观。</b><b>发生了什么</b></blockquote></p><p> A day after<b>AMC Entertainment Holdings</b>(NYSE:AMC)</p><p><blockquote>一天后<b>AMC院线控股</b>（纽约证券交易所代码：AMC）</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Yesterday's jump came after the company announcedit raised $428 million</p><p><blockquote>昨天的股价上涨是在该公司宣布筹集4.28亿美元后发生的</blockquote></p><p> First, the Centers for Disease Control and Prevention (CDC) issued a new statement on current health and safety protocols saying that fully vaccinated people can resume activities without wearing a mask or physically distancing, including indoors.</p><p><blockquote>首先，美国疾病控制和预防中心（CDC）发布了一份关于当前健康和安全协议的新声明，称完全接种疫苗的人可以在不戴口罩或保持身体距离的情况下恢复活动，包括在室内。</blockquote></p><p> This should allow theaters to open back up at full capacity and be a desirable destination for vaccinated movie patrons. Also yesterday,<b>Walt Disney</b>(NYSE:DIS)announced its quarterly earnings report, and CEO Bob Chapek noted \"increased production at our studios.\" While that is a positive for theater operators, Disney also reported disappointing subscriber growth in itsstreaming services.</p><p><blockquote>这将使电影院能够满负荷开放，并成为接种疫苗的电影顾客的理想目的地。同样在昨天，<b>迪斯尼</b>（纽约证券交易所股票代码：DIS）宣布了季度收益报告，首席执行官鲍勃·查佩克指出“我们工作室的产量有所增加”。虽然这对影院运营商来说是积极的，但迪士尼也报告称其流媒体服务的用户增长令人失望。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> Lower streaming subscriptions could be a positive sign for the theater business. As vaccinations continue to roll out, and with the CDC now officially giving its approval to gather indoors with crowds and without masks, theater attendance may resume quickly.</p><p><blockquote>流媒体订阅量的下降对影院业务来说可能是一个积极的信号。随着疫苗接种的继续推广，以及疾病预防控制中心现在正式批准在不戴口罩的情况下与人群聚集在室内，剧院的上座率可能会很快恢复。</blockquote></p><p> Vaccinations are going to drive people back to activities outside the home. Movie theaters are likely to be a favorite destination after more than a year of mostly watching at home. On the heels of another capital raise, AMC investors may be thinking this company finally has a promising path ahead.</p><p><blockquote>疫苗接种将促使人们回到户外活动。在一年多的时间里，电影院可能会成为人们最喜欢的目的地。在另一次融资之后，AMC投资者可能认为这家公司终于有了一条充满希望的未来之路。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why AMC Entertainment Stock Jumped Again Friday<blockquote>为什么AMC院线股价周五再次上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy AMC Entertainment Stock Jumped Again Friday<blockquote>为什么AMC院线股价周五再次上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-05-14 23:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p>  <b>AMC investors have reason for more optimism on the heels of another capital raise.</b>  <b>What happened</b></p><p><blockquote><b>在再次融资后，AMC投资者有理由更加乐观。</b><b>发生了什么</b></blockquote></p><p> A day after<b>AMC Entertainment Holdings</b>(NYSE:AMC)</p><p><blockquote>一天后<b>AMC院线控股</b>（纽约证券交易所代码：AMC）</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Yesterday's jump came after the company announcedit raised $428 million</p><p><blockquote>昨天的股价上涨是在该公司宣布筹集4.28亿美元后发生的</blockquote></p><p> First, the Centers for Disease Control and Prevention (CDC) issued a new statement on current health and safety protocols saying that fully vaccinated people can resume activities without wearing a mask or physically distancing, including indoors.</p><p><blockquote>首先，美国疾病控制和预防中心（CDC）发布了一份关于当前健康和安全协议的新声明，称完全接种疫苗的人可以在不戴口罩或保持身体距离的情况下恢复活动，包括在室内。</blockquote></p><p> This should allow theaters to open back up at full capacity and be a desirable destination for vaccinated movie patrons. Also yesterday,<b>Walt Disney</b>(NYSE:DIS)announced its quarterly earnings report, and CEO Bob Chapek noted \"increased production at our studios.\" While that is a positive for theater operators, Disney also reported disappointing subscriber growth in itsstreaming services.</p><p><blockquote>这将使电影院能够满负荷开放，并成为接种疫苗的电影顾客的理想目的地。同样在昨天，<b>迪斯尼</b>（纽约证券交易所股票代码：DIS）宣布了季度收益报告，首席执行官鲍勃·查佩克指出“我们工作室的产量有所增加”。虽然这对影院运营商来说是积极的，但迪士尼也报告称其流媒体服务的用户增长令人失望。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> Lower streaming subscriptions could be a positive sign for the theater business. As vaccinations continue to roll out, and with the CDC now officially giving its approval to gather indoors with crowds and without masks, theater attendance may resume quickly.</p><p><blockquote>流媒体订阅量的下降对影院业务来说可能是一个积极的信号。随着疫苗接种的继续推广，以及疾病预防控制中心现在正式批准在不戴口罩的情况下与人群聚集在室内，剧院的上座率可能会很快恢复。</blockquote></p><p> Vaccinations are going to drive people back to activities outside the home. Movie theaters are likely to be a favorite destination after more than a year of mostly watching at home. On the heels of another capital raise, AMC investors may be thinking this company finally has a promising path ahead.</p><p><blockquote>疫苗接种将促使人们回到户外活动。在一年多的时间里，电影院可能会成为人们最喜欢的目的地。在另一次融资之后，AMC投资者可能认为这家公司终于有了一条充满希望的未来之路。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/05/14/why-amc-entertainment-stock-jumped-again-friday/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2021/05/14/why-amc-entertainment-stock-jumped-again-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163454382","content_text":"AMC investors have reason for more optimism on the heels of another capital raise.\n\nWhat happened\nA day afterAMC Entertainment Holdings(NYSE:AMC)\nSo what\nYesterday's jump came after the company announcedit raised $428 million\nFirst, the Centers for Disease Control and Prevention (CDC) issued a new statement on current health and safety protocols saying that fully vaccinated people can resume activities without wearing a mask or physically distancing, including indoors.\nThis should allow theaters to open back up at full capacity and be a desirable destination for vaccinated movie patrons. Also yesterday,Walt Disney(NYSE:DIS)announced its quarterly earnings report, and CEO Bob Chapek noted \"increased production at our studios.\" While that is a positive for theater operators, Disney also reported disappointing subscriber growth in itsstreaming services.\nNow what\nLower streaming subscriptions could be a positive sign for the theater business. As vaccinations continue to roll out, and with the CDC now officially giving its approval to gather indoors with crowds and without masks, theater attendance may resume quickly.\nVaccinations are going to drive people back to activities outside the home. Movie theaters are likely to be a favorite destination after more than a year of mostly watching at home. On the heels of another capital raise, AMC investors may be thinking this company finally has a promising path ahead.","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":413,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180001149,"gmtCreate":1623162897981,"gmtModify":1634036264623,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Pls comment. Thank you&nbsp;","listText":"Pls comment. Thank you&nbsp;","text":"Pls comment. Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/180001149","repostId":"1136550999","repostType":4,"isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":196212297,"gmtCreate":1621056370919,"gmtModify":1634194221904,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"htmlText":"Pls like &amp; comment","listText":"Pls like &amp; comment","text":"Pls like & comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/196212297","repostId":"1174509827","repostType":4,"repost":{"id":"1174509827","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1621004388,"share":"https://www.laohu8.com/m/news/1174509827?lang=zh_CN&edition=full","pubTime":"2021-05-14 22:59","market":"us","language":"en","title":"Delta Mandates All New Employees Must Have COVID-19 Vaccinations<blockquote>达美航空要求所有新员工必须接种COVID-19疫苗</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1174509827","media":"Benzinga","summary":"Delta Air Lines, Inc. DAL 4.24% has announced a new corporate mandate requiring all future employees to be vaccinated against COVID-19 before joining the company.What Happened: The Atlanta-headquartered carrier issued a statement praising the vaccines for protecting individuals and speeding the end of the pandemic, adding that the new mandate will ensure its employees will not face a reprise of the health crisis.“Delta people have made great progress to achieve herd immunity within our workforce","content":"<p><b>Delta Air Lines, Inc.</b>&nbsp;DAL 4.24%&nbsp;has announced a new corporate mandate requiring all future employees to be vaccinated against COVID-19 before joining the company.</p><p><blockquote><b>达美航空公司。</b>DAL 4.24%宣布了一项新的公司规定，要求所有未来的员工在加入公司之前接种新冠肺炎疫苗。</blockquote></p><p> <b>What Happened:</b>&nbsp;The Atlanta-headquartered carrier issued a statement praising the vaccines for protecting individuals and speeding the end of the pandemic, adding that&nbsp;the new mandate will ensure its employees will not face a reprise of the health crisis.</p><p><blockquote><b>发生了什么：</b>这家总部位于亚特兰大的航空公司发表声明，赞扬疫苗保护个人并加速疫情的结束，并补充说新的授权将确保其员工不会面临健康危机的重演。</blockquote></p><p> “Delta people have made great progress to achieve herd immunity within our workforce, so to help us maintain that trajectory, we will be requiring all new hires in the U.S. to be vaccinated against COVID-19 unless they qualify for an accommodation,” said Elizabeth Ninomiya, manager of strategic communications. “This is an important move to protect our workforce and our customers as our business recovers and demand for air travel continues to rise.”</p><p><blockquote>“达美航空员工在实现员工群体免疫方面取得了巨大进展，因此为了帮助我们维持这一轨迹，我们将要求美国所有新员工接种COVID-19疫苗，除非他们有资格获得住宿，”战略传播经理伊丽莎白·二宫(Elizabeth Ninomiya)说道。“随着我们业务的复苏和航空旅行需求的持续增长，这是保护我们员工和客户的重要举措。”</blockquote></p><p> Speaking on&nbsp;CNN, Delta CEO Ed Bastian clarified this mandate won't apply to current employees.</p><p><blockquote>达美航空首席执行官埃德·巴斯蒂安(Ed Bastian)在接受美国有线电视新闻网(CNN)采访时澄清，这一规定不适用于现有员工。</blockquote></p><p> “I am not going to mandate and force people if they have some specific reason why they don’t want to get vaccinated,” he said. “I am going to strongly encourage them that they understand the risks of not getting vaccinated.”</p><p><blockquote>他说：“如果人们有一些具体原因不想接种疫苗，我不会强制他们。”“我将强烈鼓励他们了解不接种疫苗的风险。”</blockquote></p><p> However, he noted&nbsp;employees who are not vaccinated may be excluded from certain assignments, including international flights. He added that 60% of Delta’s workforce has at least one vaccine shot.</p><p><blockquote>然而，他指出，未接种疫苗的员工可能会被排除在某些任务之外，包括国际航班。他补充说，达美航空60%的员工至少接种过一次疫苗。</blockquote></p><p> <i>Related Link:CDC Says Fully Vaccinated People Can Mostly Stop Wearing Masks</i></p><p><blockquote><i>相关链接：CDC称完全接种疫苗的人大多可以停止戴口罩</i></blockquote></p><p> <b>Why It Matters:</b>&nbsp;Delta is the first U.S. carrier to announce it will only hire vaccinated individuals.The New York Timesreported&nbsp;<b>United Airlines Holdings&nbsp;Inc.</b>UAL 4.73%CEO Scott Kirby voiced his support for the idea in a video forum in January, but decided not to go forward because the carrier could not “realistically be the only company” to take this action.</p><p><blockquote><b>为什么重要：</b>达美航空是第一家宣布只雇佣接种疫苗的个人的美国航空公司。《纽约时报》报道<b>联合航空控股公司。</b>UAL 4.73%首席执行官斯科特·柯比(Scott Kirby)在1月份的一个视频论坛上表示支持这一想法，但决定不继续推进，因为该运营商不可能“实际上是唯一一家”采取这一行动。</blockquote></p><p> Although most schools in the U.S. require children to have certain vaccinations, there is no precedent for companies refusing to hire people based on their vaccination status.</p><p><blockquote>尽管美国大多数学校要求儿童接种一定的疫苗，但没有公司根据疫苗接种情况拒绝雇用人员的先例。</blockquote></p><p> Current&nbsp;federal policy on employer-mandated vaccinations is focused on the rights of current employees, not potential hires.</p><p><blockquote>目前关于雇主强制接种疫苗的联邦政策侧重于当前员工的权利，而不是潜在雇员的权利。</blockquote></p><p> The Equal Employment Opportunity Commission (EEOC) issued&nbsp;guidancelast December stating companies “may encourage or possibly require COVID-19 vaccinations” of its workforce, provided their policies are in compliance with workplace laws including the Americans with Disabilities Act and Title VII of the Civil Rights Act of 1964 (Title VII).</p><p><blockquote>平等就业机会委员会（EEOC）去年12月发布了指南，指出公司“可以鼓励或可能要求”其员工接种新冠肺炎疫苗，前提是他们的政策符合工作场所法律，包括《美国残疾人法案》和1964年民权法案第七章（第七章）。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Delta Mandates All New Employees Must Have COVID-19 Vaccinations<blockquote>达美航空要求所有新员工必须接种COVID-19疫苗</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDelta Mandates All New Employees Must Have COVID-19 Vaccinations<blockquote>达美航空要求所有新员工必须接种COVID-19疫苗</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-05-14 22:59</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><b>Delta Air Lines, Inc.</b>&nbsp;DAL 4.24%&nbsp;has announced a new corporate mandate requiring all future employees to be vaccinated against COVID-19 before joining the company.</p><p><blockquote><b>达美航空公司。</b>DAL 4.24%宣布了一项新的公司规定，要求所有未来的员工在加入公司之前接种新冠肺炎疫苗。</blockquote></p><p> <b>What Happened:</b>&nbsp;The Atlanta-headquartered carrier issued a statement praising the vaccines for protecting individuals and speeding the end of the pandemic, adding that&nbsp;the new mandate will ensure its employees will not face a reprise of the health crisis.</p><p><blockquote><b>发生了什么：</b>这家总部位于亚特兰大的航空公司发表声明，赞扬疫苗保护个人并加速疫情的结束，并补充说新的授权将确保其员工不会面临健康危机的重演。</blockquote></p><p> “Delta people have made great progress to achieve herd immunity within our workforce, so to help us maintain that trajectory, we will be requiring all new hires in the U.S. to be vaccinated against COVID-19 unless they qualify for an accommodation,” said Elizabeth Ninomiya, manager of strategic communications. “This is an important move to protect our workforce and our customers as our business recovers and demand for air travel continues to rise.”</p><p><blockquote>“达美航空员工在实现员工群体免疫方面取得了巨大进展，因此为了帮助我们维持这一轨迹，我们将要求美国所有新员工接种COVID-19疫苗，除非他们有资格获得住宿，”战略传播经理伊丽莎白·二宫(Elizabeth Ninomiya)说道。“随着我们业务的复苏和航空旅行需求的持续增长，这是保护我们员工和客户的重要举措。”</blockquote></p><p> Speaking on&nbsp;CNN, Delta CEO Ed Bastian clarified this mandate won't apply to current employees.</p><p><blockquote>达美航空首席执行官埃德·巴斯蒂安(Ed Bastian)在接受美国有线电视新闻网(CNN)采访时澄清，这一规定不适用于现有员工。</blockquote></p><p> “I am not going to mandate and force people if they have some specific reason why they don’t want to get vaccinated,” he said. “I am going to strongly encourage them that they understand the risks of not getting vaccinated.”</p><p><blockquote>他说：“如果人们有一些具体原因不想接种疫苗，我不会强制他们。”“我将强烈鼓励他们了解不接种疫苗的风险。”</blockquote></p><p> However, he noted&nbsp;employees who are not vaccinated may be excluded from certain assignments, including international flights. He added that 60% of Delta’s workforce has at least one vaccine shot.</p><p><blockquote>然而，他指出，未接种疫苗的员工可能会被排除在某些任务之外，包括国际航班。他补充说，达美航空60%的员工至少接种过一次疫苗。</blockquote></p><p> <i>Related Link:CDC Says Fully Vaccinated People Can Mostly Stop Wearing Masks</i></p><p><blockquote><i>相关链接：CDC称完全接种疫苗的人大多可以停止戴口罩</i></blockquote></p><p> <b>Why It Matters:</b>&nbsp;Delta is the first U.S. carrier to announce it will only hire vaccinated individuals.The New York Timesreported&nbsp;<b>United Airlines Holdings&nbsp;Inc.</b>UAL 4.73%CEO Scott Kirby voiced his support for the idea in a video forum in January, but decided not to go forward because the carrier could not “realistically be the only company” to take this action.</p><p><blockquote><b>为什么重要：</b>达美航空是第一家宣布只雇佣接种疫苗的个人的美国航空公司。《纽约时报》报道<b>联合航空控股公司。</b>UAL 4.73%首席执行官斯科特·柯比(Scott Kirby)在1月份的一个视频论坛上表示支持这一想法，但决定不继续推进，因为该运营商不可能“实际上是唯一一家”采取这一行动。</blockquote></p><p> Although most schools in the U.S. require children to have certain vaccinations, there is no precedent for companies refusing to hire people based on their vaccination status.</p><p><blockquote>尽管美国大多数学校要求儿童接种一定的疫苗，但没有公司根据疫苗接种情况拒绝雇用人员的先例。</blockquote></p><p> Current&nbsp;federal policy on employer-mandated vaccinations is focused on the rights of current employees, not potential hires.</p><p><blockquote>目前关于雇主强制接种疫苗的联邦政策侧重于当前员工的权利，而不是潜在雇员的权利。</blockquote></p><p> The Equal Employment Opportunity Commission (EEOC) issued&nbsp;guidancelast December stating companies “may encourage or possibly require COVID-19 vaccinations” of its workforce, provided their policies are in compliance with workplace laws including the Americans with Disabilities Act and Title VII of the Civil Rights Act of 1964 (Title VII).</p><p><blockquote>平等就业机会委员会（EEOC）去年12月发布了指南，指出公司“可以鼓励或可能要求”其员工接种新冠肺炎疫苗，前提是他们的政策符合工作场所法律，包括《美国残疾人法案》和1964年民权法案第七章（第七章）。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DAL":"达美航空"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174509827","content_text":"Delta Air Lines, Inc. DAL 4.24% has announced a new corporate mandate requiring all future employees to be vaccinated against COVID-19 before joining the company.\nWhat Happened: The Atlanta-headquartered carrier issued a statement praising the vaccines for protecting individuals and speeding the end of the pandemic, adding that the new mandate will ensure its employees will not face a reprise of the health crisis.\n“Delta people have made great progress to achieve herd immunity within our workforce, so to help us maintain that trajectory, we will be requiring all new hires in the U.S. to be vaccinated against COVID-19 unless they qualify for an accommodation,” said Elizabeth Ninomiya, manager of strategic communications. “This is an important move to protect our workforce and our customers as our business recovers and demand for air travel continues to rise.”\nSpeaking on CNN, Delta CEO Ed Bastian clarified this mandate won't apply to current employees.\n“I am not going to mandate and force people if they have some specific reason why they don’t want to get vaccinated,” he said. “I am going to strongly encourage them that they understand the risks of not getting vaccinated.”\nHowever, he noted employees who are not vaccinated may be excluded from certain assignments, including international flights. He added that 60% of Delta’s workforce has at least one vaccine shot.\nRelated Link:CDC Says Fully Vaccinated People Can Mostly Stop Wearing Masks\nWhy It Matters: Delta is the first U.S. carrier to announce it will only hire vaccinated individuals.The New York Timesreported United Airlines Holdings Inc.UAL 4.73%CEO Scott Kirby voiced his support for the idea in a video forum in January, but decided not to go forward because the carrier could not “realistically be the only company” to take this action.\nAlthough most schools in the U.S. require children to have certain vaccinations, there is no precedent for companies refusing to hire people based on their vaccination status.\nCurrent federal policy on employer-mandated vaccinations is focused on the rights of current employees, not potential hires.\nThe Equal Employment Opportunity Commission (EEOC) issued guidancelast December stating companies “may encourage or possibly require COVID-19 vaccinations” of its workforce, provided their policies are in compliance with workplace laws including the Americans with Disabilities Act and Title VII of the Civil Rights Act of 1964 (Title VII).","news_type":1,"symbols_score_info":{"DAL":0.9}},"isVote":1,"tweetType":1,"viewCount":693,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}